[From nobody Sat Aug 4 08:16:43 2007 From: "Saved by Windows Internet Explorer 7" Subject: Revising a Dogma: Ketamine for Patients with Neurological Injury? -- Himmelseher and Durieux 101 (2): 524 -- Anesthesia & Analgesia Date: Fri, 3 Aug 2007 20:28:04 -0700 MIME-Version: 1.0 Content-Type: multipart/related; type="text/html"; boundary="----=_NextPart_000_0000_01C7D60C.CBB8DC70" X-MimeOLE: Produced By Microsoft MimeOLE V6.0.6000.16480 This is a multi-part message in MIME format. ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable Content-Location: http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <HTML><HEAD><TITLE>Revising a Dogma: Ketamine for Patients with = Neurological Injury? -- Himmelseher and Durieux 101 (2): 524 -- = Anesthesia & Analgesia</TITLE> <META http-equiv=3DContent-Type content=3D"text/html; = charset=3Dwindows-1252"> <SCRIPT language=3DJavaScript>=0A= <!--=0A= function startTarget(windowname,wid,hei) {=0A= =0A= var dotpos =3D windowname.indexOf(".");=0A= if (dotpos > -1)=0A= {=0A= var tempwn =3D windowname.substring(0,dotpos) +=0A= windowname.substring(dotpos + 1, windowname.length);=0A= windowname =3D tempwn;=0A= }=0A= var sizestring =3D 'width=3D' + wid + ',height=3D' + hei;=0A= window.open('',windowname,'scrollbars,resizable,' + sizestring + = '\'');=0A= }=0A= // -->=0A= </SCRIPT> <!-- has inhead tag --> <SCRIPT language=3DJavaScript>=0A= <!--=0A= if ( top !=3D self )=0A= {=0A= top.location.href =3D unescape(window.location.pathname);=0A= }=0A= //-->=0A= </SCRIPT> <STYLE type=3Dtext/css>TABLE.content_box_outer_table { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; PADDING-BOTTOM: 5px; = PADDING-TOP: 0px } TABLE.content_box_outer_table_in_sidebar_frame { PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; = PADDING-TOP: 10px } TABLE.content_box_inner_table { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 65%; PADDING-BOTTOM: = 5px; PADDING-TOP: 0px; FONT-FAMILY: Verdana,Arial,Helvetica,sans-serif; = BACKGROUND-COLOR: #f0f0f0 } TABLE.content_box_pdfinframes { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 4px; = PADDING-TOP: 0px } TD.content_box_title_highlight { PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 1px; VERTICAL-ALIGN: middle; COLOR: #ffffff; = PADDING-TOP: 1px; FONT-STYLE: italic; FONT-FAMILY: "Trebuchet = MS",Verdana,Arial,Helvetica,sans-serif; BACKGROUND-COLOR: #ccaa33; = TEXT-ALIGN: center } TD.content_box_title { PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 1px; VERTICAL-ALIGN: middle; COLOR: #ffffff; = PADDING-TOP: 1px; FONT-STYLE: italic; FONT-FAMILY: "Trebuchet = MS",Verdana,Arial,Helvetica,sans-serif; BACKGROUND-COLOR: #828282; = TEXT-ALIGN: center } TD.content_box_space_between_sections { PADDING-TOP: 2px } TD.content_box_arrow { PADDING-RIGHT: 0px; PADDING-LEFT: 5px; PADDING-BOTTOM: 3px; = PADDING-TOP: 0px; TEXT-ALIGN: right } TD.content_box_item { PADDING-RIGHT: 5px; PADDING-LEFT: 3px; PADDING-BOTTOM: 3px; = VERTICAL-ALIGN: top; PADDING-TOP: 0px; TEXT-ALIGN: left } TD.content_box_pdfinframes_citation_cell { BORDER-RIGHT: #000000 1px solid; PADDING-RIGHT: 3px; BORDER-TOP: = #000000 1px solid; PADDING-LEFT: 3px; FONT-SIZE: 65%; PADDING-BOTTOM: = 3px; BORDER-LEFT: #000000 1px solid; PADDING-TOP: 3px; BORDER-BOTTOM: = #000000 1px solid; FONT-FAMILY: Verdana,Arial,Helvetica,sans-serif; = BACKGROUND-COLOR: #ffffff; TEXT-ALIGN: left } FONT.openaccess { PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-WEIGHT: bold; = BACKGROUND-COLOR: #ffffff } FONT.openaccess_open { COLOR: #000000 } FONT.openaccess_access { COLOR: #cc0000 } FONT.openaccess_oa { =09 } .content_box_openaccess_title { WHITE-SPACE: nowrap; BACKGROUND-COLOR: #bababa; TEXT-ALIGN: center } DIV.referrer-based-search-line { PADDING-RIGHT: 25px; PADDING-LEFT: 25px; FONT-SIZE: 0.75em; = PADDING-BOTTOM: 3px; MARGIN: 0px 4px 5px 0px; PADDING-TOP: 3px; = FONT-FAMILY: arial,sans-serif; BACKGROUND-COLOR: #009918 } DIV.referrer-based-search-line .search-terms { FONT-WEIGHT: bold } DIV.referrer-based-search-line .collection-name { FONT-STYLE: italic } @media Print, Screen, Handheld =20 { .notonscreen { DISPLAY: none } } </STYLE> <SCRIPT language=3Djavascript>=0A= <!-- =0A= function popwin(url,wid,hei,fromtop,fromleft) {=0A= var winPref =3D = "channelmode=3Dno,toolbar=3Dno,location=3Dno,directories=3Dno,status=3Dno= ,menubar=3Dno,scrollbars=3Dauto,resizable=3Dno,width=3D" + wid + = ",height=3D" + hei + ",top=3D" + fromtop + ",left=3D" + fromleft;=0A= window.open(url, "popwin", winPref);=0A= }=0A= // -->=0A= </SCRIPT> <SCRIPT=20 src=3D"http://www.anesthesia-analgesia.org/javascript/ajax/xmlhttprequest= .js"=20 type=3Dtext/javascript></SCRIPT> <SCRIPT = src=3D"http://www.anesthesia-analgesia.org/javascript/ajax/utility.js"=20 type=3Dtext/javascript></SCRIPT> <SCRIPT = src=3D"http://www.anesthesia-analgesia.org/javascript/entrez/callback.js"= =20 type=3Dtext/javascript></SCRIPT> <META content=3Dnofollow name=3Drobots> <META content=3D"Anesthesia &amp; Analgesia" = name=3Dcitation_journal_title> <META content=3D"Himmelseher, Sabine; Durieux, Marcel E." = name=3Dcitation_authors> <META=20 content=3D"Revising a Dogma: Ketamine for Patients with Neurological = Injury?"=20 name=3Dcitation_title> <META content=3D08/01/2005 name=3Dcitation_date> <META content=3D101 name=3Dcitation_volume> <META content=3D2 name=3Dcitation_issue> <META content=3D524 name=3Dcitation_firstpage> <META content=3D10.1213/01.ANE.0000160585.43587.5B name=3Dcitation_doi> <META = content=3Dhttp://www.anesthesia-analgesia.org/cgi/reprint/101/2/524.pdf=20 name=3Dcitation_pdf_url> <META = content=3Dhttp://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/= 524=20 name=3Dcitation_abstract_html_url> <META = content=3Dhttp://www.anesthesia-analgesia.org/cgi/content/full/101/2/524 = name=3Dcitation_fulltext_html_url> <META content=3D16037171 name=3Dcitation_pmid> <META content=3D"Himmelseher, Sabine" name=3Ddc.Contributor> <META content=3D"Durieux, Marcel E." name=3Ddc.Contributor> <META=20 content=3D"Revising a Dogma: Ketamine for Patients with Neurological = Injury?"=20 name=3Ddc.Title> <META content=3D10.1213/01.ANE.0000160585.43587.5B name=3Ddc.Identifier> <META content=3D08/01/2005 name=3Ddc.Date> <META content=3DIARS name=3Dcitation_publisher> <META content=3DNOARCHIVE name=3DROBOTS> <META content=3D"MSHTML 6.00.6000.16481" name=3DGENERATOR></HEAD> <BODY bgColor=3D#ffffff><A name=3Dtop><!-- null --></A><!-- styles for = use with header and footer --> <STYLE type=3Dtext/css>.headerfont { BACKGROUND-POSITION: center 50%; FONT-WEIGHT: bold; FONT-SIZE: 10px; = VERTICAL-ALIGN: middle; WIDTH: auto; COLOR: #000000; FONT-STYLE: normal; = FONT-FAMILY: verdana,arial,helvetica; HEIGHT: auto; BACKGROUND-COLOR: = #ccaa33; TEXT-DECORATION: none } .footerfont { FONT-WEIGHT: bold; FONT-SIZE: 10px; COLOR: #ffffff; FONT-STYLE: normal; = FONT-FAMILY: Arial, Helvetica, sans-serif } .boxheader { FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #000000; FONT-STYLE: normal; = FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; TEXT-DECORATION: = none } .browsefont { BORDER-RIGHT: #ffffff thin; BACKGROUND-POSITION: center center; = BORDER-TOP: #ffffff thin; FONT-WEIGHT: bold; FONT-SIZE: 11px; = BORDER-LEFT: #ffffff thin; WIDTH: auto; COLOR: #000000; BORDER-BOTTOM: = #ffffff thin; FONT-STYLE: normal; FONT-FAMILY: Arial, Helvetica, = sans-serif; HEIGHT: auto; TEXT-DECORATION: none } .searchtext { FONT-WEIGHT: bold; FONT-SIZE: 9px; COLOR: #000000; FONT-STYLE: normal; = FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif } .searchboxauthor { FONT-SIZE: 10px; WIDTH: 55px; COLOR: #000000; FONT-STYLE: normal; = FONT-FAMILY: verdana,arial,helvetica } .searchboxkeyword { FONT-SIZE: 10px; WIDTH: 98px; COLOR: #000000; FONT-STYLE: normal; = FONT-FAMILY: verdana,arial,helvetica } .searchboxyvp { FONT-SIZE: 10px; WIDTH: 30px; COLOR: #000000; FONT-STYLE: normal; = FONT-FAMILY: verdana,arial,helvetica } .searchbutton { FONT-WEIGHT: bold; FONT-SIZE: 10px; BACKGROUND: #ccaa33; COLOR: = #ffffff; FONT-STYLE: normal; FONT-FAMILY: verdana,arial,helvetica; = TEXT-DECORATION: none } .articles { FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #000000; FONT-STYLE: normal; = FONT-FAMILY: "Arial Narrow", "Helvetica Narrow", Arial, Helvetica, sans-=0A= serif; TEXT-DECORATION: none } .IARSbannerfont { FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: #000066; FONT-STYLE: normal; = FONT-FAMILY: Arial, Helvetica, sans-serif } .construction { FONT-WEIGHT: bold; FONT-SIZE: 36px; WIDTH: auto; COLOR: #ccaa33; = BORDER-TOP-STYLE: ridge; FONT-STYLE: normal; FONT-FAMILY: Arial, = Helvetica, sans-serif; BORDER-RIGHT-STYLE: ridge; BORDER-LEFT-STYLE: = ridge; HEIGHT: auto; BORDER-BOTTOM-STYLE: ridge } </STYLE> <TABLE cellSpacing=3D0 cellPadding=3D0 border=3D0> <TBODY> <TR> <TD vAlign=3Dbottom noWrap width=3D"100%" colSpan=3D3> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" = bgColor=3D#ccaa33=20 border=3D1><TBODY> <TR> <TD align=3Dmiddle width=3D102><A class=3Dheaderfont=20 href=3D"http://www.anesthesia-analgesia.org/" = target=3D_top>JOURNAL=20 HOME</A> </TD> <TD align=3Dmiddle width=3D102><A class=3Dheaderfont=20 href=3D"http://cme.anesthesia-analgesia.org/" = target=3D_top>CME HOME</A>=20 </TD> <TD align=3Dmiddle width=3D95><A class=3Dheaderfont=20 href=3D"http://www.anesthesia-analgesia.org/current.shtml"=20 target=3D_top>THIS MONTH</A> </TD> <TD align=3Dmiddle width=3D115><A class=3Dheaderfont=20 = href=3D"http://www.anesthesia-analgesia.org/contents-by-date.0.shtml"=20 target=3D_top>PAST ISSUES</A> </TD> <TD align=3Dmiddle width=3D95><A class=3Dheaderfont=20 = href=3D"http://www.anesthesia-analgesia.org/subscriptions/etoc.shtml"=20 target=3D_top>ETOC</A> </TD> <TD align=3Dmiddle width=3D74><A class=3Dheaderfont=20 = href=3D"http://www.anesthesia-analgesia.org/collections/index.shtml"=20 target=3D_top>COLLECTIONS</A> </TD></TR> <TR> <TD align=3Dmiddle width=3D102><A class=3Dheaderfont=20 = href=3D"http://www.anesthesia-analgesia.org/misc/authors.shtml"=20 target=3D_top>AUTHORS</A> </TD> <TD align=3Dmiddle width=3D139><A class=3Dheaderfont=20 = href=3D"http://www.anesthesia-analgesia.org/misc/reviewers.shtml"=20 target=3D_top>REVIEWERS</A> </TD> <TD align=3Dmiddle width=3D139><A class=3Dheaderfont=20 = href=3D"http://www.anesthesia-analgesia.org/misc/edboard.shtml"=20 target=3D_top>EDITORIAL BOARD</A> </TD> <TD align=3Dmiddle width=3D115><A class=3Dheaderfont=20 href=3D"http://www.anesthesia-analgesia.org/cgi/feedback"=20 target=3D_top>FEEDBACK</A> </TD> <TD align=3Dmiddle width=3D61><A class=3Dheaderfont=20 href=3D"http://www.anesthesia-analgesia.org/rss/" = target=3D_top>RSS</A>=20 </TD> <TD align=3Dmiddle width=3D74><A class=3Dheaderfont=20 href=3D"http://www.anesthesia-analgesia.org/help/"=20 target=3D_top>HELP</A> </TD></TR></TBODY></TABLE></TD></TR> <TR> <TD colSpan=3D3 height=3D5><IMG height=3D5 alt=3D" "=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD></TR> <TR> <TD vAlign=3Dcenter><A style=3D"TEXT-DECORATION: none"=20 href=3D"http://www.anesthesia-analgesia.org/" target=3D_top><IMG = alt=3DA&amp;A=20 src=3D"http://www.anesthesia-analgesia.org/misc/title220.gif" = border=3D0></A>=20 <A href=3D"http://www.iars.org/default/default.asp" = target=3D_top><IMG=20 alt=3D"International Anesthesia Research Society"=20 src=3D"http://www.anesthesia-analgesia.org/misc/IARS.gif" = width=3D60=20 border=3D0></A> <!--#echo var=3D"HTTP_AD_HTML_STRING_1"--></TD> <TD><IMG height=3D5 alt=3D" "=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD> <TD vAlign=3Dcenter align=3Dright> <TABLE cellSpacing=3D1 cellPadding=3D0 bgColor=3D#000000 = border=3D0> <TBODY> <TR> <FORM name=3Dsearch action=3D/cgi/search method=3Dget><INPUT = type=3Dhidden=20 value=3Dand name=3Dandorexactfulltext><INPUT type=3Dhidden = value=3D1=20 name=3Dresourcetype><INPUT type=3Dhidden = name=3Ddisp_type><INPUT type=3Dhidden=20 value=3Drelevance name=3Dsortspec> <TD vAlign=3Dcenter align=3Dmiddle> <TABLE cellSpacing=3D0 cellPadding=3D1 bgColor=3D#dbdbdb = border=3D0> <TBODY> <TR> <TD bgColor=3D#ccaa33><IMG height=3D2 alt=3D" "=20 = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D2></TD> <TD vAlign=3Dcenter noWrap = bgColor=3D#ccaa33><STRONG><FONT=20 face=3Dverdana,arial,helvetica,sans-serif = color=3D#ffffff=20 size=3D-2><EM>QUICK</EM> = SEARCH:&nbsp;</FONT></STRONG></TD> <TD vAlign=3Dcenter noWrap align=3Dright = bgColor=3D#ccaa33><A=20 style=3D"COLOR: #ffffff; TEXT-DECORATION: none"=20 = href=3D"http://www.anesthesia-analgesia.org/search.dtl"><FONT=20 face=3Dverdana,arial,helvetica color=3D#ffffff=20 size=3D-2>&nbsp;[advanced]</FONT></A></TD> <TD bgColor=3D#ccaa33><IMG height=3D2 alt=3D" "=20 = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D2></TD></TR> <TR> <TD bgColor=3D#dbdbdb><IMG height=3D2 alt=3D" "=20 = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D2></TD> <TD bgColor=3D#dbdbdb colSpan=3D2> <TABLE cellSpacing=3D0 cellPadding=3D0 border=3D0> <TBODY> <TR> <TD vAlign=3Dbottom align=3Dmiddle><INPUT = style=3D"FONT-WEIGHT: bold; FONT-SIZE: 10px; BACKGROUND: #ffffff; COLOR: = #000000; FONT-FAMILY: verdana,arial,helvetica; TEXT-DECORATION: none" = type=3Dsubmit value=3DGo></TD> <TH align=3Dleft colSpan=3D2><FONT=20 face=3Dverdana,arial,helvetica,sans-serif = color=3D#000000=20 size=3D-2><LABEL=20 = for=3Dqsintdefsauthor1>Author:</LABEL><BR></FONT><INPUT=20 id=3Dqsintdefsauthor1=20 style=3D"FONT-SIZE: 10px; FONT-FAMILY: = verdana,arial,helvetica"=20 maxLength=3D80 size=3D9 name=3Dauthor1></TH> <TH align=3Dleft colSpan=3D3><FONT=20 face=3Dverdana,arial,helvetica,sans-serif = color=3D#000000=20 size=3D-2><LABEL=20 = for=3Dqsintdefsfulltext>Keyword(s):</LABEL><BR></FONT><INPUT=20 id=3Dqsintdefsfulltext=20 style=3D"FONT-SIZE: 10px; FONT-FAMILY: = verdana,arial,helvetica"=20 maxLength=3D80 size=3D16 = name=3Dfulltext></TH></TR> <TR> <TH><FONT = face=3Dverdana,arial,helvetica,sans-serif=20 color=3D#000000 size=3D-2><LABEL=20 = for=3Dqsintdefspubdate_year>Year:</LABEL>&nbsp;</FONT></TH> <TD><INPUT id=3Dqsintdefspubdate_year=20 style=3D"FONT-SIZE: 10px; FONT-FAMILY: = verdana,arial,helvetica"=20 maxLength=3D4 size=3D4 name=3Dpubdate_year></TD> <TH align=3Dright><FONT=20 face=3Dverdana,arial,helvetica,sans-serif = color=3D#000000=20 size=3D-2><LABEL=20 = for=3Dqsintdefsvolume>Vol:</LABEL>&nbsp;</FONT></TH> <TD><INPUT id=3Dqsintdefsvolume=20 style=3D"FONT-SIZE: 10px; FONT-FAMILY: = verdana,arial,helvetica"=20 maxLength=3D10 size=3D4 name=3Dvolume></TD> <TH><FONT = face=3Dverdana,arial,helvetica,sans-serif=20 color=3D#000000 size=3D-2><LABEL=20 = for=3Dqsintdefsfirstpage>Page:</LABEL>&nbsp;</FONT></TH> <TD><INPUT id=3Dqsintdefsfirstpage=20 style=3D"FONT-SIZE: 10px; FONT-FAMILY: = verdana,arial,helvetica"=20 maxLength=3D10 size=3D4=20 name=3Dfirstpage></TD></TR></TBODY></TABLE></TD> <TD bgColor=3D#dbdbdb><IMG height=3D2 alt=3D" "=20 = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 = width=3D2></TD></TR></TBODY></TABLE></TD></FORM></TR></TBODY></TABLE></TD= ></TR> <TR> <TD colSpan=3D3><IMG height=3D2 alt=3D" "=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D2><BR><!-- subline logic: standard default --><!-- NOT GUEST --> <HR align=3Dleft color=3D#000000 noShade SIZE=3D1> </TD></TR></TBODY></TABLE> <TABLE class=3Dcontent_box_outer_table align=3Dright> <TBODY> <TR> <TD><!-- beginning of inner table --> <TABLE class=3Dcontent_box_inner_table><!-- citation --> <TBODY> <TR> <TD class=3Dcontent_box_title_highlight colSpan=3D2>This = Article</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/52= 4">Abstract</A></STRONG>=20 <IMG height=3D7 alt=3D"Freely available"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/toc/free.gif"=20 width=3D32 border=3D0> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/reprint/101/2/524"><STRON= G>Full=20 Text</STRONG> (PDF)</A> </STRONG></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/alerts/ctalert?alertType=3D= citedby&amp;addAlert=3Dcited_by&amp;saveAlert=3Dno&amp;cited_by_criteria_= resid=3Danesthanalg;101/2/524&amp;return_type=3Darticle&amp;return_url=3D= http%3A%2F%2Fwww.anesthesia-analgesia.org%2Fcgi%2Fcontent%2Ffull%2F101%2F= 2%2F524">Alert=20 me when this article is cited</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/alerts/ctalert?alertType=3D= correction&amp;addAlert=3Dcorrection&amp;saveAlert=3Dno&amp;correction_cr= iteria_value=3D101/2/524&amp;return_type=3Darticle&amp;return_url=3Dhttp%= 3A%2F%2Fwww.anesthesia-analgesia.org%2Fcgi%2Fcontent%2Ffull%2F101%2F2%2F5= 24">Alert=20 me if a correction is posted</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>Services</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/mailafriend?url=3Dhttp%3A= %2F%2Fwww.anesthesia-analgesia.org%2Fcgi%2Fcontent%2Ffull%2F101%2F2%2F524= &amp;title=3DRevising+a+Dogma%3A+Ketamine+for+Patients+with+Neurological+= Injury%3F">Email=20 this article to a colleague</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/search?qbe=3Danesthanalg;= 101/2/524&amp;journalcode=3Danesthanalg&amp;minscore=3D5000">Similar=20 articles in this journal</A> </STRONG></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= anesthanalg%3B101%2F2%2F524&amp;link_type=3DISI_RelatedRecords">Similar=20 articles in ISI Web of Science</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 16037171&amp;link_type=3DMED_NBRS">Similar=20 articles in PubMed</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/alerts/etoc">Alert me=20 to new issues of the journal</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/citmgr?gca=3Danesthanalg;= 101/2/524">Download=20 to citation manager</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#ot= herarticles">Cited=20 by other online articles</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG>Search for citing = articles in:=20 <BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= anesthanalg%3B101%2F2%2F524&amp;link_type=3DISI_Citing">ISI=20 Web of Science (7)</A> </STRONG></TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>Google = Scholar</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://scholar.google.com/scholar?q=3D%22author%3AS.+author%3AHim= melseher%22"=20 target=3D_blank>Articles by Himmelseher, S.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 href=3D"http://scholar.google.com/scholar?q=3D%22author%3AM. = E.+author%3ADurieux%22"=20 target=3D_blank>Articles by Durieux, M. E.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= http://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/524&amp;li= nk_type=3DGOOGLESCHOLAR"=20 target=3D_blank>Articles citing this Article</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= http://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/524&amp;li= nk_type=3DGOOGLESCHOLARRELATED"=20 target=3D_blank>Search for Related Content</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>PubMed</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 16037171&amp;link_type=3DPUBMED">PubMed=20 Citation</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= Himmelseher+S&amp;link_type=3DAUTHORSEARCH"=20 target=3D_blank>Articles by Himmelseher, S.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= Durieux+ME&amp;link_type=3DAUTHORSEARCH"=20 target=3D_blank>Articles by Durieux, M. E.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>Related = Collections</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/collection/neuroanesthesi= a">Neuroanesthesia</A></STRONG>=20 <BR></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/collection/pharmacology">= Pharmacology</A></STRONG>=20 <BR></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/collection/trauma">Trauma= </A></STRONG>=20 = </TD></TR></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE><FONT=20 size=3D-1><BR>Anesth Analg 2005;101:524-534<BR>=A9 2005 <A=20 href=3D"http://www.anesthesia-analgesia.org/misc/terms.shtml">Internation= al=20 Anesthesia Research Society</A><BR>doi: = 10.1213/01.ANE.0000160585.43587.5B=20 </FONT><BR> <H3> <HR align=3Dleft width=3D"50%" noShade SIZE=3D1> NEUROSURGICAL ANESTHESIA</H3> <H2>Revising a Dogma: Ketamine for Patients with Neurological Injury?=20 </H2><STRONG></NOBR><NOBR>Sabine Himmelseher, MD<SUP>*</SUP></NOBR>, and = <NOBR>Marcel E. Durieux, MD, PhD<SUP><IMG alt=3D{dagger}=20 src=3D"http://www.anesthesia-analgesia.org/math/dagger.gif" = border=3D0></SUP></NOBR>=20 </STRONG> <P><FONT size=3D-1>*Klinik fuer Anaesthesiologie, Klinikum rechts der = Isar,=20 Technische Universit=E4t, M=FCnchen, Germany; and <IMG alt=3D{dagger}=20 src=3D"http://www.anesthesia-analgesia.org/math/dagger.gif" = border=3D0>Department of=20 Anesthesiology, University of Virginia Health System, Charlottesville, = Virginia=20 </FONT> <P><FONT size=3D-1>Address correspondence and reprint requests to Marcel = E.=20 Durieux, MD, PhD, Department of Anesthesiology, University of Virginia = Health=20 System, PO Box 800710, Charlottesville, VA 22908-0710. Address e-mail to = <SPAN=20 id=3Dem0>durieux{at}virginia.edu</SPAN> <SCRIPT type=3Dtext/javascript><!--=0A= var u =3D "durieux", d =3D "virginia.edu"; = document.getElementById("em0").innerHTML =3D '<a href=3D"mailto:' + u + = '@' + d + '">' + u + '@' + d + '<\/a>'//--></SCRIPT> .</FONT> <P><A name=3DABS><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 Abstract </FONT></TH></TR></TBODY></TABLE> <TABLE cellPadding=3D5 align=3Dright border=3D1> <TBODY> <TR> <TH align=3Dleft><FONT size=3D-1><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#to= p"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Top<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/dot.gif" = width=3D11=20 border=3D0><FONT color=3D#464c53>Abstract</FONT><BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BD= Y"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Introduction<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C1"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Methods<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C2"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Results<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C3"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Discussion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C4"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Conclusion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BI= BL"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 = border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>W= e=20 evaluated reports of randomized clinical trials in the = perioperative<SUP>=20 </SUP>and intensive care setting concerning ketamine=92s effects<SUP> = </SUP>on the=20 brain in patients with, or at risk for, neurological<SUP> </SUP>injury. = We also=20 reviewed other studies in humans on the drug=92s<SUP> </SUP>effects on = the brain,=20 and reports that examined ketamine in<SUP> </SUP>experimental brain = injury. In=20 the clinical setting, level II<SUP> </SUP>evidence indicates that = ketamine does=20 not increase intracranial<SUP> </SUP>pressure when used under conditions = of=20 controlled ventilation,<SUP> </SUP>coadministration of a <IMG = alt=3D{gamma}=20 src=3D"http://www.anesthesia-analgesia.org/math/ggr.gif" = border=3D0>-aminobutyric=20 acid (GABA) receptor agonist,<SUP> </SUP>and without nitrous oxide. = Ketamine may=20 thus safely be used<SUP> </SUP>in neurologically impaired patients. = Compared=20 with other anesthetics<SUP> </SUP>or sedatives, level II and III = evidence=20 indicates that hemodynamic<SUP> </SUP>stimulation induced by ketamine = may=20 improve cerebral perfusion;<SUP> </SUP>this could make the drug a = preferred=20 choice in sedative regimes<SUP> </SUP>after brain injury. In the = laboratory,=20 ketamine has neuroprotective,<SUP> </SUP>and <I>S</I>(+)-ketamine = additional=20 neuroregenerative effects, even<SUP> </SUP>when administered after onset = of a=20 cerebral insult. However,<SUP> </SUP>improved outcomes were only = reported in=20 studies with brief recovery<SUP> </SUP>observation intervals. In = developing=20 animals, and in certain<SUP> </SUP>brain areas of adult rats without = cerebral=20 injury, neurotoxic<SUP> </SUP>effects were noted after large-dose = ketamine.=20 These were prevented<SUP> </SUP>by coadministration of GABA receptor=20 agonists.<SUP> </SUP> <P><A name=3DBDY><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 Introduction </FONT></TH></TR></TBODY></TABLE> <TABLE cellPadding=3D5 align=3Dright border=3D1> <TBODY> <TR> <TH align=3Dleft><FONT size=3D-1><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#to= p"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Top<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#AB= S"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Abstract<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/dot.gif" = width=3D11=20 border=3D0><FONT color=3D#464c53>Introduction</FONT><BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C1"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Methods<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C2"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Results<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C3"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Discussion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C4"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Conclusion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BI= BL"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 = border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>P= harmacological=20 modulation of excessive <I>N</I>-methyl-d-aspartate<SUP> </SUP>(NMDA) = receptor=20 stimulation may be used as part of a multi-targeted<SUP> </SUP>approach = to=20 ameliorate secondary brain injury (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= -39">1</A>).=20 The benefits=97if<SUP> </SUP>any=97of the NMDA receptor antagonist = ketamine,=20 however,<SUP> </SUP>remain undefined in this setting, in part because of = the=20 persisting<SUP> </SUP>dogma that the drug not be used in patients at = risk for=20 increases<SUP> </SUP>in intracranial pressure (ICP) (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= -39">2,3</A>).=20 Thirty years ago, increases<SUP> </SUP>in cerebral oxygen consumption, = cerebral=20 blood flow (CBF), and<SUP> </SUP>ICP were indeed reported during = anesthesia with=20 ketamine (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= -39">4,5</A>).<SUP>=20 </SUP> <P>Advances in our knowledge of ketamine=92s cerebral effects<SUP> = </SUP>and=20 progress in therapeutic interventions for brain injury warrant<SUP> = </SUP>a=20 reevaluation of this verdict. First, preclinical and clinical<SUP> = </SUP>data=20 show that the cerebral hemodynamic and metabolic effects<SUP> </SUP>of = ketamine=20 depend on study setting (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= -39">4=968</A>),=20 the absence<SUP> </SUP>or presence of controlled ventilation (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= -39">8=9610</A>),=20 background<SUP> </SUP>anesthetics, and other drugs (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 1-39">11=9615</A>).=20 In patients with<SUP> </SUP>intracranial pathology, ketamine has been = used=20 safely under<SUP> </SUP>appropriate conditions (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16=9618</A>).=20 Second, as the important<SUP> </SUP>role of NMDA receptor signaling in = pathways=20 inducing neuronal<SUP> </SUP>death has been defined (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 9-39">19</A>),=20 interest in clinically available<SUP> </SUP>NMDA antagonists has been = renewed.=20 Because preclinical studies<SUP> </SUP>report neuroprotective effects = for=20 racemic ketamine in cell<SUP> </SUP>and animal models (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 0-39">20=9623</A>),=20 and additional regenerative<SUP> </SUP>effects for <I>S</I>(+)-ketamine = in=20 cultured neurons (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 0-39">20,24</A>),=20 the drug<SUP> </SUP>may potentially be of benefit for patients with = brain=20 injury.<SUP> </SUP> <P>This review will provide an update on ketamine=92s cerebral<SUP> = </SUP>effects,=20 and will attempt to answer the question whether use<SUP> </SUP>of = ketamine in=20 the neurosurgical patient is acceptable, and<SUP> </SUP>whether = potential=20 benefits should be further investigated.<SUP> </SUP> <P><A name=3DSEC1><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 Methods </FONT></TH></TR></TBODY></TABLE> <TABLE cellPadding=3D5 align=3Dright border=3D1> <TBODY> <TR> <TH align=3Dleft><FONT size=3D-1><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#to= p"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Top<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#AB= S"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Abstract<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BD= Y"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Introduction<BR></A><IMG height=3D9 alt=3D" " = hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/dot.gif" = width=3D11=20 border=3D0><FONT color=3D#464c53>Methods</FONT><BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C2"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Results<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C3"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Discussion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C4"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Conclusion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BI= BL"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 = border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>T= he early=20 literature on ketamine=92s cerebral effects has<SUP> </SUP>been = discussed=20 previously (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= -39">2,3</A>),=20 and will not be extensively<SUP> </SUP>repeated. We will focus on data = from the=20 last decade. Actually,<SUP> </SUP>almost all of the early reports do not = meet=20 current quality<SUP> </SUP>criteria for randomized, controlled trials: = the=20 studies often<SUP> </SUP>were unblinded observations, and without=20 randomization.<SUP> </SUP> <P>Computer literature searches in the electronic databases MEDLINE<SUP> = </SUP>and EMBASE from 1994 to October 2004 were performed using the<SUP> = </SUP>following terms: ketamine, NMDA receptor antagonist, = hemodynamics,<SUP>=20 </SUP>ICP, (neuro)anesthesia, sedation, emergence, psychic, = adverse/side<SUP>=20 </SUP>effects, neuroprotection, brain, cerebral, injury, ischemia,<SUP>=20 </SUP>and (neuro)toxicity. Searches were conducted without language<SUP> = </SUP>restriction, but limited to items with English abstracts. = After<SUP>=20 </SUP>abstract screening, only articles deemed relevant were = obtained.<SUP>=20 </SUP>A manual search for additional reports in reference lists was<SUP> = </SUP>performed. A systematic review filter was applied. Abstracts,<SUP> = </SUP>letters, case reports, or unpublished data were not included.<SUP> = </SUP>Authors were not contacted. If a preclinical study reported<SUP>=20 </SUP>effects similar to those reported in a clinical trial, the=20 preclinical<SUP> </SUP>study was not included because of space = limitations.=20 Literature<SUP> </SUP>from the veterinary field was not considered.<SUP> = </SUP> <P>Reports of randomized, controlled trials, and nonrandomized<SUP>=20 </SUP>controlled or cohort trials in adults were included. Where=20 applicable,<SUP> </SUP>trials were scored using a 3-item, 1=965 quality = scale (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 5-39">25</A>).<SUP>=20 </SUP>Trial evidence was stratified according to accepted level of<SUP>=20 </SUP>evidence ratings (level I=96level IV), and conclusions were<SUP> = </SUP>based=20 on this evidence. Specific trial evidence levels are indicated<SUP> = </SUP>in the=20 text as appropriate. In view of the heterogeneity in<SUP> </SUP>study = design and=20 settings, and the small number of trials with<SUP> </SUP>comparable = objectives,=20 meta-analyses were not possible.<SUP> </SUP> <P>For preclinical human studies, a methodological quality of = randomized,<SUP>=20 </SUP>controlled investigation with allocation concealment and = blinding<SUP>=20 </SUP>of study assessment was deemed necessary. In laboratory work,<SUP> = </SUP>studies had to model a clinical scenario, and the primary = outcome<SUP>=20 </SUP>measure had to be relevant for or represent a measure of=20 neuroprotection.<SUP> </SUP> <P><A name=3DSEC2><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 Results </FONT></TH></TR></TBODY></TABLE> <TABLE cellPadding=3D5 align=3Dright border=3D1> <TBODY> <TR> <TH align=3Dleft><FONT size=3D-1><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#to= p"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Top<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#AB= S"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Abstract<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BD= Y"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Introduction<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C1"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Methods<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/dot.gif" = width=3D11=20 border=3D0><FONT color=3D#464c53>Results</FONT><BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C3"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Discussion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C4"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Conclusion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BI= BL"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 = border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR><= STRONG>Identification=20 of Studies</STRONG><BR>The literature searches identified 246 articles = that=20 examined<SUP> </SUP>the use of ketamine in brain insults or the setting = of=20 neuroanesthesia.<SUP> </SUP>Seventy-nine studies were included. There = were 5=20 volunteer and<SUP> </SUP>16 patient trials (with &gt;500 patients). = Frequent=20 reasons<SUP> </SUP>for study exclusion were use of ketamine as = anesthetic in=20 brain<SUP> </SUP>injury experiments or description of pathophysiological = phenomena<SUP> </SUP>only, and flawed study design, such as lack of = blinding or=20 randomization.<SUP> </SUP>Many narrative reviews were found, but no = systematic=20 review<SUP> </SUP>on any aspect of this work was available.<SUP> </SUP> <P>We will discuss evidence for cerebral hemodynamic effects and<SUP>=20 </SUP>neuroprotection separately. In addition, we will review = evidence<SUP>=20 </SUP>for additional beneficial and detrimental effects of the = compound,<SUP>=20 </SUP>and briefly discuss the potential role for = <I>S</I>(+)-ketamine.<SUP>=20 </SUP> <P><STRONG>Cerebral Hemodynamics</STRONG><BR>Study details are presented = in <A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#T1= 39">Table=20 1</A>. The effect of ketamine<SUP> </SUP>on ICP was studied in patients = with=20 intracranial compromise<SUP> </SUP>under controlled normocapnic = ventilation=20 during brain tumor<SUP> </SUP>or aneurysm surgery (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 1-39">11</A>),=20 and in severe head injury in the intensive<SUP> </SUP>care unit (ICU) = (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16=9618</A>).=20 When applied as 1 mg/kg bolus<SUP> </SUP>to neurosurgical patients = during=20 isoflurane/nitrous oxide (N<SUB>2</SUB>O)<SUP> </SUP>anesthesia, = ketamine=20 reduced ICP and middle cerebral artery<SUP> </SUP>flow velocity (VMCA), = but did=20 not affect mean arterial blood<SUP> </SUP>pressure (MAP) (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 1-39">11</A>).=20 After administration of a 1, 3, or 5 mg/kg<SUP> </SUP>bolus to = head-injured=20 patients with increased ICP under propofol<SUP> </SUP>sedation, the drug = reduced=20 ICP, but had no effect on either<SUP> </SUP>VMCA or MAP (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 7-39">17</A>)=20 (level III evidence). In sedative regimens<SUP> </SUP>for severely = head-injured=20 patients, ICP was similar during sedation<SUP> </SUP>with either=20 ketamine/midazolam or with fentanyl/midazolam. With<SUP>=20 </SUP>ketamine/midazolam, however, less vasopressors were needed = and<SUP>=20 </SUP>greater cerebral perfusion pressures (CPP) were found (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16</A>)=20 (level<SUP> </SUP>II evidence). In another study, the combination of=20 ketamine<SUP> </SUP>and midazolam versus sufentanil and midazolam did = not=20 result<SUP> </SUP>in a different ICP or CPP (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 8-39">18</A>).=20 The sufentanil-treated patients,<SUP> </SUP>however, required more = fluids on the=20 first day and showed a<SUP> </SUP>trend to need more vasopressors (level = II=20 evidence). During<SUP> </SUP>the 4-day study, ketamine was associated = with more=20 rapid heart<SUP> </SUP>rates on 2 days. In normocapnic, ventilated = patients=20 without<SUP> </SUP>cerebral compromise, ketamine increased VMCA during=20 air/oxygen/isoflurane<SUP> </SUP>anesthesia when used alone or in the = presence=20 of esmolol; after<SUP> </SUP>midazolam, VMCA decreased (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 2-39">12</A>).=20 During propofol anesthesia and<SUP> </SUP>hypo- or hyperventilation, = ketamine=20 did not affect the VMCA<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 6-39">26</A>).=20 During air/oxygen/isoflurane anesthesia and hypoventilation,<SUP> = </SUP>it also=20 did not reduce VMCA, but pulsatility index decreased<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 7-39">27</A>)=20 (level III evidence). Importantly, during propofol anesthesia,<SUP>=20 </SUP><I>S</I>(+)-ketamine did not impair dynamic cerebrovascular=20 autoregulation<SUP> </SUP>in patients without cerebral compromise (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 8-39">28</A>)=20 (level III evidence).<SUP> </SUP>Early work showed that in the presence = of=20 N<SUB>2</SUB>O, ketamine may<SUP> </SUP>increase CBF even under = controlled=20 ventilation (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= -39">4</A>).=20 In spontaneously<SUP> </SUP>breathing volunteers, a subanesthetic dose = of=20 ketamine given<SUP> </SUP>as bolus (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 9-39">29</A>),=20 infusion (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= -39">8</A>),=20 or a combination of both (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R3= 0-39">30</A>),<SUP>=20 </SUP>increased regional CBF and metabolism (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= -39">8,29</A>)=20 (level III evidence).<SUP> </SUP>In spontaneously breathing patients, an = increase in arterial<SUP> </SUP>Paco<SUB>2</SUB> was identified as a = major=20 factor responsible for an increase<SUP> </SUP>in CBF or ICP (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= -39">4,14</A>).<SUP>=20 </SUP> <P><A name=3DT139><!-- null --></A><BR clear=3Dall> <CENTER> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%"> <TBODY> <TR bgColor=3D#e1e1e1> <TD> <TABLE cellSpacing=3D2 cellPadding=3D2> <TBODY> <TR bgColor=3D#e1e1e1> <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><STRONG>View = this=20 table:</STRONG><BR><NOBR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524/T1= 39">[in=20 this window]</A><BR><A=20 onmouseover=3D"window.status=3D'View table in a separate = window'; return true"=20 onclick=3D"startTarget('T139', 749, 733); = this.href=3D'/cgi/content-nw/full/101/2/524/T139'"=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content-nw/full/101/2/524= /T139"=20 target=3DT139>[in a new window]</A><BR>&nbsp;</NOBR> </TD> <TD vAlign=3Dtop align=3Dleft><B>Table 1.</B> Cerebral = Hemodynamic=20 Effects of Ketamine in Human = <P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp= ;<BR><SUP></SUP> <P>Laboratory data confirm ketamine=92s known inhibition of<SUP> = </SUP>metabolism=20 in certain brain areas and simultaneous stimulation<SUP> </SUP>of = others, which=20 is partially reflected in decreased CBF in<SUP> </SUP>regions with = reduced=20 metabolism and <I>vice versa</I> (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= -39">6,31</A>).=20 The effects<SUP> </SUP>were dependent on preexisting cerebrovascular = tone and=20 its modulation<SUP> </SUP>by background anesthetics (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 3-39">13=9615,32=9634</A>).=20 Concomitant<SUP> </SUP>use of ketamine and anesthetics may stimulate = regional=20 metabolism,<SUP> </SUP>impair autoregulation, or induce direct = vasodilation (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R3= 2-39">32=9634</A>).<SUP>=20 </SUP>In the presence of anesthetics that depress brain metabolism<SUP>=20 </SUP>(i.e., <IMG alt=3D{gamma}=20 src=3D"http://www.anesthesia-analgesia.org/math/ggr.gif" = border=3D0>-aminobutyric=20 acid [GABA] receptor agonists), global<SUP> </SUP>ICP is <I>not</I> = increased by=20 ketamine (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16=9618</A>).=20 In normocapnic,<SUP> </SUP>ventilated pigs, racemic ketamine did not = impair CBF=20 autoregulation<SUP> </SUP>when used alone (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R3= 5-39">35</A>).<SUP>=20 </SUP> <P>In summary, the clinical evidence can be assessed as follows.<SUP>=20 </SUP>Ketamine increases CBF and metabolism in spontaneously = breathing<SUP>=20 </SUP>volunteers (level III evidence). However, under conditions of<SUP> = </SUP>controlled ventilation and sedation, the drug does not = increase<SUP>=20 </SUP>ICP (level III evidence). Instead, a greater CPP is = maintained<SUP>=20 </SUP>when ketamine is used for sedation than when opiates are = administered<SUP>=20 </SUP>(level II evidence) and need for vasopressors is reduced = (level<SUP>=20 </SUP>II evidence). During anesthesia, ketamine does not reduce = VMCA<SUP>=20 </SUP>(level III evidence) or impair autoregulation (level III = evidence).<SUP>=20 </SUP>This may, however, not be true in the presence of = N<SUB>2</SUB>O.<SUP>=20 </SUP> <P><STRONG>Neuroprotection</STRONG><BR>Trials that compared ketamine = with=20 fentanyl (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16</A>)=20 or sufentanil<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 8-39">18</A>)=20 for sedation after head injury did not find a different<SUP> </SUP>6-mo = outcome=20 after 10- (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16</A>)=20 or 4-day (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 8-39">18</A>)=20 ketamine use (level<SUP> </SUP>II evidence). The drug doses used were = adjusted=20 to maintain<SUP> </SUP>ICP &lt;25 mm Hg in resting patients.<SUP> </SUP> <P><I>In vitro</I> and animal studies with a duration of up to 7 = days<SUP>=20 </SUP>reported neuroprotective effects when ketamine was used = before,<SUP>=20 </SUP>during, or after induction of various brain insults. In = neurons<SUP>=20 </SUP>in culture (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 0-39">20,24,36=9638</A>),=20 and in brain slices (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R3= 9-39">39=9642</A>),<SUP>=20 </SUP>ketamine protected against hypoxic, ischemic, mechanical, and<SUP> = </SUP>chemical neuronal damage. When used at subanesthetic doses = and<SUP>=20 </SUP>postinjury in cultured neurons, neuroprotective effects were<SUP>=20 </SUP>found (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 0-39">20,24</A>).=20 In whole-animal rat models, ketamine use before<SUP> </SUP>insult or as=20 anesthesia during regional ischemia attenuated<SUP> </SUP>injury from = permanent=20 (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= 3-39">43</A>)=20 or transient cerebral artery occlusion<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 3-39">23</A>),=20 and from global ischemia (four-vessel occlusion) and reperfusion<SUP> = </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= 4-39">44=9649</A>).=20 After fluid-percussion brain trauma in rats,<SUP> </SUP>ketamine = administered=20 postinjury improved behavioral functions<SUP> </SUP>and outcome over 48 = h (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 1-39">21</A>).=20 The drug reduced hippocampal damage<SUP> </SUP>in the immature rat brain = when=20 injected after hypoxia-ischemia<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 2-39">22</A>).=20 After seizure onset, ketamine terminated convulsions and<SUP> = </SUP>reduced=20 cognitive decline (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R5= 0-39">50=9652</A>).=20 Anesthesia with ketamine<SUP> </SUP>decreased mortality after = hypothermic=20 circulatory arrest in<SUP> </SUP>pigs (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R5= 3-39">53</A>).=20 In a schizophrenia model in adult rats, repeated<SUP> = </SUP>subanesthetic=20 ketamine doses evoked neurogenesis, but the new<SUP> </SUP>neurons did = not=20 functionally integrate (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R5= 4-39">54</A>).=20 Ketamine showed<SUP> </SUP>a trend to reduce ischemic injury when = applied after=20 simulation<SUP> </SUP>of a subdural hematoma with clotted blood (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R5= 5-39">55</A>).<SUP>=20 </SUP> <P>Most investigators related the observed decrease in necrosis<SUP> = </SUP>to a=20 reduction in glutamate neurotoxicity (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 0-39">20=9622,38=9640,42,44=9649,52,56</A>)<SUP>=20 </SUP>resulting from NMDA receptor blockade by ketamine (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R5= 7-39">57</A>).=20 A decrease<SUP> </SUP>in DNA fragmentation and apoptotic protein = activation=20 after<SUP> </SUP>racemic or <I>S</I>(+)-ketamine was also found (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 3-39">23,45,58</A>).=20 Although<SUP> </SUP>there is still a lack of data on the molecular = machinery=20 behind<SUP> </SUP>ketamine neuroprotection, some consequences of the=20 prevention<SUP> </SUP>of pathological NMDA receptor up-regulation were = reported:=20 At<SUP> </SUP>brain synapses, postsynaptic density (PSD) proteins bind = and<SUP>=20 </SUP>cluster NMDA receptors to the cytoskeleton and sets of = signaling<SUP>=20 </SUP>proteins, such as nitric oxide synthase (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R5= 9-39">59,60</A>),=20 or calcium<SUP> </SUP>sensors (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 1-39">61</A>).=20 Increased excitatory NMDA receptor input activates<SUP> </SUP>protein = kinase C=20 isoforms and tyrosine kinase cascades, which<SUP> </SUP>facilitate = assembly of=20 signaling molecules with PSD proteins<SUP> </SUP>in the NMDA receptor. = This=20 leads to further kinase activation,<SUP> </SUP>NMDA receptor = phosphorylation,=20 and up-regulation of NMDA currents.<SUP> </SUP>In this vicious circle, = enhanced=20 downstream signals enhance<SUP> </SUP>NMDA receptor function, and = finally,=20 induce cell injury (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= 4-39">44,59</A>).<SUP>=20 </SUP>In studies of postischemic brain tissue, ketamine reduced the<SUP> = </SUP>injury-related increase in NMDA receptor-PSD-protein kinase<SUP>=20 </SUP>assembly (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= 4-39">44,46</A>),=20 decreased subsequent transcription factor<SUP> </SUP>activation (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= 7-39">47=9649,61</A>),=20 and apoptotic processing (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R4= 5-39">45</A>)=20 (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#F1= 39">Fig.=20 1</A>).<SUP> </SUP>The reduction of harmful interactions of NMDA = receptors<SUP>=20 </SUP>with cascades that transduce signals to destructive = intracellular<SUP>=20 </SUP>mechanisms may thus represent one effect underlying ketamine<SUP>=20 </SUP>neuroprotection.<SUP> </SUP> <P><A name=3DF139><!-- null --></A><BR clear=3Dall> <CENTER> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%"> <TBODY> <TR bgColor=3D#e1e1e1> <TD> <TABLE cellSpacing=3D2 cellPadding=3D2> <TBODY> <TR bgColor=3D#e1e1e1> <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524/F1= 39"><IMG=20 height=3D157 alt=3D" " hspace=3D10=20 = src=3D"http://www.anesthesia-analgesia.org/content/vol101/issue2/images/s= mall/39FF1.gif"=20 width=3D200 vspace=3D5 border=3D2></A><BR><STRONG>View = larger=20 version</STRONG> (55K):<BR><NOBR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524/F1= 39">[in=20 this window]</A><BR><A=20 onmouseover=3D"window.status=3D'View figure in a separate = window'; return true"=20 onclick=3D"startTarget('F139', 590, 546); = this.href=3D'/cgi/content-nw/full/101/2/524/F139'"=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content-nw/full/101/2/524= /F139"=20 target=3DF139>[in a new window]</A><BR>&nbsp;</NOBR> </TD> <TD vAlign=3Dtop align=3Dleft><B>Figure 1.</B> Pharmacological = effects=20 reported for racemic and <I>S</I>(+)-ketamine which are = presumed to=20 be relevant for neuroprotection. After onset of brain = injury,=20 blockade of excessive stimulation of = <I>N</I>-methyl-d-aspartate=20 (NMDA) receptors by ketamine reduces calcium influx through = the=20 receptor channel <IMG height=3D10 alt=3D{U2460}=20 = src=3D"http://www.anesthesia-analgesia.org/content/vol101/issue2/images/m= edium/U2460.gif"=20 width=3D11 border=3D0>. This attenuates supraphysiological = increases in=20 the assembly and interaction of NMDA receptor subunits, = postsynaptic=20 density proteins, and other intracellular signaling systems = such as=20 protein kinases <IMG height=3D10 alt=3D{U2461}=20 = src=3D"http://www.anesthesia-analgesia.org/content/vol101/issue2/images/m= edium/U2461.gif"=20 width=3D10 border=3D0>;. Thus, several kinase transduction = cascades=20 become less activated. This improves preservation of = metabolism and=20 maintenance of the mitochondrial transmembrane potential = <IMG=20 height=3D10 alt=3D{U2462}=20 = src=3D"http://www.anesthesia-analgesia.org/content/vol101/issue2/images/m= edium/U2462.gif"=20 width=3D10 border=3D0>. This, in turn, reduces pathological = activation=20 of transcription factors <IMG height=3D11 alt=3D{U2463}=20 = src=3D"http://www.anesthesia-analgesia.org/content/vol101/issue2/images/m= edium/U2463.gif"=20 width=3D10 border=3D0>. Proteins involved in apoptosis are = less=20 activated, which is associated with less DNA fragmentation = <IMG=20 height=3D10 alt=3D{U2464}=20 = src=3D"http://www.anesthesia-analgesia.org/content/vol101/issue2/images/m= edium/U2464.gif"=20 width=3D11 border=3D0>. A better preservation of synaptic = proteins=20 occurs, and the expression of growth proteins indicating=20 regeneration in adult neurons is enhanced. The prevention of = pathological amplification of NMDA receptor signaling = finally=20 results in increased cellular survival, preserved cellular = and=20 synaptic integrity, and regenerative efforts. *Superiority=20 of/effects induced by <I>S</I>(+)-ketamine, only. = <P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp= ;<BR><SUP></SUP> <P>One study demonstrated no reduction in cellular death when = ketamine<SUP>=20 </SUP>was used for anesthesia in a rat model of incomplete, and=20 near-complete<SUP> </SUP>ischemia, whereas isoflurane anesthesia was=20 neuroprotective<SUP> </SUP>in near-complete ischemia in the same study = (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 2-39">62</A>).=20 Both compounds<SUP> </SUP>improved motor function after near-complete = injury. It=20 is conceivable<SUP> </SUP>that only repeated ketamine injections which = are=20 extended into<SUP> </SUP>the postischemic period, i.e., into the phase = of=20 delayed injury<SUP> </SUP>evolution, may prevent neuronal death. It is = also=20 possible that,<SUP> </SUP>especially in the rat, ketamine must be = combined with=20 other<SUP> </SUP>drugs such as GABA-mimetics to prevent unfavorable=20 neuronal<SUP> </SUP>effects from blockade of synaptic transmission by = ketamine=20 anesthesia<SUP> </SUP>(see below).<SUP> </SUP> <P>Particularly important in this area would be studies = investigating<SUP>=20 </SUP>long-term outcomes after cerebral injury in the presence of<SUP>=20 </SUP>ketamine, because studies using other presumed protectants = (such<SUP>=20 </SUP>as isoflurane) have shown that early benefits may not be = sustained.<SUP>=20 </SUP> <P>In summary, although a wealth of animal and cellular studies<SUP>=20 </SUP>demonstrate neuroprotective effects of ketamine in various = settings,<SUP>=20 </SUP>virtually no clinical trial data are available. It is = essentially<SUP>=20 </SUP>impossible to extrapolate the available animal data to human<SUP>=20 </SUP>brain injury. We do know, however, that outcome is no worse<SUP>=20 </SUP>when ketamine, rather than sufentanil or fentanyl, is used = for<SUP>=20 </SUP>sedation of head-injured patients (level II evidence).<SUP> </SUP> <P><STRONG>Other Beneficial Effects</STRONG><BR>The stimulation of the=20 cardiovascular system by racemic or <I>S</I>(+)-ketamine<SUP> = </SUP>combined=20 with other anesthetics and sedatives was described<SUP> </SUP>previously = (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 3-39">63</A>).=20 Maintenance of hemodynamic stability and potential<SUP>=20 </SUP>vasopressor-sparing effects are of special interest within = settings<SUP>=20 </SUP>where circulatory depression should be avoided, such as with<SUP>=20 </SUP>head injury (level II evidence). Two trials (reported above)<SUP>=20 </SUP>found sufficient and comparable sedative levels when = midazolam<SUP>=20 </SUP>was combined with either ketamine, or with fentanyl (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16</A>)=20 or<SUP> </SUP>sufentanil (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 8-39">18</A>),=20 in head-injured patients (level II evidence).<SUP> </SUP>When sedation = was=20 stopped in the second trial (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 8-39">18</A>),=20 ketamine<SUP> </SUP>was associated with a slightly longer recovery = period, but=20 no<SUP> </SUP>prolonged ICU stay. In the first study (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 6-39">16</A>),=20 improved food intake<SUP> </SUP>was found with ketamine. Both studies = did not=20 report differences<SUP> </SUP>in adverse effects. In the = non-neurosurgical=20 critically ill<SUP> </SUP>patient population, several trials described=20 advantages of ketamine<SUP> </SUP>for sedation and analgesia: prevention = of=20 hemodynamic depression<SUP> </SUP>and a reduced need for catecholamines = (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 4-39">64,65</A>),=20 better tolerance<SUP> </SUP>of enteral nutrition because of improved=20 gastrointestinal motility<SUP> </SUP>as compared with opioids (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 6-39">66</A>),=20 less tachyphylaxis and withdrawal<SUP> </SUP>phenomena (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 7-39">67,68</A>),=20 and improved pain control (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 9-39">69</A>)=20 (level II<SUP> </SUP>and III evidence). However, ketamine must be used=20 cautiously<SUP> </SUP>in long-term sedation of cardiac patients with = left heart=20 failure.<SUP> </SUP>One study reported a decrease in cardiac index after = sufentanil<SUP> </SUP>was replaced by ketamine following sedation with=20 sufentanil<SUP> </SUP>and midazolam for several days (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R7= 0-39">70</A>).=20 After brain injury, pharmacokinetic<SUP> </SUP>analyses of ketamine and = its=20 active metabolites found a larger<SUP> </SUP>increase in the = distribution volume=20 than in total clearance,<SUP> </SUP>so that a drug half-life longer than = estimated must be considered<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R7= 1-39">71</A>).=20 This could be less relevant with <I>S</I>(+)-ketamine (see below).<SUP>=20 </SUP>The trials did not report differences in emergence reactions<SUP> = </SUP>or=20 other side effects regardless of ketamine use.<SUP> </SUP> <P>In summary, ketamine provides adequate and controllable sedation<SUP> = </SUP>in critically ill patients (level II evidence), and, when = compared<SUP>=20 </SUP>with opiates, provides better hemodynamic stability, better<SUP>=20 </SUP>tolerance of enteral nutrition, less withdrawal phenomena, = and<SUP>=20 </SUP>better pain control (level II and III evidence).<SUP> </SUP> <P><STRONG>Neurotoxicity</STRONG><BR>In rodents, profound blockade of = normal=20 NMDA receptor activity<SUP> </SUP>led to poor brain cell survival and=20 physiological outcome, because<SUP> </SUP>signal transduction via NMDA = receptors=20 is necessary to express<SUP> </SUP>neurotrophins and survival-promoting = proteins=20 (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R7= 2-39">72</A>).=20 In rats,<SUP> </SUP>physiological signals were reduced directly by NMDA=20 receptor<SUP> </SUP>antagonists, such as ketamine, and indirectly by=20 GABA-mimetics,<SUP> </SUP>such as volatile anesthetics and barbiturates = (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R7= 3-39">73=9678</A>).<SUP>=20 </SUP>In the developing rat brain, a combination of anesthetics or<SUP>=20 </SUP>large-dose NMDA receptor antagonists caused apoptosis, = synaptic<SUP>=20 </SUP>deficits, and cognitive impairment, especially during the = vulnerable<SUP>=20 </SUP>phase of synaptogenesis (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R7= 3-39">73,76=9679</A>).=20 In adult rats without<SUP> </SUP>brain injury, ketamine induced acute, = but=20 usually transient,<SUP> </SUP>vacuolar changes in posterior=20 cingulate/retrosplenial cortices<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R7= 4-39">74=9676</A>).=20 The effect was dose-, age-, and sex-dependent,<SUP> </SUP>with younger = rats=20 being essentially resistant, and females being<SUP> </SUP>more sensitive = than=20 males. The latter was likely attributable<SUP> </SUP>to sex differences = in drug=20 metabolism with more efficient hepatic<SUP> </SUP>biotransformation in = males.=20 After coadministration of ketamine<SUP> </SUP>and the NMDA antagonist=20 N<SUB>2</SUB>O, increased vacuolization occurred,<SUP> </SUP>whereas the = combination with a GABA-agonist completely prevented<SUP> </SUP>these = changes=20 (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R7= 4-39">74</A>).=20 Although the mechanisms presumed to underlie<SUP> </SUP>these phenomena = are as=20 yet unclear, they likely involve a disinhibition<SUP> </SUP>of = excitatory=20 pathways which heavily innervate cerebrocortical<SUP> </SUP>neurons (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#F2= 39">Fig.=20 2</A>).<SUP> </SUP> <P><A name=3DF239><!-- null --></A><BR clear=3Dall> <CENTER> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"95%"> <TBODY> <TR bgColor=3D#e1e1e1> <TD> <TABLE cellSpacing=3D2 cellPadding=3D2> <TBODY> <TR bgColor=3D#e1e1e1> <TD vAlign=3Dtop align=3Dmiddle bgColor=3D#ffffff><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524/F2= 39"><IMG=20 height=3D130 alt=3D" " hspace=3D10=20 = src=3D"http://www.anesthesia-analgesia.org/content/vol101/issue2/images/s= mall/39FF2.gif"=20 width=3D200 vspace=3D5 border=3D2></A><BR><STRONG>View = larger=20 version</STRONG> (27K):<BR><NOBR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524/F2= 39">[in=20 this window]</A><BR><A=20 onmouseover=3D"window.status=3D'View figure in a separate = window'; return true"=20 onclick=3D"startTarget('F239', 590, 485); = this.href=3D'/cgi/content-nw/full/101/2/524/F239'"=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content-nw/full/101/2/524= /F239"=20 target=3DF239>[in a new window]</A><BR>&nbsp;</NOBR> </TD> <TD vAlign=3Dtop align=3Dleft><B>Figure 2.</B> Because of the=20 requirement for physiological glutamate signaling, and the = toxic=20 effects of excessive glutamate signaling,=20 <I>N</I>-methyl-d-aspartate (NMDA) receptor block by = ketamine can=20 have both beneficial and detrimental effects. The toxic = effects can=20 be prevented by a <IMG alt=3D{gamma}=20 src=3D"http://www.anesthesia-analgesia.org/math/ggr.gif"=20 border=3D0>-aminobutyric acid (GABA) receptor agonist, as = explained:=20 A, the physiological glutamate signaling pathway is shown.=20 Stimulation of cell 1 with glutamate results in release of = GABA.=20 This inhibits cell 2, and as a result, cell 3 is exposed to = a=20 limited amount of glutamate, only. In the presence of = ketamine, the=20 inhibition of cell 2 by GABA is diminished. The result is an = overexcitation of cell 3, and resulting damage, as observed = in=20 retrosplenial cortex and cingulate gyrus in adult rats = exposed to=20 ketamine. The detrimental effect can be blocked by = administration of=20 exogenous GABA agonists (volatile anesthetics, barbiturates, = or=20 benzodiazepines), which will prevent glutamate secretion = from cell=20 2. B, Toxic glutamate signaling is shown. An excess = glutamate,=20 acting through NMDA receptor, induces cellular toxicity. = This effect=20 is blocked by ketamine. NMDA-R =3D NMDA receptor, GABA-R =3D = GABA=20 receptor, Glu =3D glutamate, Glu-R =3D glutamate receptor, + = =3D=20 stimulating effect, =96 =3D inhibiting effect. = <P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></CENTER>&nbsp= ;<BR><SUP></SUP> <P>In summary, animal data suggest that under some conditions,<SUP>=20 </SUP>ketamine (and N<SUB>2</SUB>O) may induce neurotoxicity. This has = only=20 been<SUP> </SUP>demonstrated in rats.<SUP> </SUP> <P><STRONG><I>S</I>(+)-Ketamine</STRONG><BR>Several advantages of = <I>S</I>(+)-=20 over racemic ketamine with regard<SUP> </SUP>to its cardiovascular = profile and=20 neuroprotective effects have<SUP> </SUP>been reported. At a comparable = depth of=20 anesthesia [which requires<SUP> </SUP>approximately half the dose of=20 <I>S</I>(+)-ketamine as compared with<SUP> </SUP>the racemate],=20 <I>S</I>(+)-ketamine caused similar cardiovascular stimulation<SUP> = </SUP>as=20 racemic ketamine (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 0-39">80,81</A>)=20 (level II evidence). When combined<SUP> </SUP>with midazolam for ICU = sedation,=20 racemic or <I>S</I>(+)-ketamine (at<SUP> </SUP>a dose of 55%=9675% of = the=20 racemate) provided hemodynamic<SUP> </SUP>stability, and sometimes = allowed=20 reduced vasopressor support.<SUP> </SUP><I>S</I>(+)-Ketamine combined = with=20 propofol had minimal effects on<SUP> </SUP>the systemic circulation (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R6= 3-39">63,64</A>)=20 (level II evidence). In contrast<SUP> </SUP>to the racemate, the=20 <I>S</I>(+)-isomer maintained muscle sympathetic<SUP> </SUP>activity = during a=20 hypotensive challenge in volunteers (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 2-39">82</A>).<SUP>=20 </SUP><I>S</I>(+)-Ketamine showed a shorter half-life than the racemic=20 mixture<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 0-39">80,81</A>),=20 which is favorable for a rapid neurological assessment.<SUP> = </SUP>However, no=20 different incidence of side effects after <I>S</I>(+)-<SUP> </SUP>or = racemic=20 ketamine was found (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 0-39">80,83</A>)=20 (level II evidence). A<SUP> </SUP>recent study compared a combined = anesthetic=20 regimen of <I>S</I>(+)-ketamine<SUP> </SUP>and propofol with = remifentanil and=20 propofol for open-heart surgery<SUP> </SUP>(<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 4-39">84</A>).=20 In a neuropsychological test evaluation 10 wk after the<SUP> = </SUP>procedure,=20 the overall test performance was not different. Unfortunately,<SUP> = </SUP>by the=20 standards of the consensus statement on assessment of<SUP> = </SUP>neurobehavioral=20 outcome in cardiac surgery trials (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 5-39">85</A>),=20 this<SUP> </SUP>study was greatly underpowered, and the inability to = find a<SUP>=20 </SUP>difference between the approaches is therefore not = surprising.<SUP> </SUP> <P>Laboratory data indicate a better cardiovascular profile for<SUP> = </SUP>the=20 <I>S</I>(+)-isomer with less myocardial depression (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 6-39">86</A>)=20 and less<SUP> </SUP>vasorelaxation of the aorta (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 7-39">87</A>)=20 than induced by the racemate.<SUP> </SUP>In contrast to the racemate,=20 <I>S</I>(+)-ketamine did not reverse late<SUP> </SUP>cardiac = preconditioning (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 8-39">88</A>).=20 <I>S</I>(+)-Ketamine showed better protective<SUP> </SUP>and even = regenerative=20 efficacy in rat brain slices (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R3= 9-39">39,41</A>)=20 and<SUP> </SUP>neuronal cultures (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 0-39">20,24</A>).=20 In contrast to the racemate, it preserved<SUP> </SUP>neuronal = metabolism, and=20 increased the expression of proteins<SUP> </SUP>related to plasticity = and repair=20 in the adult brain (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R2= 0-39">20,24</A>).<SUP>=20 </SUP>In a rat model of global brain ischemia, <I>S</I>(+)-ketamine,=20 injected<SUP> </SUP>postinjury, maintained cortical oxygen saturation = and=20 neuronal<SUP> </SUP>survival as compared with <I>R</I>(=96)-ketamine (<A = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R8= 9-39">89</A>),=20 and in incomplete<SUP> </SUP>brain ischemia, anesthesia with=20 <I>S</I>(+)-ketamine improved behavioral<SUP> </SUP>outcome 3 days after = injury=20 (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 0-39">90</A>).<SUP>=20 </SUP> <P>In summary, although preclinical data suggest benefits of = <I>S</I>(+)<SUP>=20 </SUP>over racemic ketamine in cardiovascular and neuroprotective<SUP>=20 </SUP>profiles, clinical evidence at this time only supports equal<SUP>=20 </SUP>hemodynamic and side effect profile (level II evidence).<SUP> = </SUP> <P><A name=3DSEC3><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 Discussion </FONT></TH></TR></TBODY></TABLE> <TABLE cellPadding=3D5 align=3Dright border=3D1> <TBODY> <TR> <TH align=3Dleft><FONT size=3D-1><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#to= p"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Top<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#AB= S"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Abstract<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BD= Y"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Introduction<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C1"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Methods<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C2"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Results<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/dot.gif" = width=3D11=20 border=3D0><FONT color=3D#464c53>Discussion</FONT><BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C4"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 border=3D0>Conclusion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BI= BL"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 = border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>F= rom the=20 standpoint of cerebral hemodynamics, the available<SUP> = </SUP>information=20 demonstrates that ketamine does not increase ICP<SUP> </SUP>in = neurologically=20 impaired patients during controlled ventilation<SUP> </SUP>and = coadministration=20 of a GABA receptor agonist. Coadministration<SUP> </SUP>with = N<SUB>2</SUB>O is=20 to be avoided. Thus, the drug can safely be used.<SUP> </SUP>Ketamine = has been=20 considered unsuitable in neurosurgical patients<SUP> </SUP>because of = its=20 cataleptic actions and psychotomimetic adverse<SUP> </SUP>effects. = However,=20 clinical studies did not report an increase<SUP> </SUP>in adverse = reactions or=20 emergence delirium when ketamine and<SUP> </SUP>GABA-mimetics were used = as=20 compared with regimens without ketamine.<SUP> </SUP>Likely, the = coadministration=20 of GABA-agonists prevented these<SUP> </SUP>effects.<SUP> </SUP> <P><STRONG>Hemodynamics</STRONG><BR>Ketamine=92s interaction with = regional=20 cerebral hemodynamics<SUP> </SUP>and metabolism is complex. We know that = the=20 drug=92s global<SUP> </SUP>action on CBF, brain metabolism, and ICP is = determined=20 by a<SUP> </SUP>combination of effects on cerebral and systemic=20 hemodynamics,<SUP> </SUP>although we do not know what this means in case = of a=20 brain insult<SUP> </SUP>on a regional level. Even if "optimal CPP" is = still a=20 matter<SUP> </SUP>of debate, it is beyond doubt that systemic = hypotension is=20 detrimental<SUP> </SUP>in brain injury. Ketamine=92s stimulation of the=20 cardiovascular<SUP> </SUP>system may prevent hypotension and thus = maintain the=20 CPP, which=97together<SUP> </SUP>with its other advantages over = opiate-based=20 sedation=97could<SUP> </SUP>make the drug a first choice in sedative = regimens for=20 patients<SUP> </SUP>with brain insults.<SUP> </SUP> <P><STRONG>Neuroprotection</STRONG><BR>The renewed interest in ketamine = as a=20 clinically available neuroprotectant<SUP> </SUP>has been fostered by a = shift in=20 thinking about neuroprotection<SUP> </SUP>by anesthetics: from = suppression of=20 brain metabolism to inhibition<SUP> </SUP>of excitotoxicity. A key role = in the=20 injury cascade seems to<SUP> </SUP>be played by the unbalanced = activation of=20 NMDA receptors by<SUP> </SUP>toxic glutamate concentrations with = subsequent cell=20 death (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 9-39">19,91</A>).<SUP>=20 </SUP>Cerebral microdialysis in patients confirmed increased = glutamate<SUP>=20 </SUP>concentrations in the extracellular space during and after = critical<SUP>=20 </SUP>periods of brain injury (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 2-39">92,93</A>).=20 This prompted therapeutic approaches<SUP> </SUP>with NMDA receptor = antagonists.=20 Drug regimens used early after<SUP> </SUP>insults may especially target=20 secondary injury processes within<SUP> </SUP>the therapeutic window of=20 opportunity (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 4-39">94</A>).=20 Ketamine acts at<SUP> </SUP>many different signal transduction sites, = but its=20 neuroprotective<SUP> </SUP>effects seem at least for the most part to be = explained by blockade<SUP> </SUP>of NMDA receptor activation. It binds=20 noncompetitively to the<SUP> </SUP>phencyclidine site in the receptor = channel,=20 and additionally<SUP> </SUP>acts through allosteric modification (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R5= 7-39">57</A>).<SUP>=20 </SUP> <P>There is a large body of experimental data indicating that = racemic<SUP>=20 </SUP>ketamine is neuroprotective; <I>S</I>(+)-ketamine may have = protective<SUP>=20 </SUP>and neuroregenerative effects that exceed those of the = racemic<SUP>=20 </SUP>mixture. With regard to the drug doses used, the experimental<SUP> = </SUP>data cannot readily be extrapolated to the clinical setting,<SUP>=20 </SUP>but comparisons can be made. Ketamine injected IV is rapidly<SUP>=20 </SUP>distributed to the brain, and concentrations in rat and human<SUP> = </SUP>brain are approximately five times more than blood values (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 5-39">95=9699</A>).<SUP>=20 </SUP>For anesthesia, rats need 10 times larger ketamine doses than<SUP> = </SUP>humans (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R3= 1-39">31</A>),=20 and many studies in whole-animal models used rat<SUP> = </SUP>anesthetic-dose=20 ketamine (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 5-39">95=9697</A>).=20 <I>In vitro</I>, drug concentrations<SUP> </SUP>several-fold = (approximately=20 5=961000 times) lower than those<SUP> </SUP>reached in rat brain tissue = after=20 anesthesia induction (peak<SUP> </SUP>level 400 =B5M) were used (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 5-39">95</A>).=20 Ketamine is significantly<SUP> </SUP>plasma protein bound (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 5-39">95=9699</A>)=20 and because plasma concentrations<SUP> </SUP>larger than 0.5 =B5M = racemate were=20 reached in surgical anesthesia<SUP> </SUP>in humans, the doses effective = for=20 experimental neuroprotection<SUP> </SUP>seem to be within a range = relevant for=20 clinical use. Nevertheless,<SUP> </SUP>limitations other than the drug = doses=20 used have to be considered<SUP> </SUP>for the available animal data. = First, the=20 major caveat is that<SUP> </SUP>almost all of the studies were performed = in=20 small animal models,<SUP> </SUP>and the past decade has seen a series of = high-profile failures<SUP> </SUP>in clinical trials of drugs that were = highly=20 effective in these<SUP> </SUP>models. No trial has yet reported = neuroprotective=20 efficacy of<SUP> </SUP>ketamine after human brain injury. Second, we = have no=20 long-term<SUP> </SUP>outcome data demonstrating persistent benefit of=20 neuroprotection<SUP> </SUP>after ketamine anesthesia or ketamine = administration=20 after onset<SUP> </SUP>of brain insults. This appears to be very = important,=20 because<SUP> </SUP>in a rat model of near-complete ischemia, it was = recently=20 found<SUP> </SUP>that the neuroprotection provided by isoflurane had=20 dissipated<SUP> </SUP>three months after cerebral injury (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 00-39">100</A>).=20 Last, but not least,<SUP> </SUP>we lack investigations that examine = prolonged=20 ketamine treatment<SUP> </SUP>after brain injury. It is unlikely that = one=20 injection of a short-acting<SUP> </SUP>drug will completely prevent = delayed=20 inflammation or other injury-related<SUP> </SUP>signals associated with = NMDA=20 receptor-mediated transduction<SUP> </SUP>during the evolution of brain = insults.=20 Thus, further study in<SUP> </SUP>higher animal species with ketamine = use beyond=20 initial brain<SUP> </SUP>insults, evaluation of drug combinations, and=20 longer-term outcome<SUP> </SUP>studies appear to be indicated. Even if = previous=20 clinical trials<SUP> </SUP>with NMDA antagonists reported only minor = benefit on=20 outcome<SUP> </SUP>after cardiopulmonary bypass (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 01-39">101</A>)=20 or were stopped after head<SUP> </SUP>trauma (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 02-39">102</A>)=20 or stroke (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 03-39">103</A>),=20 it is not time to conclude that<SUP> </SUP>NMDA antagonists failed to = provide=20 clinical neuroprotection.<SUP> </SUP>All of these studies applied = competitive=20 NMDA blockers only,<SUP> </SUP>which cause a sustained transmission = blockade and=20 thus, probably<SUP> </SUP>unfavorable, effects on the brain. In = contrast, a=20 recent prospective,<SUP> </SUP>randomized, placebo-controlled, = double-blind,=20 multicenter pilot<SUP> </SUP>trial demonstrated improved patient outcome = after=20 use of a noncompetitive<SUP> </SUP>NMDA receptor antagonist after = traumatic=20 brain injury (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 04-39">104</A>).<SUP>=20 </SUP>Similar to ketamine, the drug applied had a lower binding = affinity<SUP>=20 </SUP>to the phencyclidine site in the NMDA receptor channel than<SUP>=20 </SUP>dizocilpine. A recent study demonstrated that, in mice,=20 hyperactivation<SUP> </SUP>of NMDA receptors after injury is = short-lived, and is=20 followed<SUP> </SUP>by a profound and long-lasting loss of function (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 05-39">105</A>).=20 In fact,<SUP> </SUP>administration of NMDA 24 and 48 h postinjury=20 significantly<SUP> </SUP>attenuated neurological deficits. Thus, = appropriate=20 timing and<SUP> </SUP>duration of NMDA receptor blockade is likely to be = critical.<SUP> </SUP> <P><STRONG>Neurotoxicity</STRONG><BR>Whether the NMDA antagonist-induced = neurodegeneration observed<SUP> </SUP>in rats could occur in humans is = not=20 known. The potential clinical<SUP> </SUP>relevance of the rat data = remains to be=20 clarified, although<SUP> </SUP>psychotomimetic effects after NMDA = antagonists=20 may represent<SUP> </SUP>a correlate to the changes observed in rat = brain (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R1= 06-39">106</A>).=20 However,<SUP> </SUP>the pathological conditions after brain injury are=20 profoundly<SUP> </SUP>different from the physiological state of intact,=20 uninjured<SUP> </SUP>tissue. Cerebral insults cause massive increases in = extracellular<SUP> </SUP>excitatory transmitter concentration and brain = ischemia=20 induces<SUP> </SUP>GABA release (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#R9= 1-39">91</A>).=20 During these periods, it seems unlikely that<SUP> </SUP>ketamine would = be able=20 to induce an over-inhibition of NMDA<SUP> </SUP>receptor signaling.<SUP> = </SUP> <P><A name=3DSEC4><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 Conclusion </FONT></TH></TR></TBODY></TABLE> <TABLE cellPadding=3D5 align=3Dright border=3D1> <TBODY> <TR> <TH align=3Dleft><FONT size=3D-1><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#to= p"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Top<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#AB= S"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Abstract<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BD= Y"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Introduction<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C1"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Methods<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C2"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Results<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C3"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Discussion<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/dot.gif" = width=3D11=20 border=3D0><FONT color=3D#464c53>Conclusion</FONT><BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BI= BL"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/darrow.gif" = width=3D11=20 = border=3D0>References<BR></A></FONT></TH></TR></TBODY></TABLE>&nbsp;<BR>S= everal=20 clinical trials addressed the use of ketamine as a sedative<SUP> = </SUP>drug in=20 the ICU, and based on this evidence, the drug seems<SUP> = </SUP>appropriate for=20 that setting. The major perceived contraindications<SUP> </SUP>for = ketamine use=20 in neurologically impaired patients have been<SUP> </SUP>refuted. = Ketamine=92s=20 circulatory effects and preclinical<SUP> </SUP>data indicating = neuroprotection=20 merit further animal and patient<SUP> </SUP>investigation, but we do not = yet=20 have evidence of ketamine neuroprotection<SUP> </SUP>in humans. Based on = the=20 known pathological responses of the<SUP> </SUP>brain to injury and = extrapolation=20 of knowledge from pain therapy<SUP> </SUP>using ketamine, it is our bias = that=20 human trials will only be<SUP> </SUP>successful if ketamine will be = present=20 during the whole period<SUP> </SUP>of NMDA receptor overstimulation = after and=20 during the evolution<SUP> </SUP>of brain injuries.<SUP> </SUP> <P>We gratefully acknowledge the expert assistance of David Alpern<SUP> = </SUP>in=20 the preparation of the manuscript.<SUP> </SUP> <P><SUP></SUP> <P><A name=3DFN><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 Footnotes </FONT></TH></TR></TBODY></TABLE>&nbsp;<BR><A=20 name=3D""><!-- null --></A>Accepted for publication February 9, = 2005.<SUP> </SUP> <P><SUP></SUP> <P><A name=3DBIBL><!-- null --></A><BR clear=3Dright> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%" bgColor=3D#e1e1e1> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dleft width=3D"5%" bgColor=3D#ffffff><IMG = height=3D21=20 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif"=20 width=3D10></TD> <TH vAlign=3Dcenter align=3Dleft width=3D"95%"><FONT = size=3D+2>&nbsp;&nbsp;=20 References </FONT></TH></TR></TBODY></TABLE> <TABLE cellPadding=3D5 align=3Dright border=3D1> <TBODY> <TR> <TH align=3Dleft><FONT size=3D-1><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#to= p"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Top<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#AB= S"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Abstract<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#BD= Y"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Introduction<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C1"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Methods<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C2"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Results<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C3"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Discussion<BR></A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/524#SE= C4"><IMG=20 height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif" = width=3D11=20 border=3D0>Conclusion<BR></A><IMG height=3D9 alt=3D" " hspace=3D5=20 src=3D"http://www.anesthesia-analgesia.org/icons/toc/dot.gif" = width=3D11=20 border=3D0><FONT=20 color=3D#464c53>References</FONT><BR></FONT></TH></TR></TBODY></TABLE>&nb= sp;<BR> <OL compact><A name=3DR1-39><!-- null --></A> <LI value=3D1>Doppenberg EMR, Choi SC, Bullock R. Clinical trials in = traumatic=20 brain injury. J Neurosurg Anesthesiol 2004;16:87=9694.<!-- HIGHWIRE = ID=3D"101:2:524:1" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000187659800018&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 14676577&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR2-39><!-- null --></A>=20 <LI value=3D2>Madson JB, Cold GE. The effects of anaesthetics upon = cerebral=20 circulation and metabolism: experimental and clinical studies. New = York:=20 Springer, 1990.<!-- HIGHWIRE ID=3D"101:2:524:2" --><!-- /HIGHWIRE = --><A=20 name=3DR3-39><!-- null --></A>=20 <LI value=3D3>Sakabe T, Nakakimura K. Effects of anesthetic agents and = other=20 drugs on cerebral blood flow, metabolism, and intracranial pressure. = In:=20 Cottrell JE, Smith DS, eds. Anesthesia and neurosurgery. St. Louis, = MO: Mosby,=20 2001:136=9648.<!-- HIGHWIRE ID=3D"101:2:524:3" --><!-- /HIGHWIRE --><A = name=3DR4-39><!-- null --></A>=20 <LI value=3D4>Takeshita H, Okuda Y, Sari A. The effects of ketamine on = cerebral=20 circulation and metabolism in man. Anesthesiology 1972;36:69=9675.<!-- = HIGHWIRE ID=3D"101:2:524:4" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1972L239800011&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 5006989&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR5-39><!-- null --></A>=20 <LI value=3D5>Shapiro HM, Wyte SR, Harris AB. Ketamine anesthesia in = patients=20 with intracranial pathology. Br J Anaesth 1972;44:1200=964.<!-- = HIGHWIRE ID=3D"101:2:524:5" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dbrjana&amp;resid=3D44/11/1200"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR6-39><!-- null --></A>=20 <LI value=3D6>Chi O, Wei HM, Klein SL, Weiss HR. Effect of ketamine on = heterogeneity of cerebral microregional venous O<SUB>2</SUB> = saturation in the=20 rat. Anesth Analg 1994;79:860=966.<!-- HIGHWIRE ID=3D"101:2:524:6" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D79/5/860">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR7-39><!-- null --></A>=20 <LI value=3D7>Miyamaoto E, Nakao S, Tomimoto H, et al. Ketamine = attenuates=20 hypocapnia-induced neuronal damage in the caudoputamen in a rat model = of=20 chronic cerebral hypoperfusion. Neurosci Lett 2004;354:26=969.<!-- = HIGHWIRE ID=3D"101:2:524:7" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000188298500008&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 14698474&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR8-39><!-- null --></A>=20 <LI value=3D8>Langsj=F6 JW, Kaisti KK, Aalto S, et al. Effects of = subanesthetic=20 doses of ketamine on regional cerebral blood flow, oxygen consumption, = and=20 blood volume in humans. Anesthesiology 2003;99:614=9623.<!-- HIGHWIRE = ID=3D"101:2:524:8" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000184987400014&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12960545&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR9-39><!-- null --></A>=20 <LI value=3D9>Friesen RH, Honda AT. Changes in anterior fontanel = pressure in=20 preterm neonates receiving isoflurane, halothane, fentanyl or = ketamine. Anesth=20 Analg 1987;66:431=964.<!-- HIGHWIRE ID=3D"101:2:524:9" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D66/5/431">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR10-39><!-- null --></A>=20 <LI value=3D10>Pfenninger E, Reith A. Ketamine and intracranial = pressure. In:=20 Domino EF, ed. Status of ketamine in anaesthesiology. Ann Arbor, MI: = NPP=20 Books, 1990:109=9618.<!-- HIGHWIRE ID=3D"101:2:524:10" --><!-- = /HIGHWIRE --><A=20 name=3DR11-39><!-- null --></A>=20 <LI value=3D11>Mayberg TS, Lam AM, Matta BF, et al. Ketamine does not = increase=20 blood flow velocity or intracranial pressure during isoflurane/nitrous = oxide=20 anesthesia in patients undergoing craniotomy. Anesth Analg = 1995;81:84=969.<!-- HIGHWIRE ID=3D"101:2:524:11" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D81/1/84">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR12-39><!-- null --></A>=20 <LI value=3D12>Strebel S, Kaufman M, Maitre L, Schaefer HG. Effects of = ketamine=20 on cerebral blood flow velocity in humans: influence of pre-treatment = with=20 midazolam or esmolol. Anaesthesia 1995;50:223=968.<!-- HIGHWIRE = ID=3D"101:2:524:12" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1995QL29700010&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 7717488&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR13-39><!-- null --></A>=20 <LI value=3D13>Nimkoff L, Quinn C, Silver P, Sagy M. The effects of = intravenous=20 anesthetics on intracranial pressure and cerebral perfusion pressure = in two=20 feline models of brain edema. J Crit Care 1997;12:132=966.<!-- = HIGHWIRE ID=3D"101:2:524:13" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1997XY23600004&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9328852&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR14-39><!-- null --></A>=20 <LI value=3D14>Ohata H, Iida H, Nagase K, Dohi S. The effects of = topical and=20 intravenous ketamine on cerebral arterioles in dogs receiving = pentobarbital or=20 isoflurane anesthesia. Anesth Analg 2001;93:697=96702.<!-- HIGHWIRE = ID=3D"101:2:524:14" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D93/3/697"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR15-39><!-- null --></A>=20 <LI value=3D15>Nagase K, Ida H, Dohi S. Effects of ketamine on = isoflurane- and=20 sevoflurane-induced cerebral vasodilation in rabbits. J Neurosurg = Anesthesiol=20 2003;15:98=96103.<!-- HIGHWIRE ID=3D"101:2:524:15" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000181865900005&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12657994&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR16-39><!-- null --></A>=20 <LI value=3D16>Kolenda H, Gremmelt A, Rading S, et al. Ketamine for=20 analgosedative therapy in intensive care treatment of head-injured = patients.=20 Acta Neurochir 1996;138:1193=969.<!-- HIGHWIRE ID=3D"101:2:524:16" = --><!-- /HIGHWIRE --><A=20 name=3DR17-39><!-- null --></A>=20 <LI value=3D17>Albanese J, Arnaud S, Rey M, Thomachot L, et al. = Ketamine=20 decreases intracranial pressure and electroencephalographic activity = in=20 traumatic brain injury patients during propofol sedation. = Anesthesiology=20 1997;87:1328=9634.<!-- HIGHWIRE ID=3D"101:2:524:17" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1997YK50900011&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9416717&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR18-39><!-- null --></A>=20 <LI value=3D18>Bourgoin A, Albanese J, Wereszcynski N, et al. Safety = of sedation=20 with ketamine in severe head injury patients: comparison with = sufentanil. Crit=20 Care Med 2003;31:711=967.<!-- HIGHWIRE ID=3D"101:2:524:18" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000181846800008&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12626974&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR19-39><!-- null --></A>=20 <LI value=3D19>Hardingham GE, Bading H. The Yin and Yang of NMDA = receptor=20 signalling. Trends Neurosci 2003;26:81=969.<!-- HIGHWIRE = ID=3D"101:2:524:19" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000180681600008&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12536131&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR20-39><!-- null --></A>=20 <LI value=3D20>Himmelseher S, Pfenninger E, Georgieff M. The effects = of=20 ketamine-isomers on neuronal injury and regeneration in rat = hippocampal=20 neurons. Anesth Analg 1996;83:505=9612.<!-- HIGHWIRE = ID=3D"101:2:524:20" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D83/3/505">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR21-39><!-- null --></A>=20 <LI value=3D21>Shapira Y, Lam AM, Engl CC, et al. Therapeutic time = window and=20 dose response of the beneficial effects of ketamine in experimental = head=20 injury. Stroke 1994;25:1637=9643.<!-- HIGHWIRE ID=3D"101:2:524:21" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dstrokeaha&amp;resid=3D25/8/1637">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR22-39><!-- null --></A>=20 <LI value=3D22>Spandou E, Karkavelas G, Soubasi V, et al. Effect of = ketamine on=20 hypoxic-ischemic brain damage in newborn rats. Brain Res = 1999;819:1=967.<!-- HIGHWIRE ID=3D"101:2:524:22" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000078597300001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 10082854&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR23-39><!-- null --></A>=20 <LI value=3D23>Chang ML, Yang J, Kem S, et al. Nicotinamide and = ketamine reduce=20 infarct volume and DNA fragmentation in rats after brain ischemia and=20 reperfusion. Neurosci Lett=20 2002;322:137=9640.<!-- HIGHWIRE ID=3D"101:2:524:23" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000174809800001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11897157&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR24-39><!-- null --></A>=20 <LI value=3D24>Himmelseher S, Pfenninger E, Kochs E, Auchter M. = S(+)-Ketamine=20 up-regulates neuronal regeneration associated proteins following = glutamate=20 injury in cultured rat hippocampal neurons. J Neurosurg Anesthesiol=20 2000;12:84=9694.<!-- HIGHWIRE ID=3D"101:2:524:24" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000086281300003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 10774601&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR25-39><!-- null --></A>=20 <LI value=3D25>Jadad AR, Moore RA, Carroll D, et al. Assessing the = quality of=20 reports of randomized clinical trials: is blinding necessary? Control = Clin=20 Trials 1996;17:1=9612.<!-- HIGHWIRE ID=3D"101:2:524:25" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1996UA39800001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 8721797&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR26-39><!-- null --></A>=20 <LI value=3D26>Sakai K, Cho S, Fukusaki M, et al. The effects of = propofol with=20 and without ketamine on human cerebral blood flow velocity and = response.=20 Anesth Analg 2000;90:377=9682.<!-- HIGHWIRE ID=3D"101:2:524:26" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D90/2/377"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR27-39><!-- null --></A>=20 <LI value=3D27>Nagase K, Iida H, Ohata H, Dohi S. Ketamine, not = propofol,=20 attenuates cerebrovascular response to carbon dioxide in humans with=20 isoflurane anesthesia. J Clin Anesth 2001;13:551=965.<!-- HIGHWIRE = ID=3D"101:2:524:27" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000172993300001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11755322&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR28-39><!-- null --></A>=20 <LI value=3D28>Engelhard K, Werner C, M=F6llenberg O, Kochs E.=20 S(+)-Ketamine/propofol maintain dynamic cerebrovascular autoregulation = in=20 humans. Can J Anaesth 2001;48:1034=969.<!-- HIGHWIRE = ID=3D"101:2:524:28" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dcanjana&amp;resid=3D48/10/1034"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR29-39><!-- null --></A>=20 <LI value=3D29>Vollenweider FX, Leenders KL, Oye I, et al. = Differential=20 psychopathology and patterns of cerebral glucose utilisation produced = by (S)-=20 and (R)-ketamine in healthy volunteers using positron emission = tomography. Eur=20 Neuropsychopharmacol 1997;7:25=9638.<!-- HIGHWIRE ID=3D"101:2:524:29" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1997WN51600003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9088882&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR30-39><!-- null --></A>=20 <LI value=3D30>Holcomb HH, Lahti AC, Medorff DR, et al. Sequential = regional=20 cerebral blood flow brain scans using PET with = H<SUB>2</SUB><SUP>15</SUP>O=20 demonstrate actions in CNS dynamically. Neuropsychopharmacology=20 2001;25:165=9672.<!-- HIGHWIRE ID=3D"101:2:524:30" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000170653800002&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11425500&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR31-39><!-- null --></A>=20 <LI value=3D31>Freo U, Ori C. Effects of anesthesia and recovery from = ketamine=20 racemate and enantiomers on regional cerebral glucose metabolism in = rats.=20 Anesthesiology 2004;100:1172=968.<!-- HIGHWIRE ID=3D"101:2:524:31" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000221070400019&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15114215&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR32-39><!-- null --></A>=20 <LI value=3D32>Wendling WW, Chen D, Daniels FB, et al. The effects of=20 N-methyl-D-aspartate agonists and antagonists on isolated bovine = cerebral=20 arteries. Anesth Analg 1996;82:264=968.<!-- HIGHWIRE = ID=3D"101:2:524:32" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D82/2/264">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR33-39><!-- null --></A>=20 <LI value=3D33>Shakunaga K, Kojima S, Jomura K, et al. Ketamine = suppresses the=20 production and release of endothelin 1 from cultured bovine = endothelial cells.=20 Anesth Analg 1998;86:1098=96102.<!-- HIGHWIRE ID=3D"101:2:524:33" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D86/5/1098">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR34-39><!-- null --></A>=20 <LI value=3D34>Nagase K, Ida H, Dohi S. L-Arginine and nitroglycerin = restore=20 hypercapnia-induced cerebral vasodilation in rabbits after its = attenuation by=20 ketamine. Anesth Analg 2002;94:954=968.<!-- HIGHWIRE = ID=3D"101:2:524:34" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D94/4/954"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR35-39><!-- null --></A>=20 <LI value=3D35>Schmidt A, Ryding E, Akeson J. Racemic ketamine does = not abolish=20 cerebrovascular autoregulation in the pig. Acta Anaesthesiol Scand=20 2003;47:569=9675.<!-- HIGHWIRE ID=3D"101:2:524:35" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000182304400012&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12699515&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR36-39><!-- null --></A>=20 <LI value=3D36>Gonzales JM, Loeb AL, Reichard PS, Irvine S. Ketamine = inhibits=20 glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP = production=20 in cultured cerebral neurons. Anesthesiology 1995;82:205=9613.<!-- = HIGHWIRE ID=3D"101:2:524:36" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1995QC46000026&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 7832303&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR37-39><!-- null --></A>=20 <LI value=3D37>Paquet-Durand F, Bicker G. Hypoxic/ischemic cell damage = in=20 cultured human NT-2 neurons. Brain Res 2004;1011:33=9647.<!-- HIGHWIRE = ID=3D"101:2:524:37" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000221939200004&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15140642&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR38-39><!-- null --></A>=20 <LI value=3D38>Ozden S, Isenmann S. Neuroprotective properties of = different=20 anesthetics on axotomized rat retinal ganglion cells in vivo. J = Neurotrauma=20 2004;1:73=9682.<!-- HIGHWIRE ID=3D"101:2:524:38" --><!-- /HIGHWIRE = --><A=20 name=3DR39-39><!-- null --></A>=20 <LI value=3D39>Mathews KS, Toner CC, McLaughlin DP, Stamford JA. = Comparison of=20 ketamine stereoisomers on tissue metabolic activity in an in-vitro = model of=20 global cerebral ischaemia. Neurochem Int 2001;38:367=9672.<!-- = HIGHWIRE ID=3D"101:2:524:39" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000167534100001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11222916&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR40-39><!-- null --></A>=20 <LI value=3D40>Zhan RZ, Wu C, Fujihara H, et al. Intravenous = anesthetics=20 differentially reduce neurotransmission damage caused by = oxygen-glucose=20 deprivation in rat hippocampal slices in correlation with = N-methyl-D-aspartate=20 receptor inhibition. Crit Care Med 2001;29:808=9613.<!-- HIGHWIRE = ID=3D"101:2:524:40" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000168063700017&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11373474&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR41-39><!-- null --></A>=20 <LI value=3D41>Tso MM, Blatchford KL, Callado LF, et al. = Stereoselective effects=20 of ketamine on dopamine, serotonin and noradrenaline release and = uptake in rat=20 brain slices. Neurochem Int 2004;44:1=967.<!-- HIGHWIRE = ID=3D"101:2:524:41" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000185556200001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12963082&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR42-39><!-- null --></A>=20 <LI value=3D42>Xue QS, Yu BW, Wang ZJ, Chen HZ. Effects of ketamine, = midazolam,=20 thiopental, and propofol on brain ischemic injury in rat cerebral = cortical=20 slices. Acta Pharmacol Sin=20 2004;25:115=9620.<!-- HIGHWIRE ID=3D"101:2:524:42" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000187915700018&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 14704132&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR43-39><!-- null --></A>=20 <LI value=3D43>Lin SZ, Chiou AL, Wang Y. Ketamine antagonizes nitric = oxide=20 release from cerebral cortex after middle cerebral artery ligation in = rats.=20 Stroke 1996;27:747=9652.<!-- HIGHWIRE ID=3D"101:2:524:43" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dstrokeaha&amp;resid=3D27/4/747"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR44-39><!-- null --></A>=20 <LI value=3D44>Liu Y, Zhang G, Gao C, Hou X. NMDA receptor activation = results in=20 tyrosine phosphorylation of NMDA receptor subunit 2A (NR2A) and = interaction of=20 Pyk2 with NR2A after transient cerebral ischemia and reperfusion. = Brain Res=20 2001;909:51=968.<!-- HIGHWIRE ID=3D"101:2:524:44" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000170626800005&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11478920&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR45-39><!-- null --></A>=20 <LI value=3D45>Zhang C, Shen W, Zhang G. N-methyl-D-aspartate receptor = and=20 L-type voltage-gated Ca channel antagonists suppress the release of = cytochrome=20 c and the expression of procaspase-3 in rat hippocampus after global = brain=20 ischemia. Neurosci Lett 2002;328:265=968.<!-- HIGHWIRE = ID=3D"101:2:524:45" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000177750300016&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12147322&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR46-39><!-- null --></A>=20 <LI value=3D46>Hou XY, Zhang GY, Yan JZ, et al. Activation of NMDA = receptors and=20 L-type voltage-gated calcium channels mediates enhanced formation of=20 Fyn-PSD95-NR2A complex after transient cerebral ischemia. Brain Res=20 2002;955:123=9632.<!-- HIGHWIRE ID=3D"101:2:524:46" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000179424800014&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12419528&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR47-39><!-- null --></A>=20 <LI value=3D47>Shen W, Zhang C, Zhang G. Nuclear factor <IMG = alt=3D{kappa}=20 src=3D"http://www.anesthesia-analgesia.org/math/kgr.gif" border=3D0>B = activation=20 is mediated by NMDA and non-NMDA receptor and L-type voltage-gated=20 Ca<SUP>2+</SUP> channel following severe global ischemia in rat = hippocampus.=20 Brain Res 2002;933:23=9630.<!-- HIGHWIRE ID=3D"101:2:524:47" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000175361200003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11929632&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR48-39><!-- null --></A>=20 <LI value=3D48>Li H, Zhang Q, Zhang G. Signal transducer and activator = of=20 transcription-3 activation mediated by N-methyl-D-aspartate receptor = and=20 L-type voltage gated Ca<SUP>2+</SUP> channel during ischemia in rat=20 hippocampus. Neurosci Lett 2003;345:61=964.<!-- HIGHWIRE = ID=3D"101:2:524:48" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000183691000016&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12809989&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR49-39><!-- null --></A>=20 <LI value=3D49>Shen WH, Zhang CY, Zhang GY. Modulation of I<I>k</I>B = kinase=20 autophosphorylation and activity following brain ischemia. Acta = Pharmacol Sin=20 2003;24:311=965.<!-- HIGHWIRE ID=3D"101:2:524:49" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000182030200005&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12676069&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR50-39><!-- null --></A>=20 <LI value=3D50>Fujikawa DG. Neuroprotective effect of ketamine = administered=20 after status epilepticus onset. Epilepsia 1995;36:186=9695.<!-- = HIGHWIRE ID=3D"101:2:524:50" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1995QF19200011&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 7821277&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR51-39><!-- null --></A>=20 <LI value=3D51>Borowicz KK, Czuczwar SJ. Effects of etomidate, = ketamine or=20 propofol, and their combinations with conventional antiepileptic drugs = on=20 amygdala kindled convulsions in rats. Neuropharmacology = 2003;45:315=9624.<!-- HIGHWIRE ID=3D"101:2:524:51" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000184559900003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12871649&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR52-39><!-- null --></A>=20 <LI value=3D52>Fournier NM, Persinger MA. The neuromatrix and the = epileptic=20 brain: behavioral and learning preservation in limbic epileptic rats = treated=20 with ketamine but not acepromazine. Epilepsy Behav = 2004;5:119=9627.<!-- HIGHWIRE ID=3D"101:2:524:52" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000188814900019&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 14751217&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR53-39><!-- null --></A>=20 <LI value=3D53>Juvonen T, Biancari F, Rimpilainen J, et al. = Determinants of=20 mortality after hypothermic circulatory arrest in a chronic porcine = model. Eur=20 J Cardiothorac Surg 2001;20:803=9610.<!-- HIGHWIRE ID=3D"101:2:524:53" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dejcts&amp;resid=3D20/4/803"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR54-39><!-- null --></A>=20 <LI value=3D54>Keilhoff G, Bernstein HG, Becker A, et al. Increased = neurogenesis=20 in a rat model of schizophrenia. Biol Psychiatry 2004;56:317=9622.<!-- = HIGHWIRE ID=3D"101:2:524:54" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000223580100003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15336513&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR55-39><!-- null --></A>=20 <LI value=3D55>Uchida K, Nakakimura K, Kuroda Y, et al. Dizocilpine, = but not=20 ketamine reduces the volume of ischaemic damage after subdural = haematoma in=20 the rat. Eur J Anaesthesiol 2001;18:295=96302.<!-- HIGHWIRE = ID=3D"101:2:524:55" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000168627300003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11350471&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR56-39><!-- null --></A>=20 <LI value=3D56>Lupp A, Kest S, Karge E. Evaluation of possible pro- or = antioxidative properties and of interaction capacity with the = microsomal=20 cytochrome P450 system of different NMDA-receptor ligands and of = taurine in=20 vitro. Exp Toxicol Pathol 2003;54:441=968.<!-- HIGHWIRE = ID=3D"101:2:524:56" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000184228600013&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12877357&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR57-39><!-- null --></A>=20 <LI value=3D57>Orser BA, Pennefather PS, MacDonald JF. Multiple = mechanisms of=20 ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology=20 1997;86:903=9617.<!-- HIGHWIRE ID=3D"101:2:524:57" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1997WT00800023&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9105235&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR58-39><!-- null --></A>=20 <LI value=3D58>Engelhard K, Werner C, Ebersp=E4cher E, et al. The = effect of the=20 <IMG alt=3D{alpha} = src=3D"http://www.anesthesia-analgesia.org/math/agr.gif"=20 border=3D0><SUB>2</SUB>-agonist dexmedetomidine and the = N-methyl-D-aspartate=20 antagonist S(+)-ketamine on the expression of apoptosis-regulating = proteins=20 after incomplete cerebral ischemia and reperfusion in rats. Anesth = Analg=20 2003;96:524=9631.<!-- HIGHWIRE ID=3D"101:2:524:58" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D96/2/524"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR59-39><!-- null --></A>=20 <LI value=3D59>Xu Y, Zhang B, Hua Z, et al. Targeted disruption of = PSD-93 gene=20 reduces platelet-activation factor-induced neurotoxicity in cultured = cortical=20 neurons. Exp Neurol 2004;189:16=9624.<!-- HIGHWIRE ID=3D"101:2:524:59" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000223253000004&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15296832&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR60-39><!-- null --></A>=20 <LI value=3D60>Storvik M, Linden AM, Kontkanen O, et al. Induction of = cAMP=20 response element modulator (CREM) and inducible cAMP early repressor = (ICER)=20 expression in rat brain by uncompetitive N-methyl-D-aspartate receptor = antagonists. J Pharmacol Exp Ther 2000;294:52=9660.<!-- HIGHWIRE = ID=3D"101:2:524:60" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Djpet&amp;resid=3D294/1/52"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR61-39><!-- null --></A>=20 <LI value=3D61>Bernstein HG, Becker A, Keilhoff G, et al. Brain = region-specific=20 changes in the expression of calcium sensor proteins after repeated=20 applications of ketamine to rats. Neurosci Lett 2003;339:95=968.<!-- = HIGHWIRE ID=3D"101:2:524:61" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000181411600002&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12614903&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR62-39><!-- null --></A>=20 <LI value=3D62>Miura Y, Grocott HP, Bart RD, et al. Differential = effects of=20 anesthetic agents on outcome from near-complete but not incomplete = global=20 ischemia in the rat. Anesthesiology 1998;89:391=96400.<!-- HIGHWIRE = ID=3D"101:2:524:62" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000075297200015&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9710398&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR63-39><!-- null --></A>=20 <LI value=3D63>Adams HA. S(+)-ketamine: circulatory interactions = during total=20 intravenous anesthesia and analgosedation. Anaesthesist = 1997;46:1081=967.<!-- HIGHWIRE ID=3D"101:2:524:63" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000071300400011&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9451493&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR64-39><!-- null --></A>=20 <LI value=3D64>Adams HA, Brausch M, Schmitz CS, et al. Analgosedation = with=20 (S)-ketamine/propofol vs. (S)-ketamine/midazolam: control and quality = of=20 sedation, stress response and haemodynamic reactions. Anaesthesiol = Intensivmed=20 Notfallmed Schmerzther 2001;36:417=9624.<!-- HIGHWIRE = ID=3D"101:2:524:64" --><!-- /HIGHWIRE --><A=20 name=3DR65-39><!-- null --></A>=20 <LI value=3D65>Botero CA, Smith CE, Holbrook C, et al. Total = intravenous=20 anesthesia with a propofol-ketamine combination during coronary artery = surgery. J Cardiothorac Vasc Anesth 2000;11:409=9615.<!-- HIGHWIRE = ID=3D"101:2:524:65" --><!-- /HIGHWIRE --><A=20 name=3DR66-39><!-- null --></A>=20 <LI value=3D66>Kolbel CB, Rippel K, Klar H, et al. Esophageal motility = disorders=20 in critically ill patients: a 24-hour manometric study. Intensive Care = Med=20 2000;26:1421=967.<!-- HIGHWIRE ID=3D"101:2:524:66" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000090127100003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11126251&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR67-39><!-- null --></A>=20 <LI value=3D67>K=F6ppel C, Arndt I, Ibe K. Effects of enzyme = induction, renal and=20 cardiac function on ketamine plasma kinetics in patients with ketamine = long-term analgosedation. Eur J Drug Metab Pharmacokinet = 1990;15:259=9663.<!-- HIGHWIRE ID=3D"101:2:524:67" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1990EC91200012&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 2253657&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR68-39><!-- null --></A>=20 <LI value=3D68>Tsubo T, Sakai I, Okawa H, et al. Ketamine and = midazolam kinetics=20 during continuous hemodiafiltration in patients with multiple organ=20 dysfunction syndrome. Intensive Care Med 2001;27:1087=9690.<!-- = HIGHWIRE ID=3D"101:2:524:68" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000169745600022&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11497143&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR69-39><!-- null --></A>=20 <LI value=3D69>Guillou N, Tanguy M, Seguin P, et al. The effects of = small dose=20 ketamine on morphine consumption in surgical intensive care unit = patients=20 after major abdominal surgery. Anesth Analg 2003;97:843=967.<!-- = HIGHWIRE ID=3D"101:2:524:69" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D97/3/843"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR70-39><!-- null --></A>=20 <LI value=3D70>Christ G, Mundigler G, Merhaut C, et al. Adverse = cardiovascular=20 effects of ketamine infusion in patients with catecholamine-dependent = heart=20 failure. Anaesth Intensive Care 1997;25:255=969.<!-- HIGHWIRE = ID=3D"101:2:524:70" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1997XF47300008&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9209606&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR71-39><!-- null --></A>=20 <LI value=3D71>Hijazi Y, Bodonian C, Bolon M, et al. Pharmacokinetics = and=20 haemodynamics of ketamine in intensive care patients with brain or = spinal cord=20 injury. Br J Anaesth 2003;90:155=9660.<!-- HIGHWIRE = ID=3D"101:2:524:71" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dbrjana&amp;resid=3D90/2/155"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR72-39><!-- null --></A>=20 <LI value=3D72>Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic = NMDARs oppose=20 synaptic NMDARs by triggering CREB shut-off and cell death pathways. = Nat=20 Neurosci 2002;5:405=9614.<!-- HIGHWIRE ID=3D"101:2:524:72" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000175272000010&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11953750&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR73-39><!-- null --></A>=20 <LI value=3D73>Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA = receptors=20 and apoptotic neurodegeneration in the developing brain. Science=20 1999;283:70=964.<!-- HIGHWIRE ID=3D"101:2:524:73" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dsci&amp;resid=3D283/5398/70"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR74-39><!-- null --></A>=20 <LI value=3D74>Jevtovic-Todorovic V, Benshoff N, Olney JW. Ketamine = potentiates=20 cerebrocortical damage induced by the common anaesthetic agent nitrous = oxide=20 in adult rats. Br J Pharmacol 2000;130:1692=968.<!-- HIGHWIRE = ID=3D"101:2:524:74" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000088673500034&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 10928976&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR75-39><!-- null --></A>=20 <LI value=3D75>Jevtovic-Todorovic V, Wozniak DF, Benshoff N, Olney JW. = A=20 comparative evaluation of the neurotoxic properties of ketamine and = nitrous=20 oxide. Brain Res 2001;895:264=967.<!-- HIGHWIRE ID=3D"101:2:524:75" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000167742400036&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11259788&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR76-39><!-- null --></A>=20 <LI value=3D76>Nakao S, Miyamoto E, Masuzawa M, et al. = Ketamine-induced c-fos=20 expression in the mouse posterior cingulate and retrosplenial cortices = is=20 mediated not only via NMDA receptors but also sigma receptors. Brain = Res=20 2002;926:191=966.<!-- HIGHWIRE ID=3D"101:2:524:76" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000173904000025&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11814424&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR77-39><!-- null --></A>=20 <LI value=3D77>Hayashi H, Dikkes P, Soriano SG. Repeated = administration of=20 ketamine may lead to neuronal degeneration in the developing rat = brain.=20 Paediatr Anaesth 2002;12:770=964.<!-- HIGHWIRE ID=3D"101:2:524:77" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000180061000004&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12519135&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR78-39><!-- null --></A>=20 <LI value=3D78>Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early = exposure=20 to common anesthetics agents causes widespread neurodegeneration in = the=20 developing rat brain and persistent learning deficits. J Neurosci=20 2003;23:876=9682.<!-- HIGHWIRE ID=3D"101:2:524:78" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Djneuro&amp;resid=3D23/3/876"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR79-39><!-- null --></A>=20 <LI value=3D79>Scallet AC, Schmued LC, Slikker W Jr, et al. = Developmental=20 neurotoxicity of ketamine: morphometric confirmation, exposure = parameters, and=20 multiple fluorescent labeling of apoptotic neurons. Toxicol Sci=20 2004;81:364=9670.<!-- HIGHWIRE ID=3D"101:2:524:79" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dtoxsci&amp;resid=3D81/2/364"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR80-39><!-- null --></A>=20 <LI value=3D80>Bornscheuer A, Lubbe N, Mahr KH, et al. Endocrine = reactions,=20 circulatory and resuscitation behaviour after ketamine-midazolam = anesthesia: a=20 comparative study of ketamine racemate vs. (S)-ketamine in knee = surgery.=20 Anaesthesist 1997;46:1043=969.<!-- HIGHWIRE ID=3D"101:2:524:80" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000071300400004&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9451487&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR81-39><!-- null --></A>=20 <LI value=3D81>Engelhardt W, Stahl K, Marouche A, Hartung E. Recovery = time after=20 (S)-ketamine or ketamine racemate after short term anesthesia in = volunteers.=20 Anaesthesist 1998;47:184=9692.<!-- HIGHWIRE ID=3D"101:2:524:81" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000073009100003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9567151&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR82-39><!-- null --></A>=20 <LI value=3D82>Kienbaum P, Heuter T, Pavlakovic G, et al. = S(+)-Ketamine=20 increases muscle sympathetic activity and maintains the neural = response to=20 hypotensive challenges in humans. Anesthesiology 2001;94:252=966.<!-- = HIGHWIRE ID=3D"101:2:524:82" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000166694900010&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11176089&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR83-39><!-- null --></A>=20 <LI value=3D83>Pfenninger EG, Durieux ME, Himmelseher S. Cognitive = impairment=20 after small-dose ketamine isomers in comparison to equianalgesic = racemic=20 ketamine in human volunteers. Anesthesiology 2002;96:357=9666.<!-- = HIGHWIRE ID=3D"101:2:524:83" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000173606400018&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11818769&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR84-39><!-- null --></A>=20 <LI value=3D84>Nagels W, Demeyere R, van Hemelrijck J, et al. = Evaluation of the=20 neuroprotective effects of S(+)-ketamine during open-heart surgery. = Anesth=20 Analg 2004;98:1595=96603.<!-- HIGHWIRE ID=3D"101:2:524:84" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D98/6/1595"><NOBR>[Abstract/<FONT = color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR85-39><!-- null --></A>=20 <LI value=3D85>Murkin JM, Newman SP, Stump DA, Blumenthal JA. = Statement of=20 consensus on assessment of neurobehavioral outcome after cardiac = surgery. Ann=20 Thorac Surg 1995;59:1289=9695.<!-- HIGHWIRE ID=3D"101:2:524:85" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DFULL&am= p;journalCode=3Dannts&amp;resid=3D59/5/1289"><NOBR>[<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR86-39><!-- null --></A>=20 <LI value=3D86>Kunst G, Martin E, Graf BM, et al. Actions of ketamine = and its=20 isomers on contractility and calcium transients in human myocardium.=20 Anesthesiology 1999;90:1363=9671.<!-- HIGHWIRE ID=3D"101:2:524:86" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000080009200020&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 10319785&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR87-39><!-- null --></A>=20 <LI value=3D87>Kanellopoulos A, Lenz G, M=FChlbauer B. Stereoselective = differences=20 in the vasorelaxing effects of S(+) and R(=96) ketamine on rat = isolated aorta.=20 Anesthesiology 1998;88:718=9624.<!-- HIGHWIRE ID=3D"101:2:524:87" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000072378800023&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9523816&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR88-39><!-- null --></A>=20 <LI value=3D88>M=FCllenheim J, Rulands R, Wietschorke T, et al. Late=20 preconditioning is blocked by racemic ketamine, but not by = S(+)-ketamine.=20 Anesth Analg 2001;93:265=9670.<!-- HIGHWIRE ID=3D"101:2:524:88" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D93/2/265"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR89-39><!-- null --></A>=20 <LI value=3D89>Proescholdt M, Heimann A, Kempski O. Neuroprotection of = S(+)=20 ketamine isomer in global forebrain ischemia. Brain Res = 2001;904:245=9651.<!-- HIGHWIRE ID=3D"101:2:524:89" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000169589000007&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 11406122&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR90-39><!-- null --></A>=20 <LI value=3D90>Reeker W, Werner C, M=F6llenberg O, et al. High-dose = S(+)-ketamine=20 improves neurological outcome following incomplete cerebral ischemia. = Can J=20 Anaesth 2000;47:572=968.<!-- HIGHWIRE ID=3D"101:2:524:90" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dcanjana&amp;resid=3D47/6/572"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR91-39><!-- null --></A>=20 <LI value=3D91>Arundine M, Thymianski M. Molecular mechanisms of=20 glutamate-dependent neurodegeneration in ischemia and traumatic brain = injury.=20 Cell Mol Life Sci 2004;61:657=9668.<!-- HIGHWIRE ID=3D"101:2:524:91" = --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000220497200004&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15052409&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR92-39><!-- null --></A>=20 <LI value=3D92>Bullock R, Zauner A, Woodward JJ, et al. Factors = affecting=20 excitatory amino acid release following severe head injury. J = Neurosurg=20 1998;89:507=9618.<!-- HIGHWIRE ID=3D"101:2:524:92" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000076073000001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 9761042&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR93-39><!-- null --></A>=20 <LI value=3D93>Sarrafzadeh AS, Kiening KL, Callsen TA, Unterberg AW. = Metabolic=20 changes during impending and manifest cerebral hypoxia in traumatic = brain=20 injury. Br J Neurosurg 2003;17:340=966.<!-- HIGHWIRE = ID=3D"101:2:524:93" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000185363900007&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 14579900&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR94-39><!-- null --></A>=20 <LI value=3D94>Narayan RK, Michel ME, and The Clinical Trials in Head = Injury=20 Study Group. Clinical trials in head injury. J Neurotrauma = 2002;19:503=9618.<!-- HIGHWIRE ID=3D"101:2:524:94" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000175915900001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 12042091&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR95-39><!-- null --></A>=20 <LI value=3D95>Cohen ML, Chan SL, Way WL, et al. Distribution in the = brain and=20 metabolism of ketamine in the rat after intravenous administration.=20 Anesthesiology 1973;39:370=966.<!-- HIGHWIRE ID=3D"101:2:524:95" --><A = = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1973Q991400002&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 4758343&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR96-39><!-- null --></A>=20 <LI value=3D96>Marietta MP, Way WL, Castagnoli N, et al. On the = pharmacology of=20 the ketamine enantiomorphs in the rat. J Pharmacol Exp Ther = 1977;202:157=9665.<!-- HIGHWIRE ID=3D"101:2:524:96" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DPDF&amp= ;journalCode=3Djpet&amp;resid=3D202/1/157"><NOBR>[<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR97-39><!-- null --></A>=20 <LI value=3D97>Livingston A, Waterman AE, Goodrich JE, et al. The = development of=20 tolerance to ketamine in rats and the significance of hepatic = metabolism. Br J=20 Pharmacol 1978;64:63=969.<!-- HIGHWIRE ID=3D"101:2:524:97" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1978FP47800010&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 698482&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR98-39><!-- null --></A>=20 <LI value=3D98>Domino EF, Zsigmond EK, Domino LE, et al. Plasma levels = of=20 ketamine and two of its metabolites in surgical patients using a gas=20 chromatographic mass fragmentographic assay. Anesth Analg = 1982;61:87=9692.<!-- HIGHWIRE ID=3D"101:2:524:98" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Danesthanalg&amp;resid=3D61/2/87">[Abstract]</A><!-- = /HIGHWIRE --><A=20 name=3DR99-39><!-- null --></A>=20 <LI value=3D99>Hartvig P, Valtysson J, Lindner KH, et al. Central = nervous system=20 effects of subdissociative doses of S(+)-ketamine are related to = plasma and=20 brain concentrations measured with positron emission tomography in = healthy=20 volunteers. Clin Pharmacol Ther 1995;58:165=9673.<!-- HIGHWIRE = ID=3D"101:2:524:99" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= A1995RR29000007&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 7648766&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR100-39><!-- null --></A>=20 <LI value=3D100>Elsersy H, Sheng H, Lynch JR, et al. Effects of = isoflurane=20 versus fentanyl-nitrous oxide anesthesia in long-term outcome from = severe=20 forebrain ischemia in the rat. Anesthesiology 2004;100:1160=966.<!-- = HIGHWIRE ID=3D"101:2:524:100" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000221070400017&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15114213&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR101-39><!-- null --></A>=20 <LI value=3D101>Arrowsmith JE, Harrison MJ, Newman SP, et al. = Neuroprotection of=20 the brain during cardiopulmonary bypass: randomized trial of = remacemide during=20 coronary artery bypass in 171 patients. Stroke 1998;29:2357=9662.<!-- = HIGHWIRE ID=3D"101:2:524:101" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dstrokeaha&amp;resid=3D29/11/2357"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR102-39><!-- null --></A>=20 <LI value=3D102>Morris GF, Bullock R, Marshall SB, et al. Failure of = the=20 competitive N-methyl-D-aspartate antagonist selfotel (CGS 19755) in = the=20 treatment of severe head injury: results of two phase III clinical = trials. The=20 selfotel investigators. J Neurosurg 1999;91:737=9643.<!-- HIGHWIRE = ID=3D"101:2:524:102" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000083251800003&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 10541229&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR103-39><!-- null --></A>=20 <LI value=3D103>Albers GW, Goldstein LB, Hall D, et al. Aptiganel = hydrochloride=20 in acute ischemic stroke: a randomized controlled trial. JAMA=20 2001;286:2673=9682.<!-- HIGHWIRE ID=3D"101:2:524:103" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Djama&amp;resid=3D286/21/2673"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR104-39><!-- null --></A>=20 <LI value=3D104>Lepeintre JF, D=92Arbigny P, Mathe JF, et al. = Neuroprotective=20 effect of gacyclidine: a multicenter double-blind pilot trial in = patients with=20 acute traumatic brain injury. Neurochirurgie 2004;50:83=9695.<!-- = HIGHWIRE ID=3D"101:2:524:104" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000222266900001&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15213636&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE --><A=20 name=3DR105-39><!-- null --></A>=20 <LI value=3D105>Biegon A, Fry PA, Paden CM, et al. Dynamic changes in=20 N-methyl-D-aspartate receptors after closed head injury in mice: = implications=20 for treatment of neurological and cognitive deficits. Proc Natl Acad = Sci USA=20 2004;101:5117=9622.<!-- HIGHWIRE ID=3D"101:2:524:105" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/ijlink?linkType=3DABST&am= p;journalCode=3Dpnas&amp;resid=3D101/14/5117"><NOBR>[Abstract/<FONT=20 color=3D#cc0000>Free</FONT>&nbsp;Full&nbsp;Text]</NOBR></A><!-- = /HIGHWIRE --><A=20 name=3DR106-39><!-- null --></A>=20 <LI value=3D106>Anand KJS, Soriano SG. Anesthetic agents and the = immature brain:=20 are these toxic or therapeutic? Anesthesiology 2004;101:527=9630.<!-- = HIGHWIRE ID=3D"101:2:524:106" --><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 000222940100032&amp;link_type=3DISI">[ISI]</A><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 15277935&amp;link_type=3DMED">[Medline]</A><!-- /HIGHWIRE = --></LI></OL><BR=20 clear=3Dall><FONT face=3D""></FONT><BR clear=3Dall><BR clear=3Dall><A=20 name=3Dotherarticles><!-- null --></A> <P><FONT size=3D+2><STRONG>This article has been cited by other=20 articles:</STRONG></FONT> (<A=20 href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= http://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/524&amp;li= nk_type=3DGOOGLESCHOLAR"=20 target=3D_blank>Search Google Scholar for Other Citing Articles</A>)=20 <P> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0> <TBODY> <TR bgColor=3D#d9d4c5> <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D25><BR></TD> <TD width=3D5><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD> <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20 href=3D"http://bja.oxfordjournals.org/"><IMG height=3D80 = alt=3D"Home page"=20 = src=3D"http://bja.oxfordjournals.org/portal_imgs/search_result.gif" = width=3D59=20 vspace=3D5 border=3D1></A><BR></TD> <TD width=3D5><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD> <TD vAlign=3Dtop noWrap width=3D499><A=20 href=3D"http://bja.oxfordjournals.org/"><IMG height=3D16 alt=3D"Br = J Anaesth"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/searchall/journal= s/brjana.gif"=20 width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home = page"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/search/homelink.g= if"=20 width=3D49 vspace=3D5 border=3D0></A><BR><FONT = face=3Dverdana,arial,helvetica=20 size=3D-1>A. R. Absalom, M. Lee, D. K. Menon, S. R. Sharar, T. De = Smet, J.=20 Halliday, M. Ogden, P. Corlett, G. D. Honey, and P. C.=20 Fletcher<BR><STRONG>Predictive performance of the Domino, Hijazi, = and=20 Clements models during low-dose target-controlled ketamine = infusions in=20 healthy volunteers</STRONG><BR>Br. J. Anaesth., = May&nbsp;1,&nbsp;2007;=20 98(5): 615 - 623. <BR><A=20 = href=3D"http://bja.oxfordjournals.org/cgi/content/abstract/98/5/615">[Abs= tract]</A>=20 <A = href=3D"http://bja.oxfordjournals.org/cgi/content/full/98/5/615">[Full=20 Text]</A> <A=20 = href=3D"http://bja.oxfordjournals.org/cgi/reprint/98/5/615">[PDF]</A>=20 <BR><IMG height=3D1 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D499>=20 </FONT></TD> <TD width=3D5><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD></TR> <TR> <TD colSpan=3D6> <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1> </TD></TR></TBODY></TABLE> <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D600 border=3D0> <TBODY> <TR bgColor=3D#d9d4c5> <TD vAlign=3Dtop align=3Dmiddle width=3D25><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D25><BR></TD> <TD width=3D5><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD> <TD vAlign=3Dtop noWrap align=3Dmiddle width=3D61><A=20 href=3D"http://bja.oxfordjournals.org/"><IMG height=3D80 = alt=3D"Home page"=20 = src=3D"http://bja.oxfordjournals.org/portal_imgs/search_result.gif" = width=3D59=20 vspace=3D5 border=3D1></A><BR></TD> <TD width=3D5><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD> <TD vAlign=3Dtop noWrap width=3D499><A=20 href=3D"http://bja.oxfordjournals.org/"><IMG height=3D16 alt=3D"Br = J Anaesth"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/searchall/journal= s/brjana.gif"=20 width=3D450 vspace=3D5 border=3D0><IMG height=3D16 alt=3D"Home = page"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/search/homelink.g= if"=20 width=3D49 vspace=3D5 border=3D0></A><BR><FONT = face=3Dverdana,arial,helvetica=20 size=3D-1>S. Shibuta, S. Varathan, and T. = Mashimo<BR><STRONG>Ketamine and=20 thiopental sodium: individual and combined neuroprotective effects = on=20 cortical cultures exposed to NMDA or nitric oxide</STRONG><BR>Br. = J.=20 Anaesth., October&nbsp;1,&nbsp;2006; 97(4): 517 - 524. <BR><A=20 = href=3D"http://bja.oxfordjournals.org/cgi/content/abstract/97/4/517">[Abs= tract]</A>=20 <A = href=3D"http://bja.oxfordjournals.org/cgi/content/full/97/4/517">[Full=20 Text]</A> <A=20 = href=3D"http://bja.oxfordjournals.org/cgi/reprint/97/4/517">[PDF]</A>=20 <BR><IMG height=3D1 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D499>=20 </FONT></TD> <TD width=3D5><IMG height=3D5 alt=3D""=20 src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif" = width=3D5></TD></TR> <TR> <TD colSpan=3D6> <HR align=3Dleft width=3D600 color=3D#828282 noShade SIZE=3D1> </TD></TR></TBODY></TABLE><BR clear=3Dall> <TABLE class=3Dcontent_box_outer_table align=3Dright> <TBODY> <TR> <TD><!-- beginning of inner table --> <TABLE class=3Dcontent_box_inner_table><!-- citation --> <TBODY> <TR> <TD class=3Dcontent_box_title_highlight colSpan=3D2>This = Article</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/52= 4">Abstract</A></STRONG>=20 <IMG height=3D7 alt=3D"Freely available"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/toc/free.gif"=20 width=3D32 border=3D0> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/reprint/101/2/524"><STRON= G>Full=20 Text</STRONG> (PDF)</A> </STRONG></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/alerts/ctalert?alertType=3D= citedby&amp;addAlert=3Dcited_by&amp;saveAlert=3Dno&amp;cited_by_criteria_= resid=3Danesthanalg;101/2/524&amp;return_type=3Darticle&amp;return_url=3D= http%3A%2F%2Fwww.anesthesia-analgesia.org%2Fcgi%2Fcontent%2Ffull%2F101%2F= 2%2F524">Alert=20 me when this article is cited</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/alerts/ctalert?alertType=3D= correction&amp;addAlert=3Dcorrection&amp;saveAlert=3Dno&amp;correction_cr= iteria_value=3D101/2/524&amp;return_type=3Darticle&amp;return_url=3Dhttp%= 3A%2F%2Fwww.anesthesia-analgesia.org%2Fcgi%2Fcontent%2Ffull%2F101%2F2%2F5= 24">Alert=20 me if a correction is posted</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>Services</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/mailafriend?url=3Dhttp%3A= %2F%2Fwww.anesthesia-analgesia.org%2Fcgi%2Fcontent%2Ffull%2F101%2F2%2F524= &amp;title=3DRevising+a+Dogma%3A+Ketamine+for+Patients+with+Neurological+= Injury%3F">Email=20 this article to a colleague</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/search?qbe=3Danesthanalg;= 101/2/524&amp;journalcode=3Danesthanalg&amp;minscore=3D5000">Similar=20 articles in this journal</A> </STRONG></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= anesthanalg%3B101%2F2%2F524&amp;link_type=3DISI_RelatedRecords">Similar=20 articles in ISI Web of Science</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 16037171&amp;link_type=3DMED_NBRS">Similar=20 articles in PubMed</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/alerts/etoc">Alert me=20 to new issues of the journal</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/citmgr?gca=3Danesthanalg;= 101/2/524">Download=20 to citation manager</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG>Search for citing = articles in:=20 <BR><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= anesthanalg%3B101%2F2%2F524&amp;link_type=3DISI_Citing">ISI=20 Web of Science (7)</A> </STRONG></TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>Google = Scholar</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://scholar.google.com/scholar?q=3D%22author%3AS.+author%3AHim= melseher%22"=20 target=3D_blank>Articles by Himmelseher, S.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 href=3D"http://scholar.google.com/scholar?q=3D%22author%3AM. = E.+author%3ADurieux%22"=20 target=3D_blank>Articles by Durieux, M. E.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= http://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/524&amp;li= nk_type=3DGOOGLESCHOLAR"=20 target=3D_blank>Articles citing this Article</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= http://www.anesthesia-analgesia.org/cgi/content/abstract/101/2/524&amp;li= nk_type=3DGOOGLESCHOLARRELATED"=20 target=3D_blank>Search for Related Content</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>PubMed</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= 16037171&amp;link_type=3DPUBMED">PubMed=20 Citation</A></STRONG> </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= Himmelseher+S&amp;link_type=3DAUTHORSEARCH"=20 target=3D_blank>Articles by Himmelseher, S.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/external_ref?access_num=3D= Durieux+ME&amp;link_type=3DAUTHORSEARCH"=20 target=3D_blank>Articles by Durieux, M. E.</A></STRONG> = </TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_title colSpan=3D2>Related = Collections</TD></TR> <TR> <TD class=3Dcontent_box_space_between_sections = colSpan=3D2><IMG height=3D1=20 alt=3D" " = src=3D"http://www.anesthesia-analgesia.org/icons/spacer.gif"=20 width=3D200></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/collection/neuroanesthesi= a">Neuroanesthesia</A></STRONG>=20 <BR></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/collection/pharmacology">= Pharmacology</A></STRONG>=20 <BR></TD></TR> <TR> <TD class=3Dcontent_box_arrow vAlign=3Dtop width=3D4><IMG = height=3D11=20 alt=3D"Right arrow"=20 = src=3D"http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.g= if"=20 width=3D4 border=3D0></TD> <TD class=3Dcontent_box_item><STRONG><A=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/collection/trauma">Trauma= </A></STRONG>=20 = </TD></TR></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE><BR = clear=3Dall> <P> <HR align=3Dleft width=3D608 noShade SIZE=3D1> <TABLE cellSpacing=3D2 cellPadding=3D2 width=3D608> <TBODY> <TR> <TD align=3Dmiddle bgColor=3D#ccaa33> <TABLE> <TBODY> <TR> <TD vAlign=3Dcenter align=3Dmiddle width=3D"21%"><A=20 href=3D"http://www.lww.com/"><IMG height=3D40=20 alt=3D"Lippincott, Williams &amp; Wilkins" hspace=3D2=20 = src=3D"http://www.anesthesia-analgesia.org/icons/home/LWW.gif"=20 width=3D101 vspace=3D4 border=3D0></A> </TD> <TD class=3Dfooterfont width=3D"68%"><A class=3Dfooterfont=20 = href=3D"http://www.anesthesia-analgesia.org/cgi/content/full/101/2/"=20 target=3D_top>Anesthesia &amp; Analgesia</A>=AE is published = for the <A=20 class=3Dfooterfont href=3D"http://www.iars.org/"=20 target=3D_top>International Anesthesia Research = Society</A>=AE by <A=20 class=3Dfooterfont href=3D"http://www.lww.com/" = target=3D_top>Lippincott=20 Williams &amp; Wilkins</A> with the assistance of Stanford=20 University Libraries' <A class=3Dfooterfont=20 href=3D"http://highwire.stanford.edu/" = target=3D_top>HighWire=20 Press</A>=AE. Copyright 2006 by the <A class=3Dfooterfont=20 href=3D"http://www.iars.org/" target=3D_top>International = Anesthesia=20 Research Society.</A> Online ISSN: = 1526-7598&nbsp;&nbsp;&nbsp;Print=20 ISSN: 0003-2999 </TD> <TD vAlign=3Dcenter align=3Dmiddle width=3D"11%"><A=20 href=3D"http://highwire.stanford.edu/" target=3D_top><IMG = height=3D40=20 alt=3D"HighWire Press" hspace=3D2=20 = src=3D"http://www.anesthesia-analgesia.org/icons/home/hw.gif" width=3D40 = vspace=3D4 border=3D0></A>=20 </TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></BODY></HTML> ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/spacer.gif R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAQAICRAEAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/misc/title220.gif R0lGODlh3AA8AKIAAOzq5MyqMzMtKa2ihtTQx21jT7+4qP///yH5BAAAAAAALAAAAADcADwAAAP/ eLrc/tCBKGkDWOLNuSNGMBjT1Z2lklmbhnbfIJJQa6l3ru+HMaSUAUEHCAQIQKNyyUwBZMxBA8qM TooBWoRgHC6wVes3bHjIfrkjb81WGQs5WfnGDQjminBYUKIWCkpSC1R6AX95doIQdQJeB2CFhnCP TIBGeIOSdIaYbZ4RIYaOoF03WHcMMgUCrK2urAp1q6x/RopFrZavAnCnARSMjlizu64KocS1WVOa FlCTn9EPSoA3VEAPjJgyvAPe3+BzqqxDAASq0OffRgIi314i7cDswuwF4PhCiLPlsr+ZvCzUESWt 4IKBhrA5CGVEIYNTmN5Ao/Cm0UM7Fi+w60Qp/9E8O3hOKYowjM/DWamaRSA00eAnVW9Gmlkis4E2 BhLjqDxYYNTBjdMGyNtCb4xHFvYWFgCCjsKwNz5drmFkaSmFEMo4GkUFsCWEpjsgSmBXk8FNN0ct vPnnbOdCe4bKStUBpRunIJKURI0FdEHOG8gcLurbIB7bbEXRCpDbAJnOgDUqPhM812lFArKuGuKj 94FYgIdJKtEaGeTYtIjt1EMtulTbQxBCwVLFuHLszb2grtQ0UOFZBWA3uRbOtbCd0DY3r16sg+He lLCnbS6T2TaRinOwel2AVcAxW9g+I7KVz1ungbW3chw2woD79/ATdyRf3idD0sDd/sSItgB+6/8M yAZNEQP09JVKUMj02wGRLNESQ2h8VBxODTKR0XyR3NNYILtB5oBk3L0B4A0gZqLhA92ltIx6Kv7h 4ot/eJecEpR1NCFaawFSlSFKFDcMjDB6GCJ4M0VnFjsm9ffciAcwIqNRVjkQ3HyOLMgNLbxkOct2 kFC2oF8YFZOLfKdoaeYq26Gn0JQmMhegiExKxyN87sWE4mYaNaRYRPrl8ERnnhG2VQAvYCDbcumV pid0XoFxD52TxTljhdux2SSNl5pm4nbNYfqBoH4JhdyRqm2V6G5GMCNkfpSOygII4SBhTY55KXPX hqvcKYKNfK66BkyBanoRazP6SNYnf56Yn5H/8+noLI9v1HgBQlVoESwxxVQlZZ8HQEGCoJbywIVQ UX2Zh6jzrIJoNLKkwKZsYrJiZw7nUGMrO652aw8KjwxjH54QBCLoX5+sddqNNtYWjKnRiDdlST9c 0UF1FjBECziXlUaOZoYww+ywPW7D7UP4EbwfwgyiS1SpiiWKmcZscTORk5bdSgpu2DAimIBIJfRm risPbAenRpV1SqOgJixhSMd+pBUjMe9U4s1E65vUWEBLt8p/y44ULqnC6vtxniuqOBSpKBsm4bo1 G/jQOHgENy4r0vo7WEUOFTF2D0jSG22IWd88oUTmFI4EEiWAIQwyCIvH8MoXPnW44YXzJYIT/89c GFxd+f7s6hK+che62G7OquzXqorcoD582+IDNbB8GnaoZ6cWeYWXf+e6H0LKbDndfv49KbFmOSRL ksJBk2Iag1P6JLUVXThs403fbSylyocxC1PN1FW1xzUhVA0bABigIw8GsDIHACj5OSH78bribi0x buxZ+igDIK8z9qsQfy5jCBLwTgIZ+EnvBtsb3t7ogJXOLYR1TTLAkjTQGDpZ0D02SQahKhahhUiQ BSPAxgXhY57G1O8exhvBQVTIg/JZy3LU4BpekCcp20irhsh6BA4PxIQJUoRlOwyiEIdYEEgEwhuy ykF3fEjEJjrxia2rBA09Uy+AQfGKWHSi+P9i1JINgOB1oOviDVUwRhUk0U87eJknyucN8nzwVZiJ oxzjKAEwvvAhZzTFGsoHu26U0BxgLIS6GtNBYBTyh4ccDBM7ckc6ECIME2RIJKwFvbK9SQ2bWCQM MRI+3M2iE8PwWyKL9L1ljRFfYWEJjJpwmwpxBRK24kh3bqiKMUqSF2vK0JY2uCGCCMQWjynlU0yB Sj/xLhdctAQme/k/rtRlTMC85BRlp6ybXW14VfiDEChDDQdmypIHWmAmhEcRlfVsM7x4oTmgBU6+ bW2E7ilBRayyTtTMsi1wCppyUoOme/TwI7oBaDs99j1YpkckOkFnbRz1ICvWLHZfQFMKZHP/TpvJ 6ZobUt845fMhaFUzNYA60OiGpC21mHNlCaQDLZh5Q4SaEFfTvGRJQZq0YwzSKAazXTt8hlJPkbJt O/XPQxPVo5jGJkqAe1LbTiUbypQkoG8B3XPMp1RWcYtztJEQhwI2skypL58BO6lONckxozKjY4DZ DGUE5JiZSDUCuzrr0IJFN4rZDgTR3JY4QQTVg6WHZwVZHjGHI7gfruIH5FRRj8hq1dqNMyDDwM/C RjOTkc5NRg0sp2P1ekBPNLVThL3TKgRDM7GNSpKzO+dNh3XTttquDIrTK9E4Zzmk5ql016rqJyB0 ht7m7pIDHZJRxyGIdkXVFuI8bugA2xG3/8kuI70hqMaQl9WwbnZ6pQRtg5yru7iKNqZOcldcTuMg TQ5ktVCaELDuuh9e7oNT3iOVbR+nsYMWqpdAClJNIOQQirq1dnbdKDVuOBCNPreqwzAeR0Phtbke 7ICqII3aRCOU9DxyCZjoDi+SycW9qOkto30wNt6wnjCMUgUWQxmD1uID8zyjLF/y1qZ0xQkX+4Gu C50XXAWZvcC18BosjSogvtFiagQrCiTIAAbwOs/noCdDvuEolZaFNE9qZcK7SS4BsMWLYrbOrCBU AkzDIzBB7uVPuItebZ6RX2UItVhRia2lZNFmZVYZt7oq5RlEADpFCLYN7JGmkOucUxoL8v9ivwwT ms4E1t95mEa+M86WztRlX+JErKfhrhL3qTswJ2+iapU0lhaNpsReQDsv0tKJzzpSu6GNNE9mVniz HBqX4iVVYcFbUqXxm88KV7fQSZQ5vijBMrpBKJ2VKZyt6Rbitm3EmCYvWeMr3Bu+0a9J5d5hPzJf 2zC3NNw1l2KNdDwfVrdlm15UxbDzM2D3siyy8TM70Obpc1unJEzM7MkmCIbe4SZ5qvKmVfnNuIb6 +Mg+wXe22+SyRlcGXsHjqVd9+KP0LpLEUDrCHPO4UQh+ASH9011PNk5HGKagwMjztcJ79mbrsFsn ylrYL6PzbW5TqBAeBxNN2sOSkHd3kiWJ4G2CWDGSe1ptpPgF0Kz9xlNxf6CALx+s29Csh4MD515S NHAvG1ScC+Os3f1J9rUYGxb8nUp0xcGfJgv0hVa0cKX+ix/R2NdPF7kiX7hoZkRSTYs1DZAAcCfC /u4dz6lcG5DGHgUIjI1ixYPgi8S+dg20s+Es1M09kMc8fHKWTNKUbxSFF5cEEwAAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/misc/IARS.gif R0lGODlhPAA8AKIGAKmpLriPAObGV+bMe+bk3ebWpv///+bm5iH5BAEAAAYALAAAAAA8ADwAAAP/ aLrcbueQMoawdRQSn//gE2XkABRAWRVH6L4HtaZrYdtqVrx8E1+m2wZ1AAAOptgkWBHseq6f5kQY EACBK+C6OaGIMaagBfUQnMEb9YhFDYoZIyeCnD7Li983EmAZi1UpKRRGJlt0azhkZUiEMVt/X05C XWF/I5dfb4xob0UBkDZbExRuGhocLBJtBX1cmzwHTlQBVgF9F0uCX6UVg6kAY64SaIsgsqURWDoT g76GRtEabmqjtUUUxh52dASgQyeGJitnNEbfX1yyVFdVITKqdFavgr4pj6Dj0X0FTkUp3qx4+dBo Gp0IX4wQMiFgEpZ8DSNiCSWjVqoK2hZMefTm/yKvE6BonBoAqmE0QbdkHHCF4tWDKqe6OBsXSNO0 frfsmRQQQEAbLyiwcJjkoNjEClfGCUjak1KzWk1qmQyGBRuKLKQqNGg24ZPAhEB6CYngk0S4Wzwn XikohwqDmAqt2MHhJuwcAqSuQPXls6daNreOyMiDlCS6cTbasUosgVS/ZXEe+u0zTbAfFgpEKbl3 AijGf4xV9fv0LdjOW6jXBg1nQ8EKQ0N0bJiWqo8sT24CN4TGM2RZgW+sDK4TiGQpoEMYL6G8vCTE niZzMqGwBJsEIguzb5jA3UYM26Mo5Nvb01DJn0gCN6IUTY1TIY4Rbm+VIiXSM4YvKBS1fyT16/+E JLYdXkNwRyAHZzgH0BCoUeVTKRsgRAJ9ckxoYCoP4oWXFRIYJsdekgHBExh0yEDOdUmFN0eJ32jo XSAPNYNDEyn0lc1BVm0hg46DxNPNBCmh2ExflMV1SiE/deUdCd6oFwReB2m43BEx4LAPGsHE8Vhv x0XDRUsEynXfj1KagBULFlzgU30n7VMeVDJUAVNhXiKG411mhoeEQoHdoAJUD25B0ysCBTbnio1d 15ue1JwzUgkKPahBLRXqcNOOUEagoQQNbreKfimZSEJ5Ce050wr/sAbQj5o2uOkVs6AziQU2oKOq BmFMY16PXkSJYIPXffrQa7NOEY4Xg/BzU3D/yU3BYWMaDjsEp/WlVJyJgULox5ePbEaDJCxsahg/ EjyyKBUjZbnMLP9wiKsBlRWyhFLC1XaNpxSGJGYGahYiirODGYBDV1yANJ+mxbnoFWqFMQGSUIIu U8cTXMGWqyc4XnUhDQ0eWRaoMWnKxgYaWfmdYrLVCooSMIlXkg0+xUzVKVp0p9UCouB1FDadvYyW LECKAgooMBoRcxar0mdVAzRDFtN5F+RUBTUVpBYUdIZMrQWEGDUAD39oAuzy1P2g0grRTfwWDsZt LO3ARvfIMwVq/IjixIZ1jmNBFp/Jg80AHvyN4wgCJf2Yp1U05acJSQ2eKwEftOz4R8vOOG5gse0l Mzgv76Dq+GsNBhbSSai54fgq/UQxBaLJfOvLDWGY6Kdn8bySkQght7MeRpT0Dt9xbyy41BE9NOKF P2l8vZDe9FB3zcxEMBJvvKJo67ufQk86yBh4QNAlm7zQVdmXjj0kTdfdK1BFX+dQiUhQcbqPkOhE p+8DfVxmbPqxGaOEmf0OeMSMIlQuBB1sXiED4DFMJJJLiUokJ+iAAkMAoAbuQiQqud0EjyGfzshm DgBMAAA7 ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/shared/misc/arrowTtrim.gif R0lGODlhBAAJAIABAGZmZv///yH5BAEAAAEALAAAAAAEAAkAAAIKjAMHidsLm2HHFAA7 ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/shared/toc/free.gif R0lGODlhIAAHAIABANYTNP///yH5BAEAAAEALAAAAAAgAAcAQAIjjI+pqwDpTAzzVPjQ3Nl2Boah Q0pkd2YpVq1mW2IypZ5vVQAAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/math/dagger.gif R0lGODlhBQAMAKIAAAAAACQkJElJSW1tbZKSkra2ttvb2////yH5BAEAAAcALAAAAAAFAAwAQAMX eDeqoCJE4dp5DddjzDCKQYFHYGmlkgAAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/toc/rarrow.gif R0lGODlhCgAVAPMJAMyqM82rN86tO9GzStK0S9S3U9W5V9W5WPv58f///wAAAAAAAAAAAAAAAAAA AAAAACH5BAAAAAAALAAAAAAKABUAAAQ1MMlJazXISlKyHUH3AaE3DQApnqlqom0pwbFI18jdCobu 6rKbLEEbElPGY5K4THBMFIwmEQEAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/toc/uarrow.gif R0lGODlhCwAJAPIFAMyqM82tOubWnvLpy/j05f///wAAAAAAACH5BAAAAAAALAAAAAALAAkAAAMV WLrc7uSpEcSjAFiGs16d94XiJykJADs= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/toc/dot.gif R0lGODlhCwAJAIAAAP///0JCSiH5BAAAAAAALAAAAAALAAkAQAIMhI+pGb2PWoC0yooKADs= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/toc/darrow.gif R0lGODlhCwAJAPIFAMyqM82tOubWnvLpy/j05f///wAAAAAAACH5BAAAAAAALAAAAAALAAkAAAMW WLrc/m0EQCsVRdq7dMWMB0bB6BBNAgA7 ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/math/ggr.gif R0lGODlhBwAKAMIAAAAAACQkJElJSW1tbZKSkra2ttvb2////yH5BAEAAAcALAAAAAAHAAoAQAMd eAR1F+4MEmMwR2BDaDSDYwABYBRNNFUSC7IDdiQAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/content/vol101/issue2/images/small/39FF1.gif R0lGODdhyACdAOcAAAAAALGxsa+vr62traurq6mpqaenp6WlpaOjo6GhoZ+fn52dnZubm5mZmZeX l5WVlZOTk5GRkY+Pj42NjYuLi4mJiYeHh4WFhYODg4GBgX9/f319fXt7e3l5eXd3d3V1dXNzc3Fx cW9vb21tbWtra2lpaWdnZ2VlZWNjY2FhYV9fX11dXVtbW1lZWVdXV1VVVVNTU1FRUU9PT01NTf7+ /ktLS/z8/ElJSfr6+kdHR/j4+EVFRfb29kNDQ/T09EFBQfLy8j8/P/Dw8D09Pe7u7js7O+zs7Dk5 Oerq6jc3N+jo6DU1Nebm5jMzM+Tk5DExMeLi4i8vL+Dg4C0tLd7e3isrK9zc3Nra2icnJ9jY2CUl JdbW1iMjI9TU1CEhIdLS0h8fH9DQ0B0dHc7OzhsbG8zMzBkZGcrKyhcXF8jIyMbGxhMTE8TExBER EcLCwg8PD8DAwL6+vgsLC7y8vAkJCbq6ugcHB7i4uAUFBba2tgMDA7S0tLKysrCwsK6urqysrKqq qqioqKampqSkpKKioqCgoJ6enpycnJqampiYmJaWlpSUlJKSkpCQkI6OjoyMjIqKioiIiIaGhoSE hIKCgoCAgH5+fnx8fHp6enh4eHZ2dnR0dHJycnBwcG5ubmxsbGpqamhoaGZmZmRkZGJiYmBgYF5e XlxcXFpaWlhYWFZWVlRUVFJSUlBQUE5OTv///0xMTP39/UpKSvv7+0hISPn5+UZGRvf390RERPX1 9UJCQvPz80BAQPHx8T4+Pu/v7zw8PO3t7To6Ouvr6zg4OOnp6TY2Nufn5zQ0NOXl5TIyMuPj4zAw MOHh4S4uLt/f3ywsLN3d3SoqKtvb2ygoKNnZ2SYmJtfX1yQkJNXV1dPT0yAgINHR0c/Pz83NzcvL yxgYGMnJyRYWFsfHxxQUFMXFxRISEsPDwxAQEMHBwQ4ODr+/vwwMDL29vbu7uwgICLm5uQYGBre3 twQEBLW1tQICArOzswAAPgAAGAAAAABkTABATAAGAgAAMAAC6AAgACwAAAAAyACdAEAI/wBfCRxI sKDBgwVnXSABBKHDhxAjSpxIsaLFixgzImQjgUOzhxnCaNSIg8ivX0h29folBAlLISxNCoHZy4iR XcNeEiFSbCWRWCODCh1q0cqmTZVcdcoAZSATWgCC2Bg465WRWkQpVnCXtavXr141GRLVQcjBdq40 XOgD9mDVtnDjynVYYRCmZw7lPWIkaCCOAKIyjan4LUDXY38ESdBAaa7jhzt3Asm1K7Lly0SAWO4l pJfmnb8wE/EZORiRYFOzhgMhig8Oi4oOFMxm4oMAd4GveWvWqIOrUB0+fIRiQR4GgSx3lZGQ6Bm9 XDRw3HrFI0AtILOu1+Ljw8YsH0B0+P/IVavZNxy9bu3SscuHEJNEsAbNbMVTn1Yf5mzyxqKRPQs8 1HGELMkkAsoCwAjwCSOPfBICBwg0kMkn8nTggRMrnXQSTCcRkdpjBUEBiSmJFJNJARDQcE0HAs3h RBdwJFJFIqxEEAcbfhxkQwk6gOjjjzS8EkwcBFjCAB/jJHCDLy+IEgIgh1SwBwOapNBOL4zkIYEP BUTQiA+C5BEJE9woEMYEPiQAQi/t/BEBN8U8UkpDBt0xFRNVoDLEHcsss8c0BtkQQgNVrGCCI7zc 4MkGoSgzAgkWQGOKKBH8kIMnl5iAzKOQTKECKesYUgUIIgSyRAqeCKJCEB9MEsEUH4j/QMASpYyQ gCk9aFIBBNJoAgoVICKBRDjdfJPJDqGg0IkIH/1BTwAhKBIIAwWsw8crGZwyyCeECKSNJr+48QVB RCTggjY8uJFKAV+EAokPPOzxghs8dCOKBERwYwIFvRwzwShSvPKJWQTZAIcaAimRxB1bdDENEm/N MZ1As/CYTDACBZPMK7kAKhATxwjkgxUC5UKyQFbskvAyAulwxVQpCwRENANNo/IrMb/ihBJZKVGH IRkg4g4CLcDigimAHEBIBYnAYYk2kDzgxiTPYCKBznG0fEMelPShBimGLAAHJdyEAM8rEmRDSTqd PCCDBU6wvQMlF5zAiiWTaFJDB3m//wDBBheMsooGecuSyQUewKIJJZOwwkBEsAxTBzcQRUOCG5eM cskZhhRRSTkLjNJCH+1E0oMEbBwiCwZqKACDKOv0IYILYzCCigd18JEDCucEsgkshZzjQA0guAFI KiWcQ4AJrdADTyUOBEmUOw00koJAONDjyi7LWNLLNQ2oUUkXiyASCCCOVCCIKQgcY88LqnDgAe91 sAEURUgwcIEiH73yRRcCeUYuBIKEcsBhGDQ4gz2IMI0yrMMIr6jFdHRAhGEQ7CEKuAIkfsRBhOxi EAqowyMQ4IFzpAEElZDHOORBghSMABQocINXpNADJFRkMgRJhhu8MZVZ0CAO0dhFLv8GGBEbjEAO WpBGN2Zxgiy8IgEomIQBSFAJH+XCE154AgIEYgMVXGIgX3AFBuRxAD80AgQayIYnGpAIEBiiFZEo xCA4EY64GKEOi+iECT4BggxcYBIY4EAISuAkRsShF0LhmUHkMxIk3M9br/gDHyZQhzO4owwP6EI6 snEGPhwjFhBIADfOcIduXCMO1YjDMdzRFIwYAgCngAAAHiAQRNRhIGFAgSB6sAk2nAgUEdBFEf6w gQVggBGGiMAvspKOSQikGHOoxRzG0QUqQEEKzeBGGqjwDCksoxnWvMIYssCEMgBwICC4QgfX2RYk YMwhPGAn9nIBhF7sggdvkWdBNnb/BRSg4gyz+I5AJkanAeJADWOIhQ5qYY9xfIEG07FBj8CST30O xBvOfEUrLTqUP5hBCdMwBRTUYAJVcOscnHAEJSLhCUV0owUkcMgYxtEMHQRUCBIl4kCkNwsc9Igb bkBkQUD6SI4a9agSAUI6zvAKm9LABkABwjBegQSzxMIGNGACEnxwhXRsFKkPkYcppLfTrA0kFzLM yAAcAMGICOIQdAJrRDABgEnIgg7XOEMVB4GAM3AiBir4BBRWsAonvKIDKUjHJS6gAFYAwgMikIAJ VvCJCWjAFAkAxYJqAI9TRKIVEnhABTiBCBCYYBByTa1qV/uKG6yBHLCNLTnaAAAA/6AjARKphgCA 9YpsbOIV9uxDIFTADSas4xQgoAQlWKSISpjgXriYQCogYQkRMCoSllhBCDCwCAHkIp4QecDZXnGS Q+QBBogthAsyIIlOaMISLGDAKEahAFJ8QgIpOMApNkCLRlCAEiVwAChOkAAeXNAhl6ACDXpBBQgk wgM6qEYlUsGIEHTiG0L4BAoEUAl4LEQDmCiEJiBBCQVMABMnkEQh1AOXcDCCAKLIQMhewYZEFGAD IpCHIgTwhWtgonyvkcssfqGETGjiELngTGgC8Qt7+iBJOBACeDLTCx6EQxBzyAlnfsJajhpiFZg4 cEGs4ArcIiSiNCjGK7xxhBBUgP8FTpoAENiwihIsost4tqiYB7KHR1SDnRWYQ54HnREhxBQiBDjE UAJhgVdI6BCE+MYukPCAZ1xjF1KYxhVuQU4IMLCohA71QwbxASmMggkXOUYEVLAINWfECuMwSC8a keJ2TMwhPjiDI1IgCUUOZCYLgkUgKNGIJOSBGYqAgQkIUYwmFAAHNhhFJl5QrCvc8RnTSAMSznCG NHigGKyMxjmKARNGasQkv+DBJ/xwAgisoAUfqAQDUnHfC2QgAZ0IASYuUYhZNMARl7CAKjpRCFCE oAUg6EAiEqEJDxA7EiBQRSWM8IsPwYUHBSBFB7rhkE0oABsZQEAgXnGMVKTAEXf/SAMFguGAL3Tj DxyYgQJI/opzkCIQIegRuovRhWv8Yhm/CEMxiNANJSQDCVDYwjOM0AUoGCEMLkE3ujUUmqnDx9wZ AcIutu4DH7SHB1tvD2W83p6ut+fsZjd72c++dq6HfRdkjUg28hABQMxiHUwIwCo2sIwzeCIFUChD J1oQhmhMoAUDkMI3PKGCwHcCFWOgQgRisAoijoMTJajDLdoRz2LoohaDwMss5OHrgexoFrF4ZJBf sfrU++X1AnG9QJahyGE0Ayg+kEJDaEB7AjYjSD54RkNi0XujPgMOfOhEJ+AgD0k0gRa0SMEeIoCE SSgBAYYIxCHgIYlFXKELLDhF/wFiwIBdIEAF7uhFGliwACh8YwUN+OYHMBGGWpzBFIUIRygi8bBH JO8EcTVQB0BEu+ALPhAB39AAIYAIceANqDYQsbACGjAIs5AAFlABvRAOFoABkgYJkzAINlAIkQAJ RHAGkkAJYfALkHABBzALhIAAKVBHk+ACC/AKfYAKm9ALSnACpfANr4ABqaBo9pAKH+ADyTAKpOCD GeBEXqEc35AHZVAGkQALq9ACOeAABqAJXKEJbBAOgPAKl+AOzwABlXAHr2AIX1h0AsEAIzANigAP TAA9DNAOGMBUryAAbCEBgPAAOLAHotAL3DABasAANnAIgsAIv6ANHvAIwfAFkP9gCOOQC5WQDJ4g ZiVwTq9AA7hwDAuQVgRBCrxlAyTgCN3wAN0QB39wB5DACGrgAMNAAHGQAHHQDYcAOmfAAOHQANHQ CFswAdVgD/BQAPTQBQ7gDY6AAdUgAVTwDQdQBwcwDRKgDRIQBo2gDY9gBQrwDYhAL0TBBGNACULg O3lwAV3AADXQAMgkEIRAC7ekAxMgABQgCTpQBzaGCAmwCbfwDRxgCISgAQzAAorgBG7wATvgCSRA CvDQDNVQVGHQCqcgC2yQEdmQDsXwDQZAAXnABBNQXCwgAAQhBeSgANxwDQMBD6mwBwcRAh4jahKB BNkgEF/gAo+ADEQAB+0QCyL/kA3BAAm3MAntYAgCwAIdgAAPwALh4DAYcQsn8ArDcAEXMAKcYAUn 0AdWEAyM8AphcAJEoAOqgAGPwAcj8Bq74A2vgAql0ALPQASYeFbyUA1MgHVCAAEckAYCMQGuVhDF EIAsSRFAkAlnkAUPYAsooAoisJKOUQwwUAEmcAaRcAUDECatMAcO0A1wQAV7QAgMcAwNwAdl0Ah1 8AEWMAls8AiUEwkT0AEGEAAFUA2JMAjaEAFhYAAZcAJ34ATrAFY2IAlDQAvyMBADgDBGxQOiYACF IAOBAA9mSHLnwEmvkA5d4AbNYJZlMAY+WBCM8AEWRxGC4IPjQA/aQAITYByQ/4AJcKAAiQA6DCAK L1kRsXYLHVANUpAOhrAH3wAEWwAHZ/AAY8AN5ZAFe9BWcgEEt8YGqnABmHAOi5AOmqAGFDAHOfAN EtBtHlACbTEIpyAAr3EFxWAtacA43/AHTJgFfFBHr0AFwJILhNAC9LCXcuUECMMDc2AD5kkEC1AO EgAjbEAFBxMBgyEROYAHp0AJAEAPVxAJv+YKp0ALk1AKKbABI8AHrWABpIA4yQUJAVcBOQAIGTAC poACJOkjnqAHiPBKG6CUGdELBhAROBAM0ZAF6TANBnAG59AMY/BdEMEHtjFVd8AHcIAAW2BUGDUQ v6AJqqAJjTAJE/AIIaABjv/QCRIAAYLwCI+ACZogCfaQAacZCpRwBoqAASggChaQNZ/wZxFgCZew gitgCQpgCJCAAJpQCRdACp6gAV8qT7FwB0hQC7XwC5XwDQzQLeMQB+fRmIEgCV+wDukwBhJVC04g aKu1AgAwCC8AAONQDY2RDiIwCxTACeTVFEJgWEZwdCnyDLcQC1SgAwYABOf6ClKQCrpiAx8hBMug A7mAA82AAcHXCxCwDmzwC00RrlWRCSPgCRqDA1QQC4LgDUJgBFsQB0LQFEgwYyBiA1JwDOcwDfuZ BVegdSzasXhmbljnsRphAm+wA+ygCSKbsqw1DZLwCl1HGUOkdkKUCy87HkP/VHaoJx5DNEQ2cAte t3oOMQjnUDKUIURlBx7QhgM2W7Tj0XVeR7Net7Q88LIR8QhNYXY0u3VMS7Njx7VLW7Mv2x5A4AO3 FqAlgAkQMAplKxBQYAkJYADZSVEvMRN0OxOcUbedgbd4O7dCAGoq2xVA0AGG8FsHcQzdIAGI0AF3 +RizIATNcAMRcAojAEKo4CAicAgpsAv2MAKhwAAhMAKo0AgZwAGUcAkjEAgysAkn4bd/mxVuQAGY 0D8IYQk9imu1QAPg1bq6SxHF4AEJIAuHYG5qMAIbkAGuoAAbkAaFECivQAROcD9CcAzPkAXJYARI EAYDUAzPsAvV0AiyixER/3Cbu8ta4vMIBYAQB6AMTUEDwzBRP7IV4ztol5AFnLBMz0QJpsAJCXAK KGBWVsQMIhC/oRYNO8AVDqEDmlACeokR6YBaAqy7veAJEeEHyysQvfCAFyEPtGQBlEAKjrAIH9AB GUABppAJiNCaG2ACpKsBpTC0BcEEQaAACtAO52AI7fDAPnIMDyAAF2ACdEkEPywJKlAHgaAAa3tR mtAaFYURsbCWDmED0RAHgOAAEwAJjyAt7lANIUsQutpTNgBtqIcDsYB6saCrX2zGT6WrarzGaowD bKzGcYfDEKED7IYJlHMRftAEyyRWLHMBfrAOl9A/NAAExTAMPnAQ7OsJ3f+CHL+QC0TwCYfgDIxQ CsTwCZIwCpIwCaSwCTeQCIawAoRQCo4gA5XwCRBgCDPgCRFgApiQASLQCYkQCqCgBrkQGltsEUQA E7dgApfACu1AD27ABIIQBtzAB1AAD3vAB9ywCNMQCGWAAwvgAaIwDmUwB3lQAl9QAFfgBn2QB+Ew COsAD3mABPYwBpoRt0SxDI8QS6XnECqQABAgD5XQDHzwCANxDZyQAQyQAhoAtCzgBDigEnXgCgJh EjpwCKkACpEQAsOZAog3B0fgCmMgAjNAYCngAqhgCTwQGhxNdR69IfEhFDJBtu1xC+LhAzowGWCX C7fgZL0QC7vwC0BQT+P/wQNV9l1bN9M5rXVAAHahgc5xoQYMvQcV5QlbkA3wEAIu8AF7kAdkKSSy AASfUJ1XMAfucAml0ACHvCPuu5fopq6dEAoBAAJIUA2/UAeQkAvlkABjgAGKIAJqwAGTEAKRoAjy IAiGsKqHYA8HwAEXQG5UNxMa4iEj8Uj5lE9FddgFUQs1wAIYUKvNuQ5qxgS4wAPVMEDuQJcGUTFd Lcc+sgtpMAflcA5b0Ai4UAEH0AgycAknIAO6sAkpkAM/QAohwAtBQAqa0AM5IAMZkAIsEASjMALK IAspUAIo4AumkAqwoFMDUQiZoAKHUA24YAOMcA3B0JuI/AJ9wAR/UAMa/3AMbBAKL3ANWfAIP9AH yUAAsMABTKAGoaAK5A0JumAPTkAAUfqXh1AEDgAF9PACKiAF4XAJwJAG14AIRbAI/P0CpCAFadAB wBAO18AAPfBnYDUNexoA05AOzKMIEMAJJzAKEJBfi1AJXwAEnJAIi5AHknAJAgABYbAIzeAA36AI 3IAIaaAI1XAHfyAPeXAMinAGExAB7XAA45CA4aAAnSBUBbEO49ILQQAEQvABGpAOnuAEw2CHXHTi fRALjBAJFmAD65ABG5AMv3AJlGAPsRABkRAJNhAHlXAJxzAMmIABe0ADjpAHD3AOSMAJGGAIPrAI lzAJSJAGoJABaVAMnP9ACQzw5x1wAUbABp5ACdo2AsAJJK+gDd+wDp8AC5iACaBACaNwCCrQDRRA AIjgaG8imoVQASOQi46gAKmQMQ8ABTrwBR5jBdxQC8fgBFJwu1BwBRijBE5ABTjgBGGASLswBixD AnuWidrACFDAC0LgCBE5EH9Q6a8wC6DwCu4QA2YhBD1QnSDQsq8AD6xgFr2AC2UgECNAAQJxBzJA MPYmEGcwA69BAzEQa9hyHK8QDjOAFbNQA09tARkwFwabDFewDtWwAD3ACzOgCZnwDPCQDrPQCTe8 DJfQAK3wAHPACNXQC7DQo96EAyJghjqQAVZ8lThzCF2QCF3wANPwABz/MAYKMAfP8ADVwAjasADa YAjrwADaQAhwUAd9kA4KAAUjoOSvYAN7cAmgIABSwAO60AuIQKLBUA4YAAOKFnuiUAcloAjFcAWU 4AnekAim0A214A0ggAFOAAUPkAJfIAWJUAphYAR5YAp/8Atf0AGa0AzJsM/f0AenAA+3QAWRQAJX gAR/cArukAxBeQe/MA6gMAHtPBS/sA6CMAFskAYREAS+oAq8+QhsAA8VMA4VoAh/8AqS8ADZIAqy QTFQ8AEQZAOVMAkO8APdAgHJQAEBkAaVEDbakAlXcIABAAgt4AF5Pgo5sAd+IAmsMAlxoAAm4AJ3 0AecAAP2IAAasAMh/+QIksACZwAHFscEkEAKIDABUUAIgOAHfIAIlnACIIDttbADHJCBDoAA4QAE JPAHtRAJYYDjAGFlQgA/tShE6FNrwh4ItwYAUpCNiYU+gWxgsIAjQTs/8HZZ2JOoFoJHDGolALSI SbdGr1y+hBlTJkwjEgIdIuVpRIAMTg6tmMDnAQEUf/wscHnuR7eXcDwsYGHKybgHlNIounngy4Yr G/qkc0dq054DKDRM+vRn5loaa2GGiLO2TgpPGzpgEzVDxgkMX9Yi4bBBE6sPmTC5SIGJw4tIGTps guEhEwcXpBS7EKU41I8PHFaN6MCBlAvFpTZB8tBh1adMl0Z3cH2KA/+mTqyYuMW9dpqGYgJ6WJAk wqW3RyheKWFU5tAke43kQQpzpdE4R336VDjjIAeCdApWDcAkSlBbt0bWvNN0Yl4zl0LcpMv16sy4 bC6zjSPyykavVwJC+ZJgBRgwoWGSDZbJrZMT5Fnkm1f+QMETCwyJgIUrcsMwQw035BAmHoJ5hZAT hIhmhF2aOQQITrLJIgN5EiGEAkhsmcAeQ1r4wJQVAtEwFgFe6YWFEfZQwophxmjrgGeikYGRL3j4 5ZgtlHhpmi7kqQ6Jc3C7JR0qOwQzTDHHdKuLURJgAZR13KEEBB/COOSVSOiRB44PcsBkAxQCIII/ Mm8xIZYNx0nglWL/vlDCBpeSCUeAX16RwpuXlulmFiOMIC+mPQCghQEAcnjFEydwWKELerLpoIBC DnhkDzLJdALEVzEsxpFA3PgEHk2+qIaCGkYZxRP2ZiU2tzIE5WGaOawgM4Nkih1TFjLgCQEApF5R JI+XmuEEBCssmKSMOQRBwANFQDFBAEIWIaAAEdrR8BYJSsmgGGg7HCYTlzQAwYEHXgjkkwNUYMAP WcI5pBAJgr1EFEsYmOQCCD7x45UGUvikjhMoIeQPCgooAZMKErjkG2R8uBfaZ5h1iYYaSHgpGFA0 kWAXK3LJxodectHBiEYG4ICKlGO6o4RKvKGBDVUSgCMPOFxwBIoB/wR1KRd7cUjngxPcILMxFxDx wJ4OFsgEhEI2iKOQRDTJw5EKdunQwXFueWUcKwZxJwADAHGDnmmQLieaQOzJxp1DErkDEQEWOEPM cNgZAhw6uH7lAW2HDtOJUWAaBg4n8lhmmDuSqYOPaJqZ45o4lHDjjnBOUAHBl24pBQjMX8VBglrk GSaAA/iwx4AuChlnEQP8oMcPAvi4JpzbcQtHkTkk4UAEeyzYpJQEOJlXkAo6uWToAzx4ZZoEiLgl kThwyCOaPXB4RR4p1oGHk41QDoAQKhR9BYcS6nheAAXYITW4QASPOMUCOEEzGEwgFYyARCM+0YFI pMJBt2OCIT5hgv9JDOAMVzDCLGgQCxvUAgjNUEMgNHACTwjCCAOEYQxluJYzcEEL5GDBLB5hDBt4 gxXnuEYtnmEvl/DvFbJrmRNGNcO1xKIC1pCGI14hhM09CAJfyEQZRoCKDwACFBGIASRIkA0IRIAA GOAEIRZ4CE9wAAEl0EAEAkAsHwzjJeOQxAGMyESXjIESihDCK7wxiZfEwgrTkMIxtNEOH6yjDHGw whjocYsv0CMX04iGE+SBSCU84xkoY+IioIGMOAkBZlJYBSWqEQ07VuMXEVjGMW7TjGBEw0+4ucMY 1BAMH+BgFrPAQSx8WQscAKEYaXBDOGwnkwLcYR0KsKM39vAMPrr/ZZCvsEIlysAMBQThAgbgxAHK kAAepAMQBAhFHXJxgHJAARBxEMIgWMAGQCSCGwQIhyPg8YpSUCAGUDDENTwwiHLAQwkdCUQICpGF QXyBA12opkzOMIdY8KB8jmACN4igBnfAjwqZmIYCMBEGB83iFjyoBjciulKWxpBXucBBMgIACEq4 JA7fcMMsuAEPDryiFvQYwwCIoAMb+KEaLcVQLcKRBZcoYQ5IhWqGdBCGc8SBlrfQQSxmYQMbAJMH RojGOdLhl6jmxhDxYAEvsDCMLRDSJQOghSoyAQoEnAITicAEJxrQAb4CIhQRWMUFOGGIF0xiEBUQ hQcSYYpPXKAT/46QBCcqQAlNXCAVlOAEIipxiUGIABMY4BEKFmAESLTjAwEggSUiAIsOWAADmxCE JDIxAySu1AezcIkbevoKI1gUt/B7BXlmgYRHvUoHZUUuUjEAABKkQB3RoEQVgFANSjggGPDIhQH4 0AwhVKwdt4GHEATxADXMNhHlSEc23NAOCFyjHGMIgwIK8IA47KEAaSjHJK7RjiyoIbn/BXCABTxg As+QB9TMEBLakAMB/IAMXTIBDXpBBAr74BlO6IUQhICEYiCBCEhAgoaFAIQ+/eIXvfiFhpORYRP/ IhgWzQ1nXRKMXxBBCEywghGEgOITC+HEKRaCjX2sYRT7wAhM2P+xjVEcjEDihgYpKMcrmEwEIAyj Gj7uRTCKUQwdI8GVQ96xj41wDB/3GAnDIALcAmgEQdAtTF0AwRSJ8AsgZAETkBAI3vLAh1vAIQAB SEc6ImAPDKTjETEQgQCWQQB5IIARJKgFEWCMm0XcwSUtNsIgglEId0yiDg5gRSjkIYlx9AEOcViE IeZQBj5E4g8JKIQ8+ICJNAAiHHfYxS3dgolo0GDOJy5ECM5xBwyoYQB/sEIvGuCBdfCBEn8gwKES kAW/GSILkUhEH9QABDXDcA8OEEAiCjxucuMmFgVYAQLakQFGnKAPMVGAPaLBATcHcBZz9gEQctFi E/O4xkLYRZn/+X1ifQ+cauVmIhI28Q0YpCEmPuhDAxQggzSQwNK7AO4AcSAEKNiCAygQBCcEEQpB TOAQnXhELfgQggqMgAAbqMC4AjExXEBgBAXYBREOjvAZyoMUIrjNWm5xCnfwEQdRKgEIJtGAcUyA BI14gCLa8QggnCMCi3CHIiQAij2IAAQHSEAlGqCJDZh45zyPoRso0AEo4MYSY8DQL3ALrf1wGwjc 3sXd7a53vN99F3nfu98Bnym0x1ANjsCEFHCTAbKuRQfwk/AWIFAGA7SjG3FYWx36MA16FN7zYnpG B8aw25jE4gCG2MA3MHEhmZxUmEhQVBomIAsMVEABF+AA2C8B/4hHlGPuYvJBLT4/7mTA4RmOUIGl eYABCZmgAU5wAxuWUI8oF9IlS9TQLPbQ7TBFoujD5/kFGCE2meCAAwAQdxGJIHwmVuD74Ed4N9gA PQMAKT7VdD/8PU8PDiiC8K+Ig01IA0+YNCaShMvRP577hkq4gATgg24ohFMogCNyB5QKgRC4gi9w nhiqBEtLQM/DgHbQAKZaiz8wBD9wgA9UwdsBAk/AEAEoBGJRAWOAn2Wohd9bQfj7BZjJDQKIk1mp A3EDhSt4hEewAAKghBXgA1KYhA8oARE4AE7oBBOQhBeYo5jAgWjIhS85uxyUISa4AabADdkiDyqg l2kAE3qIgP9XiIUyCIZd4IEsGDMomIZh6AUg8AEhmAYjWIZguAYcdIlmIIUbmCwXgAJd88IY0gB4 eKy1sIIYQIRC+EGYSIcR+IR1SMRM5JAxAAUR0AQKKAEVGISMy41pmARSQADuA5Np8K+12AU+uIRg kYQGIIA8qIM7GAAG+B4U0AQCkJWYoLFlUIJqIIJoeIYtMAJtQKEx8LFr8LBfuIZ0uAaAQ7GA64Vd oDMgEAIaCziAo7BgOK7hMwBMaBwx+QVDKAULEJowsYJw+MV1SCA/MIADMABQyg0dKAAWeLeXSLE6 SIMWYAUUgIAhQAFagARGyAKSkwFRqIZ2OAUVIIUEYAVQqIT/DRCEUkgFCkiBTugAVMgADviAEOiA YfAx9iOTrvqllFTJlWTJlnTJl0zJYqGBdiABT0gHfGGAZWACVMiPV+CBbwiHY0gDCQiBFogBT+iE UIiBTRgEZuGGRTgEBxgHFICoV2ixXhiHXYAHblCDOSiHMmiAQSCdWvCGbrABeHKDMzgAd7ACRjiD dMAbgFkGAxiDRSiDNKACH1u/Wfm1XvAGPygHIeCBPLyFu+OBnckFHgACN7yFXJuGZ7iCMuABKDmG XbiFXvABHkjML3ACzewFHsg5ItijYtmCSkgBBFimDJmEbxCCdQiDV3gGFiCrAiiAWOiCUMAERTgD pjAAXHgA/wZQBD64AvKxyl+ohQZogRRQhBI4A0uAhzKwBHoQxTNoBARYQBiAA0koA2z8tT7xge4c uBozyTGxsV+4hVBgBVT4hhCAgdb6gxZABT05hU7YBE3IBAwIgFkohG1QASeQARbwABMgABm4BBQI hRJIrQs4ARO4hBhIgWIQgtFMmWBABFOQhGjIjRZIAhPYAkVwBCFQAT4gj2JYBhrYgiZ7BSLAAExg j9BRhRxQFBO7hQMQEgqwBAnSAAoABUTgBEuQhBUYhQrwhBJIQgLYtxRD0hbTy4Hby1f5NSEYAyTY gnCQBzZoBkDoAm0IgGjogi+YhjDohmUAhDHwgSuwAicIh/8yoAcmgIdykIdu4IYsyAJu+IIu2IIu aAZ6OAMSk9DbiYU7MIFPoJyY8IQsgIMUsIAycAk1yII+eIRRQANTEIcbuIQHoIcrHIZFQIUtKQHh 64VPxcN8A4KdGdVc0Ltd8IG8ywVVHdVPddVXfdVW/VRSFBMqa4ZIGAdLGIFv6ANtWIZeEABv0IFv QIAAaIBboDABIIJhuLs+yYVzgAMeIII83DEgU1J+60IYygZLKIVBACVP0AaQWAR5aLoWWAVNqABJ cIYDSIULoIC5CoULSIdw1I8SoNfC+zUfyAIHIIER+IBscAWr6IRI6IAaUIE+cAVQgISbO4FTKIEH wIRN6AD/TBgBCFABGQiFMcDG8DQx0WwpIqhQX2CAREAARHiA4/gRlxgGUJEEagqDa5gJG7DX4aOx OfvUYKiFAeiGyQxWnfnUETMCIEixYPjZEcuwDAu4JK0xfqMwneMQHbi/ZFgHBKAHH1ADP0AAKAiH AUgAtpIHRMiGWRgHPyAEKTgDPygEI9iCPDiEMACBYKiDEuCEcXiJNIhBJdAF7gOEAiyimdVEpHoG eRiEOoCDaEgAGCCEDTgABWCFVgAEQQiBHzgAQdgEYjiEAniEHZgEeuQEXxCEA9iEIFgAzM2BGyjA bLiEVVCE4yICXcABR9iCV/gGMYwJGyCBy2OAATgGNygA/wdYBjVNjmloBwYgACU4hwJIBCgAXm+w gjlgAEDYhXKAg0hggDFgg0PIgDIoBz7gAHpIg3WQBEPghuulhG8ohz7ABHdIgziwAETIVgDDASUI PstbBFYIhDtghBsoAWA4hQsgBUCIBhYohwp4hhD4g0Q4h00ABN0sAA7IA0MAgk4ogAYYgUmAgDzo hoOtABRIzZc4hjIwAgdQBWyQAkW4gmT4g56MCRpIBQ1YhEiYAYGUABSAhQmAAEzgBQ54YVhIgUVo BBp2BAjIBF3YgEWwgBmIAA7ggE6gBRLABA9gBRYIjVG4gU1Y4hsYAUzIhCieDFKAhc4QgRtYRwC7 BTYIBP9DCIQrSIMOeAFOMAEU4IAM0IVEmIAzMAA4eIUSIAU4SIQy6IBBQIQzWAQOYIRwYIQKCAR5 kAcQeMpweIAROIdA2AB7OAA1CIEgqDeY0AZtAYIeUAJ3gAFz6IE/gAO4gwkb+IRn+AA30AAhqBFI uAI3uAA+SIBjAAE1qIReeAQ/sIBqSAdIGIADUIIQSINK0AE1cIA0cAAlsIAsuAAkWIA4MIQzSIMG +IZEOAZJ0IYLGIZDYAND+AZk9oZFKKth+AYqmFI10ISDDYRO+IEdiIFWiINIeAUF6AIgMAVGSINN CAYDyIZogIYduINaaARfeAQeKIcjqIBcGIcgCIVoEIL/EjgFCriFTzAGJJCCGrCgWwhdvn2FsHIJ IPAFHkgEEUiEYfAEEKk+l5iFEeiFDNiDD+AGQhgADbiDbhiZR6CCSZCHD/iCQTAADZCHMZAABZiA Z8CAO9gVJKCEPoCAXagAnhoGeTgECjiHY6AEPmAEH4CEO+AAJLAHQoAENVCCShCARchkPtoCPtiD QPgCOOgAYmCBFUAFBeCAPuAAb2AEAoiEZIjKV3CAZnAAZvAGOICAYwiHJ3ghQtitZmAF4YMCVgjH UsDjV6ACVugqF8DQV9AARHiFT0DEWliHdjiDYdCBIQCCRnC4VwCCQKhHmIiFFIAABggACXBhtL0E W/mD/wyQBAbog0aohAfog0K4hAkwgD/AgEgwhD6AhAJYBwiIhAWAB0K4gAfgAwGABEcYBAaJhEOo AwSo7j4YgEhohECogwewgAaoLRiKhXAgAAiQADfIgw+QgQgggVR4AAgwggl4hXNggURQAAeAhwXg kQaAXURIAWzqhBd6iV1ogbZ7BUwYhFdAvZcYhfl7Bex1CQWoBJeIBlQ4LlBAUZiohjsoBh3wBSE4 BwgP6Zt8iVkogVhQS5cwggcorkHA8BlP0QjoyULYwDRAgLqVlFdohn3yKXggonAQQyn4Ph2QBwY/ A0WVoTO4gwoABQH4A0xoBUjYAQZ4gAAAgjyIgBTgHf8IeIVC4AUFiABDaIsSGIApCsdLaIRM4YB1 CIZHwAUJyIVFIIMsKAcTkMBeOIQb+AAhYINW6IReKIdTiIFqcIJNQIROGPHKoYJscIRPQAEx8IQa MIVNKIFQ2AB4OAMWtwFQeAXodglueAEa2AVYOAaXCIARaI8ZQAIgaYVXDxUeeYV0KAWX4AFWaLsU wETYhIFwXIHKTgF4yXDSEyAfgIM9sItHYARKCAUOkAVCEABDcIQIgIdio4EHkIQTWIRpMAVBeCum cECX2IQMCABT2BJGqEoJkIBzQAQ/wAQ1sIBMaIcGUMtKYANGkAd9LwSIXQdDgIcLMAR6SIBY+IRJ XwX/Q3gJGtCFYkAEDH+JLWABBn+FH8iEWwgHVYCBZEgGadiAXpCE+ZyuUcCFLxACDAAGbxACCxDd WgiAGSgFImiGEsCFNNgFGJCFWjiAFTAFKyiGDggCAdCBQfCFQNABQbAFEMgFb0AFusUcIFiHdMiA MHIEEMAES4iGb1CAV6iEERCAQwAEFSgEQFaUMAiEo3qJS0jBZZAAe3AEWBiAZpCEYsCEONiFDbAj 6FwADTCCS/CDFJgEdxCFbnAC/BQB5HCHUIiedbhdd2CACVCEVxCB+3sJbkiFQOhJWkACQVjt/kmD UCDnl6gBEQiHQhCADfCDdvgERBgHRRgDTqiDPwCE//ROgwi4hD5mAEO4hDBQBKXes0CgAEbohhCY BG2IgGyohEGAgwRwAAwYAwjIgAsIAwgYgA8YhwMY9mK5wTq4AgNghVG4hBN4BAq4hkAoAyAAhTSI BgmYhSYQhe52CTjgAyIHgVqoBVrYgzAACE7uXkFIU6CBgQymxjBx5EMSHAeEOjx49m3DjzJXGOQ4 R4WjBSnfOhxJYwURrnRUFgh7cOxOKnGiEtV6ZfMmDm18oHG6cIFRoDRGbt6MJUlaAlTVCEC45OkQ gw1EEvUBVQdOIgaU4iQqVGmapDoppBhqACrAmA0OUjyCdwLJngSQIGSzwMdEGUh7TjyLEEeUGqKC B/8TvnkrD5U+q3qcavUhAIE77Whs+taO3qxNk9JxePQqG5tXyWgNy8UAnh8w8rgheEVpjxFL3Syo EeEgVAIn7ka1ogCJVNlSFpDIE9XpWx0TIsbcaiR82B1RIsq4M+EpzLQOuDYVfmUjy5kzRwRkQHSr +6to6awYwBVpWTtSHZysG+WCzbRBPS45iaMCU38n5HBFGJPE0AU8LaDQTDiYoBLNNxzcMIAUeaSi ikWZoELFN5Yk4cZGP2iDHok3JVUDCfQccg0FvSQSiDd/vGKJI2WkMpBNGViQTTRfjPDKN4U840E6 GoSSyziCvDIJPBAQAkMo3bSzwQ0ptFCJD0TZIEX/TSWSuIASgxnhSSdW2ATIGyQoAM8ufIgSChOE cRODCt0EQ8EnBSwjAQmC0OCNBx9088sEnwDihCMkHJDLACM80k0kntiTSwIkQJDMICQw4kMyGHjC hw+VLoLpJxEIMQ4nmGTjJavLZHANIghE0wgOczTQTAgSHGOTBJ/MUcohrzASJzwd1MIHIWxEIMEN F8yxBSIrcDCBBKQUMgciXxBmwxKsIIKBNVnaJEUwN23BQ3cEVHEAJC0c8sIeBxzRQjmDASKETdPs UgYNy4iwARVEfQMKqwUbfDDCgo2RwTJ87AGkLnnk60IhrExSiwPcHGLBKwic8wo8FSgwgggLZEEP /ymskKKCZ955WQMq3RATxCw2fcMDFGmM80ws58RiwzhAqDGLG/C80gcflURASTKaLCKMASWyYIsb x+RyUxbuFEJIMwl7/TXYgyWTA47TiIAAKp/YM0cEG1BiQyBxBEABPM8UAMMlBjjQggESVLAFq0aM KNgtPNjwyjXr4LBtMVd4c8UXNxdzHmFKjBM25plrXqIfn7xCTwYLrKDAaZEccskcaWiAiCYBOMHH KTGYsoIhrwTzS8E8mELDLRyYAI8ojYTwyDOvOILDNbwwkAckk2gigic0eBeYKg7Q4sYyUhCWixPZ uLELetJvPj753Z2jCg3DXIBEOaQkQs8j7jSgQP85JASCCiVZnGNJlaT0AfYtTiC9PUSAQa8oRyKA IIRrvIII4XiFDkqRjmkw4Rs3qRcq5HGeLuzKJtooxxe8Ua/B7OIHdpiCHPjwClB0bRwhYMBN/AAB egyufDZE2DA04YNpKEAIIehC+w7whw4QYBUZ+EYcNkAKRFgCR5hrhxceyKpclEMN2jBCOdqRhpoV YwzfSEMZuqCNyIWGRHAAADsuAYAXvEIEyeBBC2rRjTuQoAXuCMMNC9MLHRAlFR64yTEykQko3ER8 XapZOcJQh1d0iUTBGMEVkkGBXBCREzPowBnsEQpHwIEBqyrfUDCnBAvahArnwJfBynCHcllhDQr/ sIm4KJfHwWAAAByoQTxIiQgnXiEBpGBAJ0wAgQiAoBAkQEEI7GGCDxxgBKPIxuVKZANM+AERHEDB IAJhiRLkYQChnOUrZlGIB5hJMMtglROQUAc2DGNxYXDEH8Q3mG8cYxjg/Foj6rEBFLCjCzZZxMMI t4GuCSYBSBCMPEuUDgwsQpBCmAYf70kUI+ACBH4QhQBEIQoUECAEjpgBHzrwCUhoQhOBwMQLONAA EoiAEJsYgQDK8ApIlMMdLFgFCTaQgU9MQBYJuAQlJAAJE8hIomHrAkFtwoMsNJIwNECX15p6MBsU 4xrfYMM5ylGGagwjoSTqhU1wcIVXDIOQTPiF/xVsIImo8YAHOlgGERwwAB/Mwgngu8LieGAF3A0j GTjQgQ9uYQUd5AIHyUAEBQZzjHMU7yZQzYU8icCDZ8hSc7coATa8gIKr0eATFbhJACJhhUQ8ghOS wAQmLrAJTFhgFRFIhQnKcQapbm4Wd9jEKDQgiS4oYSjNWFxRhHAFAWhAPunA3B04MUmiNCNgtotD 2M7wCgMggg0KAAQbGHGIDEQAERLwgz1esYkIbMERBTjEIDaAiAlMAAOE8Joad/ACAHDnFYqQ2E3i AIlzhEEJy3DEF5DghnX0Ih0BCAM3wlS+XHAABhQgghuAAAW6pSEM5ZDAIOBhDx/s4RzhkEfUbv+S DVBM4nAJqwAq/gAIC1CgACDYBARg8QlKVIIECCipKrJwMJm+ohniy4UPYkEUHYCvO4er2dfWcQpU LNImp7lJMSYAgXICAbrjIsot4FC+SSzgFUqwxxXUcAaZKgEOz1gHFeoAhYE4gB5SgAcNEhEBJNsE EonIHOVqAtWb2KCyXrqGMq7hhg0wYhBWKIQgFJAIAjTCAgRARALccQk/yMOoRBkHLWghDxiIAgOW GIQMIrGJS7RABKQAhCfIB48JECUXdUgGFeBBjy5IoRnZa4aBp9GMb8DhC90YBz2KbJNM1NDSCauZ PIFrExMbu5A1A0ItoBALHAChGLMIRi2SoYP/WDghopsDgimuxghZsKEWWwgHPMrgBG/AQRv0oAIU vtAFJpxhDmEYRzr6MFabMAEFym42wG8YhlSEQh6/+EUwkHAMRtgACjZYVDKAYAMq/DtzkdAE5Zqh CgxcYxx3cMIsplGOOmQBCaUAxR50gINQoKDISggFIgIu8zyeowXegIIIypEJR1wAEyY4QSNAcIk8 hAARrZCADV2VggY4dxY2yAAGarHnwWQhAqWAhD1nrvWtW1oJ7ngAB0YQChOQfewm+IQlEgGHb3Id BzjwKtfjrthAtEPIROiGTYQtd4TlAqq9CIVNBDGBZaygDx+IxAJG0AhGjKAulQiACR5hAA+A/wAR PUCEACbBiTps4hPlHF8XDDENrcdAD5X4BADaYYBUzCIbKHCDMf5AiwdEYwzn4EAz1JyCOeCgGnE4 xgcCkYV1NMMJcChDNI0tCABQAwUAsAcPTmAzdzjBHt3gwAMK0I0D2AMTbmAiPc7hjQK04hJhqAAh zrGIDYRDAHHA42CEXLBYHIABYO2xBQgRCNoa1R7mWEUUDIEPdMMk3MQvjMANkEAlpEImGAAIcMAK YAIpUEAnhEAFTAImbIACnEAJaEAgWEAkkJKlDYAerEIH1AObiIJNFIMUeBvm1EIcLEUWfEM0HEMW dI8T5EE1GAATaE9hxAECCEAhzEI3KIA9HP9CMcidNxTg3oGN09nEGdyAEFCBLkQAFXzAKBgCCBgA LDAAJ2zCApxCBcjAAKAHEhgAFBTDtLndLODALLyh29VCLcyC1LnDNQCOYGjDAgQh3MXdEr4CGwwB PMxBL4xDF5xLxSlBUg0GN0jPFdzfNBxUOSDAJ73CLdCZY3UBcGmD3hkMD1TaL6zDKxxDAwzAFUCC x50DAgxCNISBEySClZHQFmSDDdQMIKBhOBxAUtVBARSDAfgB+Myh3TShl/yhTQDBC8BADTiCJYCA A3xCA4wAJ8TBAmRCJ2yABGyCB1QCKFxCBHxCB7QXIGhIJMzBK5jCJnHAAogAKDQCK6CAJHD/wghQ ACVYAh+QgAlsQCVqXRggQS3wEQPQAyBokBq0QzW8ggTQgzxYlBWsQzDQgA7MwrkRI4nsQmPZBBIY wS8QwTAYgRUUg3Q1QzcAQS8Mwyx4gxP4wC4UAw6MQTMMgw4QwS9wAxQgAbocg/TEwjj0ghBEQzN0 QS78QmloAxMQATc4gbXFXRpUAw7YAIucgSdMQy6MgTvAgQ0QwDlMwjVMQxqsAxzswj8mQ7FRJFmW pWAcgBTYQC7swSQAgU38wgEIQCzcwQcQ0itYgQAgQjDEQjhEgwuaJWCW5TRMgz30wi24ndvZwLT9 DGK+nRVMQwH0ITFaATCggRd0wCtwwwbY/4T01OLBdKIRdFBhTN1fEQanYKJg4ICfGVUxIEEfXIMf PMM5NMM1aMMVuEM1DMKuBaZg/AAdZIIGAEAfWAEGIM4gEMEKuEAYmAAIGEImiEABlIBmyIAWZkAF pAIbUEAFqIIbUMEcyAIIRMIEpIIhaMIILEIE7EEjXEIAOJgsNAADjIAJDAInhILEiAIllEIkiEBp VcAKVAAolIAhIAIohIIhnAIGoObWXYEf8CZR9AEpgEDAVAAzEIFNUB8QHEIrNAITMAU3tMIiLIMh hAEFtAM3REA4pMMZREBgEIHi/ME4NIIVbMAMEMIAOECKCkADnIEg5EE4sEE2hIMH1MDD1P8BuqRB MkzDBZRBGggAIBzAFqjBOlxDGhiAAqymse2CJ2DDERAAIFbCK+SBKoRCOZhCGViADUBCfT2CKBRC LiCBEMRJLyABDvyCESCBDeDAQQmlEiwC99QCA8SBPNjAOeUCToINDXSig5IlL9hBBXwAABhAGYDp IGhAImDAJUzAEhSCLLBCI7yCBxjCMHjCFViCC3TAJVCAJkyCBgACCcTAB0jABTDABIDAA5RCB2CC IXyACbhJCAwAxyyqsCZMLViCL9hCpbVDCHxNIByCWw4rtEartE4rtVartV5rYOJAAoyAAcgftn7r zDWDHfwAHBgDOljoedSiDdQiDcTCGzr/3brC67vOK726K71KJlEo2xuuayz8DL3+K8Duay3+K7N1 B+Xsq9PRwMDCq7oqLMDG67zGq7eGzTAsgxNcLMY6QR2IwQdcJHogAhgAwzYoiQVQAxKopCJEQgCQ QgpcA1wtQARQQCwQAiEMgxU8AwUYwRUIwTBUgxIwwTUoAALARjAcwy9gKVHUgi8QzCsIARFgQiGE wiaYwDFYQTAEQzXU0zQIARRcwS4UHxFYwTJcwzAsAjwAQi9sQS8kwxXI5P11RzFgQQS8Qi9cwwmw wSaowCIAgRVEgwZMAjcEQ4EiQDAMwzEwQRYwgdAIgkYm6TAUAgHwgKJ6jTxsDc1eLgJM/4IeNIEh lMvBZAMINO0v7MIsfAICLMAFuEIHbKMmvMIiaMIHKIIkiAAJlMIlkMIClMAoXIEJXAIBaMAOSIEQ IC1RLMIdvOUv8AARuAAleIIlsMDtEkIpzIAnqFYDkIIrZAIICAIisEAodEIhbBQBpIAoCEIl1MLb dgcmRAMNEIEQ2AAc7J4ixAAJSIInjMA3JAMkXMAKlAAEgMIJMIEFBAECVMIDCEMBgEIMdIACEBlg dgEniK5M7kLhAMEt5MIu7IIPEIEG7wIQ7AIP+AAP3IIAYMA46IAQABkRNII2AIFklQgEVFoDyeQv BCUGu9UdYMA6SF0HizCQ9QII+4AQ+zBA3wGBD3wwEaRvYXQA+9Jw8t6CEEuuEDvtCEexEP9CL+SC EOxCFvdCWx0xBw9GQAAAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/content/vol101/issue2/images/medium/U2460.gif R0lGODlhCwAKAMIAALGxsYuLizs7O9TU1HJyck5OTv39/QwMDCH5BAEAAAYALAAAAAALAAoAAAMy aDpBFEOpJkEBCgQzRFFE9HGHsISEVJjgkCoCa6SjsZ5GgA3HEYUgyGAAIGAqjkfEkAAAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/content/vol101/issue2/images/medium/U2461.gif R0lGODlhCgAKAPcAAAAAAAEBAQICAgMDAwQEBAUFBQYGBgcHBwgICAkJCQoKCgsLCwwMDA0NDQ4O Dg8PDxAQEBERERISEhMTExQUFBUVFRYWFhcXFxgYGBkZGRoaGhsbGxwcHB0dHR4eHh8fHyAgICEh ISIiIiMjIyQkJCUlJSYmJicnJygoKCkpKSoqKisrKywsLC0tLS4uLi8vLzAwMDExMTIyMjMzMzQ0 NDU1NTY2Njc3Nzg4ODk5OTo6Ojs7Ozw8PD09PT4+Pj8/P0BAQEFBQUJCQkNDQ0REREVFRUZGRkdH R0hISElJSUpKSktLS0xMTE1NTU5OTk9PT1BQUFFRUVJSUlNTU1RUVFVVVVZWVldXV1hYWFlZWVpa WltbW1xcXF1dXV5eXl9fX2BgYGFhYWJiYmNjY2RkZGVlZWZmZmdnZ2hoaGlpaWpqamtra2xsbG1t bW5ubm9vb3BwcHFxcXJycnNzc3R0dHV1dXZ2dnd3d3h4eHl5eXp6ent7e3x8fH19fX5+fn9/f4CA gIGBgYKCgoODg4SEhIWFhYaGhoeHh4iIiImJiYqKiouLi4yMjI2NjY6Ojo+Pj5CQkJGRkZKSkpOT k5SUlJWVlZaWlpeXl5iYmJmZmZqampubm5ycnJ2dnZ6enp+fn6CgoKGhoaKioqOjo6SkpKWlpaam pqenp6ioqKmpqaqqqqurq6ysrK2tra6urq+vr7CwsLGxsbKysrOzs7S0tLW1tba2tre3t7i4uLm5 ubq6uru7u7y8vL29vb6+vr+/v8DAwMHBwcLCwsPDw8TExMXFxcbGxsfHx8jIyMnJycrKysvLy8zM zM3Nzc7Ozs/Pz9DQ0NHR0dLS0tPT09TU1NXV1dbW1tfX19jY2NnZ2dra2tvb29zc3N3d3d7e3t/f 3+Dg4OHh4eLi4uPj4+Tk5OXl5ebm5ufn5+jo6Onp6erq6uvr6+zs7O3t7e7u7u/v7/Dw8PHx8fLy 8vPz8/T09PX19fb29vf39/j4+Pn5+fr6+vv7+/z8/P39/f7+/v///ywAAAAACgAKAAAIbAD/mYN0 7N+/fZi8/csHCh21UbuU/dsFbdqvfQbmtHswi12jYvX87Yp3DgClicfcGSTXI4/BYMfkCfwjy1+y f8J+RcuXJdMvTYPwpVoHKlaECQ4iTOJ169+zPsrm2fP26pLBf+w2/SIWa5zBgAA7 ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/content/vol101/issue2/images/medium/U2462.gif R0lGODlhCgAKAPcAAAAAAAEBAQICAgMDAwQEBAUFBQYGBgcHBwgICAkJCQoKCgsLCwwMDA0NDQ4O Dg8PDxAQEBERERISEhMTExQUFBUVFRYWFhcXFxgYGBkZGRoaGhsbGxwcHB0dHR4eHh8fHyAgICEh ISIiIiMjIyQkJCUlJSYmJicnJygoKCkpKSoqKisrKywsLC0tLS4uLi8vLzAwMDExMTIyMjMzMzQ0 NDU1NTY2Njc3Nzg4ODk5OTo6Ojs7Ozw8PD09PT4+Pj8/P0BAQEFBQUJCQkNDQ0REREVFRUZGRkdH R0hISElJSUpKSktLS0xMTE1NTU5OTk9PT1BQUFFRUVJSUlNTU1RUVFVVVVZWVldXV1hYWFlZWVpa WltbW1xcXF1dXV5eXl9fX2BgYGFhYWJiYmNjY2RkZGVlZWZmZmdnZ2hoaGlpaWpqamtra2xsbG1t bW5ubm9vb3BwcHFxcXJycnNzc3R0dHV1dXZ2dnd3d3h4eHl5eXp6ent7e3x8fH19fX5+fn9/f4CA gIGBgYKCgoODg4SEhIWFhYaGhoeHh4iIiImJiYqKiouLi4yMjI2NjY6Ojo+Pj5CQkJGRkZKSkpOT k5SUlJWVlZaWlpeXl5iYmJmZmZqampubm5ycnJ2dnZ6enp+fn6CgoKGhoaKioqOjo6SkpKWlpaam pqenp6ioqKmpqaqqqqurq6ysrK2tra6urq+vr7CwsLGxsbKysrOzs7S0tLW1tba2tre3t7i4uLm5 ubq6uru7u7y8vL29vb6+vr+/v8DAwMHBwcLCwsPDw8TExMXFxcbGxsfHx8jIyMnJycrKysvLy8zM zM3Nzc7Ozs/Pz9DQ0NHR0dLS0tPT09TU1NXV1dbW1tfX19jY2NnZ2dra2tvb29zc3N3d3d7e3t/f 3+Dg4OHh4eLi4uPj4+Tk5OXl5ebm5ufn5+jo6Onp6erq6uvr6+zs7O3t7e7u7u/v7/Dw8PHx8fLy 8vPz8/T09PX19fb29vf39/j4+Pn5+fr6+vv7+/z8/P39/f7+/v///ywAAAAACgAKAAAIbAD//eM2 7BChUcwE/pP2iB++eP+yBfvXzhW+Qk0ILcE2zJexc/u6DPsHIFO/WsfeCYzWR4rAYMfaCYRn7Meo f8GK6RtHSaAZFv+IWQPWrAC1XhY6oUv1T9YyYZAasdvHCt2/d5kS/hNHi92/gAA7 ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/content/vol101/issue2/images/medium/U2463.gif R0lGODlhCgALAPcAAAAAAAEBAQICAgMDAwQEBAUFBQYGBgcHBwgICAkJCQoKCgsLCwwMDA0NDQ4O Dg8PDxAQEBERERISEhMTExQUFBUVFRYWFhcXFxgYGBkZGRoaGhsbGxwcHB0dHR4eHh8fHyAgICEh ISIiIiMjIyQkJCUlJSYmJicnJygoKCkpKSoqKisrKywsLC0tLS4uLi8vLzAwMDExMTIyMjMzMzQ0 NDU1NTY2Njc3Nzg4ODk5OTo6Ojs7Ozw8PD09PT4+Pj8/P0BAQEFBQUJCQkNDQ0REREVFRUZGRkdH R0hISElJSUpKSktLS0xMTE1NTU5OTk9PT1BQUFFRUVJSUlNTU1RUVFVVVVZWVldXV1hYWFlZWVpa WltbW1xcXF1dXV5eXl9fX2BgYGFhYWJiYmNjY2RkZGVlZWZmZmdnZ2hoaGlpaWpqamtra2xsbG1t bW5ubm9vb3BwcHFxcXJycnNzc3R0dHV1dXZ2dnd3d3h4eHl5eXp6ent7e3x8fH19fX5+fn9/f4CA gIGBgYKCgoODg4SEhIWFhYaGhoeHh4iIiImJiYqKiouLi4yMjI2NjY6Ojo+Pj5CQkJGRkZKSkpOT k5SUlJWVlZaWlpeXl5iYmJmZmZqampubm5ycnJ2dnZ6enp+fn6CgoKGhoaKioqOjo6SkpKWlpaam pqenp6ioqKmpqaqqqqurq6ysrK2tra6urq+vr7CwsLGxsbKysrOzs7S0tLW1tba2tre3t7i4uLm5 ubq6uru7u7y8vL29vb6+vr+/v8DAwMHBwcLCwsPDw8TExMXFxcbGxsfHx8jIyMnJycrKysvLy8zM zM3Nzc7Ozs/Pz9DQ0NHR0dLS0tPT09TU1NXV1dbW1tfX19jY2NnZ2dra2tvb29zc3N3d3d7e3t/f 3+Dg4OHh4eLi4uPj4+Tk5OXl5ebm5ufn5+jo6Onp6erq6uvr6+zs7O3t7e7u7u/v7/Dw8PHx8fLy 8vPz8/T09PX19fb29vf39/j4+Pn5+fr6+vv7+/z8/P39/f7+/v///ywAAAAACgALAAAIdAD/sUNF SJCgRe3+/VvnCRo8hc0GufqHyNw/bBwC/XP3ad40hZkA+FFojZVCUZUC8FH479Y/cIviAdjDEti/ P18cASCSKdy/VsfsnasGwE28fsNGtdH2L5mRQvPqdXLnThQ2cv/yOXPFTuG9UqWM4QrGT2FAADs= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/content/vol101/issue2/images/medium/U2464.gif R0lGODdhCwAKAMQAAP////39/XJycouLi9TU1LGxsbu7uwAAAM/Pz6qqqk5OTkVFRTExMSEhIRER Ee/v75qampCQkHZ2dlVVVQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACwAAAAA CwAKAEAFRGAgEoMgDIQonkBbCEVACO3RNFMrBMUAHIyFBCBIKVoLA8TxIIpKhmhEEQscfwlEizhr GRCJg3Y3KAAGDkaCq3qZUKIQADs= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/content/vol101/issue2/images/small/39FF2.gif R0lGODdhyACCAOcAALGxsa+vr62traurq6mpqaenp6WlpaOjo6GhoZ+fn52dnZubm5mZmZeXl5WV lZOTk5GRkY+Pj42NjYuLi4mJiYeHh4WFhYODg4GBgX9/f319fXt7e3l5eXd3d3V1dXNzc3FxcW9v b21tbWdnZ2VlZWNjY19fX1tbW1dXV1FRUf7+/ktLS/z8/ElJSfr6+kdHR/j4+EVFRfb29kNDQ/T0 9EFBQfLy8j8/P/Dw8O7u7js7O+zs7Orq6jc3N+jo6Obm5jMzM+Tk5OLi4uDg4N7e3tzc3CkpKdra 2icnJ9jY2NbW1iMjI9TU1NLS0h8fH9DQ0B0dHc7OzhsbG8zMzMrKysjIyMbGxsTExMLCwsDAwL6+ vry8vLq6uri4uLa2trS0tLKysrCwsK6urqysrKqqqqioqKampqSkpKKioqCgoJ6enpycnJqampiY mJaWlpSUlJKSkpCQkI6OjoyMjIqKioiIiIaGhoSEhIKCgoCAgH5+fnx8fHp6enh4eHZ2dnR0dHJy cnBwcG5ubmxsbGpqamhoaGZmZmRkZGBgYFxcXFpaWlhYWFJSUv///0xMTP39/UpKSvv7+/n5+UZG Rvf390RERPX19fPz8/Hx8T4+Pu/v7+3t7To6Ouvr6+np6efn5zQ0NOXl5ePj4zAwMOHh4d/f393d 3SoqKtvb29nZ2dfX1yQkJNXV1dPT09HR0c/Pz83NzcvLy8nJycfHx8XFxcPDw8HBwb+/v729vbu7 u7m5ube3t7W1tbOzswAAoAABsADQGAAB6AAABgABdADQBgABWAAAcAABewChewAKXAAA6AAD5gAA AAD/sADQAACY4wAAAAB/AAABYAAAwAAAEAADAQABCABQrAA0bABY4AAAAQA0AAAGAQAzAAAG6AA0 XAA08AA06ADA6ADAzgAFDAAEJAAD8ADwsADwsADwPgATGAATAAAEMQABMQABAgAA/wAAEAAA4AAD 8AAD/AAFAAAAmAABBwAAPgAAGAAAAABkTABATAAGAgAAMAAC6AAgACwAAAAAyACCAEAI/wAbDVrC IcqXRggTNkKTkI0lhY1yFYF4RpTCNwl/RIIIMYgkjiBDihxJsqTJkyhTqlxZ0sUAXV24kMHBsqbN mzhz6txpkpIXVElQ5dqBUwUTXrpkKUGF6gjTpqqmcOHligXPkzxu9cLS5IhTpk6PNMHyRYuPqyeV eOlCRcnXpkxVxeLypSrahC54HUlyBEsShaXauGgk6QvXKb2UNLpSBWiSx49TQZ4suXKSVJInH5mS RWGqLEVKDUHVastJGwAcY44MOfPl1qxfPy7SS5NCWLGi8KmkKxWXk7Os7F09uXhm4sczb+7cSNPH Ri5osIwEoLjxVl0edSnlBw8cQm32/P85s6vNnQ1NagWyAIfUmCbKo+hRUwo2ZFe0aEg4QOAOnxAT 4HFBBB8I0kQRtriC0CxTvGKBLGr0YkgZfWiQxgOBxAILIHVcUMQsuxQRWStTnCFBfa5hVgQXm9zC ChZybMEHBhC8IVESqkjWy2A+7ZUEKxfIkkAEDnghACweUGBHEamogooYT2CWyhGvCDDIa8dFBshd CgnBhg0K8dJKFFuoAIaUWVqW4mWrIadcLzDUdEQBRJQxhBK2iMgmm5WtyeeexKFyBSw6sdBLcvYh KuWeskl2RC/PcYkQFb3k4kUulDSywxZa2MaRDGRNEZZrkB1RxGa7ZHEJS0PoQgoDcBD/AUtntlBR S0hE8KIFK02RqsplTrGSxReoSAqSDLV8EYtXe/3a2pRHwOLFLWAay9ErP2iCiQ02aOLtt9/iAK63 TxBxFw5/xYIDK0FQIsoRMEQSRSqzPGJVIzIQpgJ0hIlSxRMIsXCEKpfkG2cjSeRg7cIMN0LDDwoj JIMYAETacCPoNtKJF64ckQUTOExByyeqNJFLKzm0YksqTFiRShRToJTwxTSjJQkODyG0aac1J/TI z0AHLfTQRBcNdM9Ic9kFE0/gQhgAr6hm2Z+NLpoEglgkrfXWLP0gBhNNtRYLLRx1UQQqRaR9Ntpo p422KX1aJ1tksFjRyAC55L3F3rnw/72FbxMlxEInjWDyyEj7QgRDzjZkyvXjhOmFnFdwZaEYRLkE RTmznHMeGaLGTVkFoSQxgYCnkKeOFi5M8DVLKyFNMYsQuxQQRBRXJETLLaYwCjqabWL2aCmqF881 Lq3wZQXsxjfvvLWsaGELFrh48vz12EMkCwEAwPJDKqQIoEQRAohCRRehdHErC2VYcEAQSYyhiiqy cJHFETwMcUkRUejiihJKqIUuLJa9AjLsCPu6hA86sYkHsAsMpBCCDwJQClFgghdPUIIbOpAKTWiB FqbgQhRQ8ZEBWGABoRACAFhBilhkoRam8MQPbDCEVnChCaaQiy4OZsAeIk0GXhgYKv+4QBQfGvGI CfEJUIRSRI5oYQqpMIQZiNCLiGnnCkyyDuiwlJkiVMEL94LIJbrgBV304ggrGUIY+KLF2BjncwAI HEgskQQmnGUlucAijkglN7l9aBdhXJAOONEFlqQCC47hSypc8QRXPKYXh1OIDUIkPOCh6QhowhFl 3JiKIuwCBzDgAi60cItbZOEWWhglLsTwikKCZBaw6JUlZ/m7uLHpFbd6gii1gAUupCoLpBSDFbrw gzn+ZJaY5JPV+KhFVHShiTqBQS644MgppQIVvchZQkTBu7d0jllwcZPvjlOEW5iLJFkIAA9CsgVe NWVz37wmKibnlT4tSgm/IUkowpD/NZB4YgumeOeovKkie2qOMlJCRRaIV7OdoY4Vu0hk1T5H0SwV QRcAw0kWbJUQSYAhapt849yIcwRXAICHPFELk7KEUPsUZ0WvYNgjvqAKU5DCFJ7MQQ5IGTGuCaEX V5BFF6qAEFRowRRINGIr4iSAKKjBAWMQQBsgQAcrZAELCQBAExrggKyRYgjn+svFkoC6pFqLBl4Y wgNMMIdSYEEImhhlWRuWsVokwAEZaIAbsmCGNGzBDFzAAC7a8AYIVOAMuLDAGmwEhwjQgg16WMAZ 7sDQhMzMrFpzKEdEUcZXjCo5TkkFFb6QBUxg9rQ5ocEuvBBJhShBCFEQztxmO9I2/0amCF74hEk8 sSrUMswTqzhECWoQipVswbPzg0yOcIQKMLggC0kwgx0CYQcOWIADcyhCBTIwiDYQgA99wEApcnG/ ydDiAhJ9zPyO0AVMdIGZknGWUS/XCB/YohERaIIaDJAEOLzhFqhgAgQAQAsBGMANteDFFnoRBQQo YBezSIMoAuFbm1jhFZhBxRdMixBLhOEWCPHBF3KBi16QohFF2AJQiJOo4MXNTUcAQL4q7FvkTel1 OWkFL3Dh2adQDm1y6UIXTkzjIisEecpjnpGXXBNdsOEAHE5JzEJMEh+0lslYRggH7ACBXLCBDGY4 wAHgcIcrtKEORZAABORAhQT0of8VcVCDHHgRPTZwoA2hsIEEXjGHNEDAB2xgQBQMwIcFMOABYIhD Lt6wBwacoTsgzrKkJ03pH+4Ck0UYSqU3vRNKXDooudgEWizhiVD84Ac+6K3qWJCDU5t6ExspHqld 7QPpNAyIe2GiSGRQhVxoQY4KmcUXePW7RKFCCby4QuKM5QMw0GKefHIW6Ew1CwAUd2FV+ALYfORS 5BzbC7VY9k5wHRQiguQRelHCIQxQhCuoohGqCFEfazvvcisZIamwBSxKkAgXmeYkLAADfOqNJZe2 hgkAGIxCaBAAImhhDp/gwr1JcgQv6GneiFoubDLdBIgMAaksyQUrHDULLlSLFFr/4EWsIRIFWmDS ln4SJ4srg4oqUEEhmthFF3LxBbHe7d8gicQZa8mambM0Rdi02BZqgQoiuCIAChPFG1TNkScwfY9H fxbM3eg6WTQiB0iYwQugUNmUdIEVFG2UKg7SCDEoOABj6EUAwNCLMADA7gAQgxjCMHcxpEEJrvEK 4LV4BA3ZQAteSMMU+teKMwTgCFygwhGU8IXEVWktZgBDAL4QAAB4vu8UE0MvxHCAGwGLCbJQDUWd +QgttKKcargFFkJ7GSflAo2NiEQAeOGFARBA83cPgN4p1vnh+70V9lQKSyMzBafthAupd+kRwACD R4CBFV54Ahl08QXuuwEBuqBC/xVYp4tWiEEVZRj4Y0whADP0DqEvowImdqGKDDKhFaxoQhNYgfyL nnMxV8AKudAAA6AXX7AGbBAAteAKXpAKXqAEYjAWvKAn0YICetALK1YczkQDujAF+BcFTMB/rdAK TcAEqdAKu5AQMgAA98cESoAFDUAGWwAGDVALSaALEOgK/McKZIBhl2EKZ5ABeRAla3KCCCApLBAJ SZAFXlAtjfAIYXAQudAEtFWFM6dczhIZrKALJuEFNAERrjAGStAJuqAnOTI1yhU6GCcUQlAS3DQS W6B+zNRHLNZHTMCFZzVjCaEJnAIm1meCGMd1WiQZStALK8cSWCALZNMI7HVxBP+nSQYHavSlE1+g fn2kcY+oBGBwiDSjWQrxBD2XgYxShWzEC1OWEpEgbLyQC4TTCLVyKwpxCb1QBSuVdimSIkVABWAw V2jRBDQ1HFMjTq+BSV4QCxczU6UwAY6AB0PwTHzIMyMBA0MwC7ggZF2gC7uQC1ZABI5jE0xAC0Tg AHJwbL+BBVSQOyTBA61wC76kCzChC1rQBNbDNZIwjVugczCxC1tgBaagh0nDBF2AC1xQC5FkCv9H MzaQBaawkAxJBKIgCh/HkBI5kRRZkQx5C1/IaSnRBHEShbPgAz8ABkWgCjiASUOQBKKgBC6QCpny Vefybo0wAV0gALVQB2wgBxT/YABoAAF5wACWYAt1IFgHwAdrQAYTsABoMAtqoAcJkABkMAdUAAAV kDuqwIsaSRKwIAqaIC44gAmY0JWXYAM4MJZfOZZiiQOvcJA7gQPvZgsTEAFTEAECwAAXQAC8YAcE AIFs0AVv8ABp0ABlwABegBKq0FNXeRJRwAVDIAQtVEg7gAu4YJXWkjGpsAa8wC8fIQkbMRg+cAWe kJkbYRUw4C7PcTgEhDCGeZgloRad1G5aoCmcIpnGogmsgBM2cGUjoQSpqZor4YkhYQmlQAVawAXX uAW28AShEEi8KWk5sDdRdglfcAXQRm8h5RXqs5yYJQMQoE0JYQm7sAuPwApc/zBPpDKHr5GFLIYK YSCb2Kk6j4AniMcFSoCHEFEEWiA1i1Ken7N1rIEKvOCPIcEEZzCP7UkSnuAEgjACPcCeIoELyzJO fdFxumAFuGALtKBgssALZIAAtFAFvBAFsMALapB9YWAL5MkXsTAAw2GLXAADu0BLx4EKx5kQQ8AB DWAABFAHdYAAT+AFCqBYZuAGFoAGDqAGAOAAdKChbhAABoCka9AEZHBamuAIkxADggCgJeEK0vks rHFRxZQLvYCNvcALZMoLACAAXsALu/AFacoLX8ALaFALL3cZTdCAV/gYXMACYtA3e7MFuNCneZMK utCGkoKbh6kKtuAjRzBaTf+ACq/QC7IDEj5Qhr9ShyJ1pyHFC+IWEprQjQUqKUh2BP8SiwwwKVSA CylwAwGAS43AA2HAbfWWhXKTI60ABob6qVoTqssjEp+AFGZEZAoRBb0ANrbVTLEQBhaBq8ZjY0ew qzwxOEKgCq7QMUHAoMqaOlrQOs06cde6nNl6TTjWreI6rhW2BxEwADkgCG+wAFOgHg8wAXfgALbQ B2egAqHwALcQAQfgAJ6wAA7QCgfQAWugBnTQCw+gBRCgB3CAAHygBzdHrs5TB6KwABOQAQHACj4g BLZAAJthCgnABApABAZwCztgAL3wCqQQALswBGYwCwjQhrGQBrPAALBACa3/wAdZsAUCEARiQABj MAtEcAawwAdYkAVg4KkQyzAVUFxrdwuxUAFqUAVIygAS8AQREAdvkAVrQAG1QAdp8AYBcAV3oAB8 AAHtAgdbMAcJAAFdMAFiRgEW8AZdEACt8AZ4oAAbsAA/mgZMkLRbgwn5NBKe0IMjUQVjsJt+u2Qw QAOMi7SJW2kysAtE0HRb0IqPu2k9ck3mdrmbRm66xrmVpkSdtLk5IQqzQEZdwCnVuBa0QAqbWjOY wARb4AW7wAVaMJyrNYUZmTSiMExrMUq5gLpX4LrWQm6QB00rQQplsRRz+CtOgai9oJbG4gK0AKlM gRlZKG1OYRC1gFLW8lNa/7AUsGocqAC90qsTPXI1mgYSmBAAsrB4XnCKT8gFt3BxyxdzV4MFu8CJ ELEDPsC/J1EKAUCsXJQosHEErBAGwIYWKrAF9TuKrIGJk1EEWKALyokTQDRPnwsRLOAFpuAHUtAD YEAFtemKWGC/MacmRXc1tPCaEEEdrxAEQYAKAJCsJ7EJYgAoyGGLBsUmAUCgCqFGWOChi4gStQAa kThOsaEiFMoTuDYlubBOCZEKzscYRPAKqlAEAFAwYWCeEVwcskoZYeCEjQAzsqAIjCARrmQSVIBI YQzGj4gjR0ALdqMQrVBylbAEdZAKa0wSlLBGaRhf6kWdg6xJRxAGUYYTvf8hGazwBa1FCgOQUZHA CrYwC4RDA2BwojuMhkXoJ0XwBRkZCWDgCjg1fYT6SSNhBY1xv/mZn1zaJ4WHjghBCq4yBWkVBZ0h CswREjKAgfspiDtcUW3yyRmZCUAAwCUxKJmBCrEABrgwC70wCwsIEruAdoU8GWHcJNaRXIOsCl6w qZrQCYeoBWIgxRxhCioGx9uchgSHCreQChARC7pAv0UUCgFwXyGhC9acvde8xI+oCpfZCIQgAn6w CCyBA5TkJpKhUDAZCTIAA9jRCtPKSI30BI000U3gCia4Jsm0xBSMCgi9F6zACqpggqrQCjlyUWVH CZQgA2EQBRN90RfNSBP/XU37+XLL1CQp2AWw0AqAB0AjOIImiIIKwQIP7c1MkNEzHdMxPXIU1dGb hAq1kAptoAiR8Agk0AYsISwr+sWogAto1AVD4AYeOgdVEABsUAcQ0AQCMAbRGgdLOgTvcRxK0Ado QASD+ASyQANrAAEB0Atn8AFdwAF8UAt+wAZE4DEK0ghWMAVEIABwUABHEAdMAAdygAW3oAakUApu 4AZnUAqy4MGRwQQYoAcH8H6k4kyYkK1TYAciSgHZ+KC1t4n4YnFOUQpeEAEGoFU4ZQqdPUVnQwSr mhmmQAYYUAEGzDJusBNKkAsnOjeoYAWEogum8ABqgAhz0AGl7QYGgAd5/8ABDpAGdxBncm2JQ1AG a4DX4+QKVuBeDjAHbyAGVBAHFQAHbbA9WpAKlYcQVRALTGABYQACe1AHfcAHDaABGpABc2AAetAG ckAEs2BxkcF+GODU1oEKupADtwA2CjABbGAG5iELWYQKW4B7njaddgAAgHABd/Cuk9UAcQA3QREA UQIssjALIGAF0wkbHMATMAAGsfB+pVIFXtcIt1ChYBYASh4AYcB3AiAAYjAGASAAYTAAA6BxmAFA vyOqrxAJogSZYA7mWwAl9NkIptAFt5sGSk7lnhcGTw53bu7mBnB1tTcFVlDjMJaCT6ALYR7mWhAA VqAL14YQt8ApZaDmd/8nBsUn5WMQ5WNg5QTg1MJDC0wAq6uxqLLME/ZZRmEwBVRQxK44BSzAC+kl N/fbRpWKW7Y2EgMQuAkBAwjwCFNQBc3yxpf4iKkQC0RFElJHdQoBA5LDzfXWJJlh66+BCrtAxndB Cs6mEERw5Dzgzs+dSUqsw24k1X3LEh2cBPvrBWdo7VYDKFrXyvuNE/apJ23yyjKnKEFRC9luLEow ABChC0cOYq4AYKjeUusMGYJCOiwhCbwQC7ugmdUROqdOyJFxUjvBBPcZqyIlUlJtjEjjiZ8QBiuW 7n/SygWXYb0w6DXxigmBC6vMyawsN4Xn6jrRCQGwTDxsi4yCTTbcM77/2QgCv+OwUal0mGmzwBIq cIggnxCXAABPUOqUgfPQ7QphsLtXAQuUtO/FNhu5sPM0QwOi0FObEpkcMQQAkHo+gql7VASxEEcs oQtyigpPIAa2sVGwqBDPpQtO4sUxqgpcsAWnuexgMAthc6mlAvYKXDN7PgRBIARVwIUz379X8AUO OnKUkwqsMAVaYBhArBKwEAW8AAqjMACmwIXmmOkQoQI3uAtX4Aqq8BV70QS0IGSscMEMswOH76Am OCpK4PhfYAt3VDM0wAulAAeKMAFEYAtwJVco8QiLQwm3WhMMZ01EgIONgAuYnRIuIAMyoHDN8wiU YAnVlzoQ5RSmQAum/7EDAhAA1noXm8AD5E/+m/DsU9gJ5p8D41/+7v/+5O8J8M8DyNutPPAKsb+P /Kd/8zOCTRDUANGqSatWUSg1QphQ4UKGDRHiOOJQ4kSKjY7kqJhR40aOHTm2ctFIRSMZEh8xFFLK Y0Ucqhop0QXgCwE0vBIkkABAjRoGMkg9INOmQIE2Y9iciTBnzJk1c8iEESMGQqhGqjCuxJpVK9ZW MBph+BDEwoM4XeTMYfDgAAIHSO0IaERK5VaGOJIgLHUph61PRGahUmLqk6onjXzQSpKDB6opP2aJ ioKDx5Enoph4qlXEiqZGiel+Bh26EchGISldwuFC0w5Lj1iwkBRJhf8KHpEapRT98O4RNV5gN6KE JRKPKJYQRmLh4gcPFiKba/ScW/r0ijyetGKlRAnBVkyqVGHCneDA8E9K5rbbCAsCNwwq5LlioIuE NGbK1MFFBsMbNxUUqInjuYqio65AAxWapRctdtGlpE5w0eKqAxVKb0KECLQww89Y+KKUClrQY4gu dshhCy0407CRlhqxRQ4IdnkgDAcAqMUBMAjYhQEHcDmAgCvcIIONMdL4YgwGxihAjQIWOEghDFOE 0iMVeEnCFFKIKGIXTTSBEEUN0+uEl1d4sEWIHEzhAhYmruhkiyOOuGKKXKZQJRYBDvjElBw+USIW U7A4L6EnoyR0o1b/vuCCl1qa26FLKGHQ4gpaJqW00kqtmNQKTCedRVNKN9200lyaLLTUrHYw0UtT V2W11YRQPdEhUnDhBRdZXFFCFSWYeIUWLr6wohNXhyV2pTZjTeiRK75ooogknn02lSRUgfbZI1Ch Ioy7iuW2W4YAwOKWXRDCJIwoUElC2nSjVTcVd9OV1t0istDCW3tLtSSLhlS5IguVdJEFXVXUrXZd eAuGVpUidGnlXoc1lOGMVxoCIBcXAIgX2nYRfvfgdd09IopcHibZQBp0yaKIhlgAY+NqOza4Y4Jf TuWVWzKqJYCSd5bIh16yeGKgVFDxQtiFsnglFWqfXbrgpg1m+mVr/28xRUUfPME6a6x5uMUWXXiO ksMDyhACKxkCUMLdjY/oRZJGSqkClloU2OULMHjZpYteeuGll7u7sDuMJ9SW9ghTPo42XSW2aEQX U1BBpQjJIy8i8iNU6eUkhIRYQRM0RCHiBxdcsOSSVGxoRRMDqvBECUlskEGJH4JAxRRe1uBMVbB9 OOUANma4xKMfeDGFWnefVsKLRrJAZQE/xOhDjy8KyQONN7wIQRWx2uBDFVxsOaLaDEQ4fOZpj+ji El3aZd/4JFgBI6EjytjlhAnoUMCBKw5wQxY3MFlABMxAhlIkIAJ9qMIdeqEJNiSgF1cIgcrAlpBP GAEWpljCFzqCif8vOItd7KqZvrRwBDBcoQILSMADEGCHOKwBAVZoQBPS4Ao3KKFr6CqcLPTgrIyp 6wi6oEEXKgc5IlbuWqlgAi8qMpKECEgkEwEDLSa4EBUgZyVbaIX5EseKcZHEE50YQgFk0alZVIGM VphFGjVlBVkowWOp8CDCksCEeuHgalrTWhZuUa8pPowHXEDFuy53hT2eqxchWYgsqBA+tckRXi7T WLzehYpc/KAitVBiHx9GhUUm4Qiv+ILbGgEDLnRBQp/4geZ2wYqDZYxmH5Saxo5ghVho0pYLuUUT 0uUKfSWEEgwo2yUEUIRbgIEUYhCWF1wBM401M3GOTEIRbDGFW1b/EyG4YEIqZtmwJm4CIVhghRcg oQMzJGFkjXCF4yKJOIKZ713uCoDRrHlLbHpyFtxkyCUCwIRSkEIVAdiBQq6Qi0BK0p3tlBZgwCDB eVYTF63wpBXw2RAV7KATTlRIKHiRhSSgInzP7NgRitCKXWiBBg1t6EMjOtGsPKIUWfBCF25xhVnQ 4gq42MUuqvAJlPa0EQ/VpkR9OlQLqXSWTCBqUgtUz20q1am5MapQnzpVuugiFkHTQmGoulWudtWr X4VSHmyRhCGkwhWkMMMTUCGAT1QBDJ/ghS0QMgsz+M91TPDAK7rAi0+EAQBiYIUpysCKD0whC1zA KFgfhodZmEIUPn94Axuo8AU/CIAAX7hDAgbwhy++oQsRSAMEthABNRhADnpogC0MoAQI2EEBqF1A HRKACsU6tQ0isEFtnRoQADs= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/math/kgr.gif R0lGODlhBwAGAMIAAAAAACQkJElJSW1tbZKSkra2ttvb2////yH5BAEAAAcALAAAAAAHAAYAQAMX eCUaM+EYcGJwJx8xSiHEZBRUMRCZECUAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/math/agr.gif R0lGODlhCAAGAMIAAAAAACQkJElJSW1tbZKSkra2ttvb2////yH5BAEAAAcALAAAAAAIAAYAQAMZ eEchaoIcQ8AcboKhAieCEQDFQ16eMQRHAgA7 ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://bja.oxfordjournals.org/portal_imgs/search_result.gif R0lGODdhOwBQAPZMAABatJTF5ou95s3m9rTV7nu95nO03v///4vF5s3m/0qUzXO05nOs3iB7xZS9 5qzV7pzF5mqs3tXm/4O95lqk1VKk1WKs3lKc1WKk3jmLzRBzvcXm9qTN7pzN7t72/+7//ymDxSmD zVqk3pzF7u72/97u/xB7vSCDxZTF7kGUzQBitHu03kGU1SB7zUqc1Rh7xTmUzdXu/0Gc1RBzxTGL zTmL1Xu05iCDzQhzvfb//ymLzTGL1TmU1RiDxVqc1eb2/wBzvRB7xTGUzb3e9ghzxUqU1TGDzQBq tABqvQhqvQBivbTV9gAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACwA AAAAOwBQAAAH/oBIgoOEhYaHiIdHEweNjo+PiZKTlIJJD5CZjYc4L0EzL6AzlaSCR0lLBx8/qwc/ OZGHQEBItLSlpUcaQ6skP74xsbjDk0czAzkeHx/KwZvE0IlHLxLLJDkfOc6IRyoqR+CD3d+E4dFH DSWrq6/PhjQUF/IZSEdIKRQU9IMiOvbnIH4IFPjBXSFqP4ykePBAAxIaH0qcMPXiAAcV0QSpoOGL hDqDhFSMKIFERUUD3zZc1HhhyA+HGUtmWEcC5CCRJAX9uHhEJUZBNlIcKPIvo4oU2AoeQCQyhswc RHuuPHLCgJIYI37GVOECm02NKEiIWPEDA0apZy8UASDgB46Y/jd9OGI68oQRATFSgPNZLwAHBwQO wCi6FcPXkiPrqXjgFi2SFxMaNDjxA4FWuCoiLD2EU6NmGip8HnFx4ZsKCCXewhV3gS7JbiMOvECr osDsekJpEIa7e9CJGDkuZGBQgsLeixdKgBjk4sCDF6sphVDrQkGR21KVpLgA4l+GItyjFwNHvugA DhoLdSNvShz7euJvBslhYwYGGjBo0KjxgkcIHTSEQEMDIWTQXwg3hBCCCxn8p4NqMR2RQQRLlBCK CzxkCAMMN8DAggswuOBCAzzo8EIKMrjAgocMhgjdajhc4MMM9twS32rsBcECDQDqR8MNPv4oII9C 8HjDjZLg/qDkkjgAweSTTCIpDXvlvWfPlfC9JyUSOATRpCCdAOEll7SYwOUgQGjwgidbgskCDyzI wMMNLgSRAQsfuoAgEXCq+OMFLrTQpiCzLEkIk07WQsQLTTZp46DD9AbppHA5+agtEBZ6JqWmBJGh DifQcAIPQgAJAw8/3sBDDTJMxCmYjjaqQaFKzuKkkq/mquuuvPbq66/ABitsrjYWa4ituprQIQw7 7AggqafuACR+N6RAw5yvWmrrtrPU4u22lBJxQ4M6mKifgDeY+N8JCvYg6qudhLAmEUF4suYN9dq7 5glBcArECyfcMEMQBBNsAsFKrqkkwpzikC4IJwgBoA4w/kz8wpDyCvgip+a0N+zHIIcs8sgkl2zy ya9KCvILjw7b4UMLsICEDjV8fIILOrggggg0uEDDxz2U+KEIGVRs8wUsWLBABynKPOwLIiTtAgpS S/KPyvHhoAMPpLlggc80zJYomFyOGcQtOMwKoaOEtlzJCzuygO8LG3KIhI4ZOqsfzioKkR/FKnLY IJ59vslCv5V4KoSKQdAgQ8861NLlwUumqeTAJtw6ww2MNnlwEBoQTK/biPApRKsX/Ed3D4S1nguV WB+yYwUshIAqj9gpEns5M4hw2zANVKxDAxnoGPk0LKTA9bg0rKgf6UjMEKQFCUyA7jAAwiAChjSo 1snWK/m92byJiQAxw5InIMCCobmcwPOaIlJCy+7qRRPEkeAEEQLK/Pfv//9tCgQAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/shared/searchall/journals/brjana.gif R0lGODlhwgEQAMQAAESP2nWs47rW8RBwzzCD1iB50u71/M7i9arM7pnC64m4597r+FWZ3WWj4C6C 1T2L2P///wBmzAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAADCARAAQAX/YCSOZGmeaKqubOu+cCzPdG3feK7vfF8DEMEIAgFEgiQBRBQoioABUeMA SUSaRqhJCWhGRRDD1XkUjo1DszJCWETXZ5JhyYS86aOBYpSA7CNaZRENCwyCTYYkAAgQC4B2aSJr QH8jBQlzBYKEhkg+n6ChoqOkPkBmTVZsBGwDEQVGA31ogJqvsWcDAK5bZGy7irwFrBG6AwPEw2y2 IrC8cSW6xCJUJwpABs/LgNoEtCMAzMauXpEE0yLnigW86unfpfHy8/T19jm2CxDM9/3+/wADChwI o8mBLo3QkVBgwNaxZgYqkcCSooC+L/EosmgA4dgBbVTg9WDmKcaBAwRT/6pcuRKIGwUHEthqFKDB nTpotEBAoMlQOY4YR3ApYABBOj/QPDVBsMhVI1cLxBDgFRXnQgjEEDSMAIcEgygcUT7Z+YosmgJk 0RqCIuBghLWQwCyAKibCgj9BAhho8BaMkLNkWQoeTNhHAUZ+9Apg1cRAzjlRiB4I8KDPgQICmC4u QEWmZX5cnbQJAODAH6JFORpgwLkKr8beIHNEEIAR687aYHZZwIoBZF6+E7ga0GSnA8vEwwDooyDA SSMcBQQIQPwAgwR8IxwwEOCrcgCQ2RhwEyC2TSuNlyd+Xri9+/ftCdSET7++/fv4bwHYH04FQ9Cv RGQCASGlwF9/pRDoy/8KASiAwAHodJFRSTCclN+FGLJ0iggKBLYCUyxohAIX84ioAiPNkEBUFaFM F0mGMMZo34YEGCAAOXkF4dsSACiRQAAOMBLFdIsMaYcA42kjiWhulLZHa0Y0IYSCOyIkHRVfJCCA PtmZGIFuAfAGyEWgGcVIdrL4kUBUsQiApAHENCBAaQgMcF0XAlySlxFBwBQXgddBiBkADYghZTFu GgCnjIw2+smGj9RFIRwaaYGYcHEEkkQR5YBhKBlKLehJV/LpY9UIc4xQTld8HOAmEbYEUpJ3QqQy XU3FLfYIRqMuQUBet/7aSCKzHuroscj+4Mmv2QgiFB2IjBXFHwgYRZF9ps+GY+NRe0QLqYm9hrbk qRySoZUmrA6SCBthuCKrEJ4ggZZRTwSgiV6PVBKuXXM9AYAhv7KCRLxmJGvwwaAYE40uMJD4jjYK AwODMtyoII0PBGjCsAi6OFQxOACaAAAxrmR8gskbI6zyyv8A4CCFLMcs88w012zzzTizEAIAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/shared/search/homelink.gif R0lGODlhMQAQAJECAAAAANYTNP///wAAACH5BAEAAAIALAAAAAAxABAAQAJQlI+py80BwwG0AkPn FbZj64TiSJbmiaYOlGTfC1fa5jYsUrs5TcebCgwKh0SgpPXbyWCaD0gRwSV5TY7sWXvcmLrp60pd KXYzstS5LKrXqAIAOw== ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/home/LWW.gif R0lGODlhZAAoAPcAALS0tFmnvrzc8JLKfrCwsJiYmDeayq6urjIyMpKSkszl9WpqaklJSXJycmRk ZG9vb4rII5ubm6zO7HO+Rszoq7a2to/G63BwcOsDWcvLy5zF4aurq4qKimBgYIaGhtzc3BYWFtHo 9mdnZ57RXdPsuGJiYqGhob3c7Ha+XYiIiL6+vleo0bi4uLHK5LSSbWZmZnt7e3Z2dmmu1ofMRlZW VlJSUlanxIrNRTw8PL3S7X2+5Pf7/fT6/fP7/15eXlpaWlhYWFRUVDg4OEBAQFxcXC0tLVBQUCIi Ivz8/P7+/v39/ff39+Tk5ISEhJGRkePj44CAgH19feDg4LOzs/r6+vn5+YKCgnx8fObm5ru7u/j4 +Ojo6NjY2NPT0/Hx8ZWVlY2NjfDw8Ozs7Pv7+4+Pj9HR0evr639/f5ycnGxsbHR0dM3NzY6Oju/v 756ensfHx8DAwG1tbeXl5dra2unp6fLy8qioqH5+fqamptnZ2aOjo9vb26mpqd/f33l5ebq6uu7u 7p+fn729vcbGxsLCwpeXl9XV1cjIyO3t7cPDw5aWlnV1dXh4eMTExIWFhfT09KysrKSkpKWlpdLS 0p2dnYGBgYODg/b29tbW1uLi4oyMjK2trc7OzvPz88/Pz/j8/eHh4cHBwdTU1Pr8/p7jbOfn5/P5 /dDQ0LKysvX19d7e3pCQkMnJyby8vJSUlKenp8XFxSmYt6LPlF+1W7i/jJa3W8bW40GivIrIKLDZ gCaTrsLet/j7/Wu6P4zF7JPJcs+ek0ZGRojAho/I2JLJ7JjO25zM5diamprfZ566aaTRjtGWkNiU lpfH6JDH3pDM21u4cMXgts3lv6C1ahuMwrqKbtja35HJeHO8YpXMfZ3M6pnDzGW3RG6+R2q8STWc tDidsE9PT/b7/pjLbVmxZ/r8/fn8/ujn5/7//5rgaafVVfPy8s3kwjyfuu/3+snl+InL9Y3L9YzN 8/T09ZnI6Oz09heHvecQXuEbX7iQbq7ZfiWWtyWZuvb8/4fFdP///yH5BAAAAAAALAAAAABkACgA AAj/AP8JHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTHUeFoJdDgg4B n1DKVMjrxAoZLTQYsOfM3cyfBM2dEDZOmbRo/nrNGiZOoBIlApcgQYhkSRKgGRWs+KVOHwkKIyBM APcO3b9JmJJUmSIFIRMASxguufQPiResB5vJkJWLFrNl02ag0CWv3z8/TcYsSWBIy5M2/8YwoaMk j5M6WrbcRbJli5IqWOr8A4CnTRc2gPAWzNGCHYljGDBUI5UtALwe/6KkGDMmERNIjMjs+XPlzJsw iSZ9afLFDCFGbp5UgBGhVAkEgiyBwDNVtUAJGnZR/wB2D58LZNcCxMPtiA2STj7sxCkQZQGNM18W TemQgAGaDg3AwEEWksRRyAOUNEDDIQXgUAFU3v2jgwH+jJBMPi7UcgMK/GhTzj9WuPLPJSLgwcE/ WDAwxB7/3KHJAhHY8c8XIKwikAeO/EMAG2e48c8hL0Q4kADUcAPBDKSkcwMu3XxjSxX/XBGDFE90 wEcTebDwQxB/cBGFCR2gscE/HBRRCSZykKFGH04UcgUjWGTBABNUCDmKMeRMgM0AA6DgDTTbWHPO P27U0IAdUKiwQBwwbNJAB4voYYgfG0xBaBNkOBBIKFYs4AAnrdCgxx7hcBCGkP/wUMwt+9hgQyzt PP9TzzzrJCEGLBV0IccHHTjRBSJpNPCGF1VIYUZqdJiBxQEqLCHFBm8goYUgZSDxBhx1ovpJCBb4 YgExCvBg0FX/PMHIE/+YoYalCSmRbXcFkYuqQOKYYsoOCz2yRlxUYILIvCNV0V1cSUAVhhhb0CEG E0vIMYZESHxAEBIP/1MFhP8sUcoSHyACCmRJaGZSGU5IkYQkWfyjRRYpbEBGJH8UoAoUZkREBxQL bDJQGJQ08g8seDzyzxtfOMHFGVlwQEjGTsBhEhY0EJAEGT5QIYUIJgDCARkEWMHEIY41IloSTMzx Tx97QFWGKFoIFEEHnvyQikCXQGGFEnAA0cVhHsz/sYUDBMTgtBhrZPJPG2vU2QYhXHxkhSVJOHKE HJMssAYLHBQyBRhSRCBFAQ800cgVDqThRxoOJHLAA2BgIVAXDLhhxT8QVpBGH38cQQAWC7BAQB4X oMLBJgmEAsAgiiwQhCZ9xHFGIR8NsgAnYJQQCB+BrHEFFGigsgoXQGRShiY1xPAAAJAswIoJaDgQ xxxTJWHHEEUY0sYUpzIBgx6K/KCIIh54wgMOoYZWpEEIB/DCHQKxAAAY4gd8EIIg7vKRM3TgFWUg wgPykAFLQMENAEjAHhYgiBhUogRqAAMTBuGEVBAgEqpQQwPQRQcGiOEVDmADGARChUjUIAplaAID 6QBQhQZkoAFwEMERpoCEJqDBA0xQQgfmsAEaRAEkdgABALRghCH8gxBXuAIH+HCHUzjACYvgQgNK YIU5ZMEDYsADG7Ygiho4zQxDOEUmgnGEN0DpH55AwOyggAAudOIFGRCBHirRhDQkogn06UMdasAJ RCQAByBZQw26QAU2qOEfrEgAGuKghwdUAApZcEADHNAEV4BiEAUAhAoikKAF5EEgUaDBHS7QACjI QSBPaIClJBGDMNQhClzwwx3AkAETFA0STmDCIxbBhys8QAQAy6Y2t8nNbnrzm+AMpzjHSc5ymvOc 6EznQAICADs= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.anesthesia-analgesia.org/icons/home/hw.gif R0lGODlhKAAoAMQAANSkpJUZGZMsLPHw8Keiok9PT69FRfj4+Orp6Xp3dyghIeHFxXpNTW9ubpWV lZ4NDcR6es7OzoR/f8iSkn8wMObk5LCwsLpfX4iIiNzc3GRkZLi4uKUAAPT09AAAAP///yH5BAAA AAAALAAAAAAoACgAQAX/oCaOZGmeqFas3ee+MHxsDMcBcf522YZpLd2rQrA5AjZO5MIxCF08H/AJ tdRsgdqDE6B+or8gteKg2ACS7cP77f0Qnbh8Tq/b64iIRTJlfwYWZk1+bVJiQhkSSFeLWwtUYH0x Gh4YER4KCVscFw1JOAoeGQ4eETCRh0IHEQ4OERUWDhYIbJEWG7i5uru8vbwWBBgNBalUCEU3hKiE M1cQym6SXseCa37LVBGeHIpJDgIcz0/YHuXm55hcNmbg3Ojv0cVtLj3bTRpJF38V/DnYMQVKfcCE AQmHCQ02VfgQasMAf/FqEbgCoCCXWhEJaTwVTQKGjyBDihxJcqSEBA1U0UTIwLKly5cwY8KMsIFA AmleDgwAMOHhtYxsViU4A80QMxo2JhQNQ2gAUk5LcT6hZkNAVHkyMly48C3JgQUQHo0DKiTCUA5H klgAp2+s0WyaODBQww0JDrdMqWTAAK4dOApbaOGVGuPYFQ4PtNjw8k/VBnxVDzuBRPZFAw8LMdm7 ADnch4DlFBxqbDk0QYMQ7D0KFXp0ZRcWNNDSIKGMDZubWjiQrYO0DsM2fCDpwvh1DqdzHywo86At 5bdeBrDscABBBgQHMEqBc6e7dzx6+IQAADs= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.anesthesia-analgesia.org/javascript/ajax/xmlhttprequest.js /*=0A= =0A= Cross-Browser XMLHttpRequest v1.2=0A= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=0A= =0A= Emulate Gecko 'XMLHttpRequest()' functionality in IE and Opera. Opera = requires=0A= the Sun Java Runtime Environment <http://www.java.com/>.=0A= =0A= by Andrew Gregory=0A= http://www.scss.com.au/family/andrew/webdesign/xmlhttprequest/=0A= =0A= This work is licensed under the Creative Commons Attribution License. To = view a=0A= copy of this license, visit = http://creativecommons.org/licenses/by-sa/2.5/ or=0A= send a letter to Creative Commons, 559 Nathan Abbott Way, Stanford, = California=0A= 94305, USA.=0A= =0A= Attribution: Leave my name and web address in this script intact.=0A= =0A= Not Supported in Opera=0A= ----------------------=0A= * user/password authentication=0A= * responseXML data member=0A= =0A= Not Fully Supported in Opera=0A= ----------------------------=0A= * async requests=0A= * abort()=0A= * getAllResponseHeaders(), getAllResponseHeader(header)=0A= =0A= */=0A= // IE support=0A= if (window.ActiveXObject && !window.XMLHttpRequest) {=0A= window.XMLHttpRequest =3D function() {=0A= var msxmls =3D new Array(=0A= 'Msxml2.XMLHTTP.5.0',=0A= 'Msxml2.XMLHTTP.4.0',=0A= 'Msxml2.XMLHTTP.3.0',=0A= 'Msxml2.XMLHTTP',=0A= 'Microsoft.XMLHTTP');=0A= for (var i =3D 0; i < msxmls.length; i++) {=0A= try {=0A= return new ActiveXObject(msxmls[i]);=0A= } catch (e) {=0A= }=0A= }=0A= return null;=0A= };=0A= }=0A= // Gecko support=0A= /* ;-) */=0A= // Opera support=0A= if (window.opera && !window.XMLHttpRequest) {=0A= window.XMLHttpRequest =3D function() {=0A= this.readyState =3D 0; // = 0=3Duninitialized,1=3Dloading,2=3Dloaded,3=3Dinteractive,4=3Dcomplete=0A= this.status =3D 0; // HTTP status codes=0A= this.statusText =3D '';=0A= this._headers =3D [];=0A= this._aborted =3D false;=0A= this._async =3D true;=0A= this._defaultCharset =3D 'ISO-8859-1';=0A= this._getCharset =3D function() {=0A= var charset =3D _defaultCharset;=0A= var contentType =3D = this.getResponseHeader('Content-type').toUpperCase();=0A= val =3D contentType.indexOf('CHARSET=3D');=0A= if (val !=3D -1) {=0A= charset =3D contentType.substring(val);=0A= }=0A= val =3D charset.indexOf(';');=0A= if (val !=3D -1) {=0A= charset =3D charset.substring(0, val);=0A= }=0A= val =3D charset.indexOf(',');=0A= if (val !=3D -1) {=0A= charset =3D charset.substring(0, val);=0A= }=0A= return charset;=0A= };=0A= this.abort =3D function() {=0A= this._aborted =3D true;=0A= };=0A= this.getAllResponseHeaders =3D function() {=0A= return this.getAllResponseHeader('*');=0A= };=0A= this.getAllResponseHeader =3D function(header) {=0A= var ret =3D '';=0A= for (var i =3D 0; i < this._headers.length; i++) {=0A= if (header =3D=3D '*' || this._headers[i].h =3D=3D header) {=0A= ret +=3D this._headers[i].h + ': ' + this._headers[i].v + '\n';=0A= }=0A= }=0A= return ret;=0A= };=0A= this.getResponseHeader =3D function(header) {=0A= var ret =3D getAllResponseHeader(header);=0A= var i =3D ret.indexOf('\n');=0A= if (i !=3D -1) {=0A= ret =3D ret.substring(0, i);=0A= }=0A= return ret;=0A= };=0A= this.setRequestHeader =3D function(header, value) {=0A= this._headers[this._headers.length] =3D {h:header, v:value};=0A= };=0A= this.open =3D function(method, url, async, user, password) {=0A= this.method =3D method;=0A= this.url =3D url;=0A= this._async =3D true;=0A= this._aborted =3D false;=0A= this._headers =3D [];=0A= if (arguments.length >=3D 3) {=0A= this._async =3D async;=0A= }=0A= if (arguments.length > 3) {=0A= opera.postError('XMLHttpRequest.open() - user/password not = supported');=0A= }=0A= this.readyState =3D 1;=0A= if (this.onreadystatechange) {=0A= this.onreadystatechange();=0A= }=0A= };=0A= this.send =3D function(data) {=0A= if (!navigator.javaEnabled()) {=0A= alert("XMLHttpRequest.send() - Java must be installed and = enabled.");=0A= return;=0A= }=0A= if (this._async) {=0A= setTimeout(this._sendasync, 0, this, data);=0A= // this is not really asynchronous and won't execute until the = current=0A= // execution context ends=0A= } else {=0A= this._sendsync(data);=0A= }=0A= }=0A= this._sendasync =3D function(req, data) {=0A= if (!req._aborted) {=0A= req._sendsync(data);=0A= }=0A= };=0A= this._sendsync =3D function(data) {=0A= this.readyState =3D 2;=0A= if (this.onreadystatechange) {=0A= this.onreadystatechange();=0A= }=0A= // open connection=0A= var url =3D new java.net.URL(new = java.net.URL(window.location.href), this.url);=0A= var conn =3D url.openConnection();=0A= for (var i =3D 0; i < this._headers.length; i++) {=0A= conn.setRequestProperty(this._headers[i].h, this._headers[i].v);=0A= }=0A= this._headers =3D [];=0A= if (this.method =3D=3D 'POST') {=0A= // POST data=0A= conn.setDoOutput(true);=0A= var wr =3D new = java.io.OutputStreamWriter(conn.getOutputStream(), this._getCharset());=0A= wr.write(data);=0A= wr.flush();=0A= wr.close();=0A= }=0A= // read response headers=0A= // NOTE: the getHeaderField() methods always return nulls for me :(=0A= var gotContentEncoding =3D false;=0A= var gotContentLength =3D false;=0A= var gotContentType =3D false;=0A= var gotDate =3D false;=0A= var gotExpiration =3D false;=0A= var gotLastModified =3D false;=0A= for (var i =3D 0; ; i++) {=0A= var hdrName =3D conn.getHeaderFieldKey(i);=0A= var hdrValue =3D conn.getHeaderField(i);=0A= if (hdrName =3D=3D null && hdrValue =3D=3D null) {=0A= break;=0A= }=0A= if (hdrName !=3D null) {=0A= this._headers[this._headers.length] =3D {h:hdrName, = v:hdrValue};=0A= switch (hdrName.toLowerCase()) {=0A= case 'content-encoding': gotContentEncoding =3D true; break;=0A= case 'content-length' : gotContentLength =3D true; break;=0A= case 'content-type' : gotContentType =3D true; break;=0A= case 'date' : gotDate =3D true; break;=0A= case 'expires' : gotExpiration =3D true; break;=0A= case 'last-modified' : gotLastModified =3D true; break;=0A= }=0A= }=0A= }=0A= // try to fill in any missing header information=0A= var val;=0A= val =3D conn.getContentEncoding();=0A= if (val !=3D null && !gotContentEncoding) = this._headers[this._headers.length] =3D {h:'Content-encoding', v:val};=0A= val =3D conn.getContentLength();=0A= if (val !=3D -1 && !gotContentLength) = this._headers[this._headers.length] =3D {h:'Content-length', v:val};=0A= val =3D conn.getContentType();=0A= if (val !=3D null && !gotContentType) = this._headers[this._headers.length] =3D {h:'Content-type', v:val};=0A= val =3D conn.getDate();=0A= if (val !=3D 0 && !gotDate) this._headers[this._headers.length] = =3D {h:'Date', v:(new Date(val)).toUTCString()};=0A= val =3D conn.getExpiration();=0A= if (val !=3D 0 && !gotExpiration) = this._headers[this._headers.length] =3D {h:'Expires', v:(new = Date(val)).toUTCString()};=0A= val =3D conn.getLastModified();=0A= if (val !=3D 0 && !gotLastModified) = this._headers[this._headers.length] =3D {h:'Last-modified', v:(new = Date(val)).toUTCString()};=0A= // read response data=0A= var reqdata =3D '';=0A= var stream =3D conn.getInputStream();=0A= if (stream) {=0A= var reader =3D new java.io.BufferedReader(new = java.io.InputStreamReader(stream, this._getCharset()));=0A= var line;=0A= while ((line =3D reader.readLine()) !=3D null) {=0A= if (this.readyState =3D=3D 2) {=0A= this.readyState =3D 3;=0A= if (this.onreadystatechange) {=0A= this.onreadystatechange();=0A= }=0A= }=0A= reqdata +=3D line + '\n';=0A= }=0A= reader.close();=0A= this.status =3D 200;=0A= this.statusText =3D 'OK';=0A= this.responseText =3D reqdata;=0A= this.readyState =3D 4;=0A= if (this.onreadystatechange) {=0A= this.onreadystatechange();=0A= }=0A= if (this.onload) {=0A= this.onload();=0A= }=0A= } else {=0A= // error=0A= this.status =3D 404;=0A= this.statusText =3D 'Not Found';=0A= this.responseText =3D '';=0A= this.readyState =3D 4;=0A= if (this.onreadystatechange) {=0A= this.onreadystatechange();=0A= }=0A= if (this.onerror) {=0A= this.onerror();=0A= }=0A= }=0A= };=0A= };=0A= }=0A= // ActiveXObject emulation=0A= if (!window.ActiveXObject && window.XMLHttpRequest) {=0A= window.ActiveXObject =3D function(type) {=0A= switch (type.toLowerCase()) {=0A= case 'microsoft.xmlhttp':=0A= case 'msxml2.xmlhttp':=0A= case 'msxml2.xmlhttp.3.0':=0A= case 'msxml2.xmlhttp.4.0':=0A= case 'msxml2.xmlhttp.5.0':=0A= return new XMLHttpRequest();=0A= }=0A= return null;=0A= };=0A= }=0A= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.anesthesia-analgesia.org/javascript/ajax/utility.js /************************************************************************= *****=0A= * javascript/ajax/utility.js=0A= *=0A= * Utility functions for working with XMLHttpRequest data.=0A= *=0A= * Copyright 2006 Board of Trustees of the Leland Stanford Junior = University.=0A= = *************************************************************************= ***/=0A= =0A= /*=0A= * Copy XML nodes into an HTMLElement. This effectively=0A= * clones XML markup which uses XHTML naming conventions=0A= * into an HTML DOM.=0A= */=0A= function copy_xml_to_html(src, dst) {=0A= if (src.nodeType =3D=3D 1) { /* Node.ELEMENT_NODE */=0A= var e =3D document.createElement(src.nodeName);=0A= for (var i =3D 0; i < src.childNodes.length; i++) {=0A= copy_xml_to_html(src.childNodes[i], e);=0A= }=0A= for (var i =3D 0; i < src.attributes.length; i++) {=0A= var n =3D src.attributes[i].name;=0A= var v =3D unescape_xml_string(src.attributes[i].value); =0A= e.setAttribute(n, v);=0A= if (n =3D=3D "class") {=0A= e.className =3D v;=0A= }=0A= else if (n =3D=3D "style") {=0A= set_css_style(v, e, "");=0A= }=0A= }=0A= dst.appendChild(e);=0A= }=0A= else if (src.nodeType =3D=3D 3) { /* Node.TEXT_NODE */=0A= dst.appendChild(document.createTextNode(src.nodeValue));=0A= }=0A= }=0A= =0A= /* =0A= * It is unclear that this is the right thing to be calling=0A= * from copy_xml_to_html, but it appears that Safari decides=0A= * to convert &amp; to the NCR &#35;, and then encodes that=0A= * NCR to &%26%2338;. So, I'm going to treat the DOM Attr=0A= * value as a plain string, and run our XML string input=0A= * through the decoding routine below.=0A= */=0A= function unescape_xml_string(s) {=0A= return s.replace(/&apos;/g, "'")=0A= .replace(/&#39;/g, "'")=0A= .replace(/&quot;/g, "\"")=0A= .replace(/&#34;/g, "\"")=0A= .replace(/&gt;/g, ">")=0A= .replace(/&#62;/g, ">")=0A= .replace(/&lt;/g, "<")=0A= .replace(/&#60;/g, "<")=0A= .replace(/&amp;/g, "&")=0A= .replace(/&#38;/g, "&");=0A= }=0A= =0A= /*=0A= * Parse set of CSS rules and apply them to an element.=0A= * This is quite horrifying, but I'm unable to determine=0A= * how else to handle this with IE 6. FireFox and other=0A= * sane browsers let you simply set the style attribute=0A= * or use e.style.setProperty(rule, value, priority),=0A= * IE 6 appears to have neither of these capabilities..=0A= */=0A= function set_css_style(css, e, priority) {=0A= var rules =3D css.split(";");=0A= for (var i =3D 0; i < rules.length; i++) {=0A= var nvpair =3D rules[i].split(":");=0A= if (nvpair.length =3D=3D 2) {=0A= try {=0A= var name =3D nvpair[0]; /* style attribute */=0A= var value =3D nvpair[1]; /* attribute value */=0A= =0A= /*=0A= * For each possible style attribute, set the=0A= * appropriate style property in the element.=0A= */=0A= if (name =3D=3D "background") {=0A= e.style.background =3D value;=0A= }=0A= else if (name =3D=3D "background-attachment") {=0A= e.style.backgroundAttachment =3D value;=0A= }=0A= else if (name =3D=3D "background-color") {=0A= e.style.backgroundColor =3D value;=0A= }=0A= else if (name =3D=3D "background-image") {=0A= e.style.backgroundImage =3D value;=0A= }=0A= else if (name =3D=3D "background-position") {=0A= e.style.backgroundPosition =3D value;=0A= }=0A= else if (name =3D=3D "background-position-x") {=0A= e.style.backgroundPositionX =3D value;=0A= }=0A= else if (name =3D=3D "background-position-y") {=0A= e.style.backgroundPositionY =3D value;=0A= }=0A= else if (name =3D=3D "background-repeat") {=0A= e.style.backgroundRepeat =3D value;=0A= }=0A= else if (name =3D=3D "behavior") {=0A= e.style.behavior =3D value;=0A= }=0A= else if (name =3D=3D "border") {=0A= e.style.border =3D value;=0A= }=0A= else if (name =3D=3D "border-bottom") {=0A= e.style.borderBottom =3D value;=0A= }=0A= else if (name =3D=3D "border-bottom-color") {=0A= e.style.borderBottomColor =3D value;=0A= }=0A= else if (name =3D=3D "border-bottom-style") {=0A= e.style.borderBottomStyle =3D value;=0A= }=0A= else if (name =3D=3D "border-bottom-width") {=0A= e.style.borderBottomWidth =3D value;=0A= }=0A= else if (name =3D=3D "border-collapse") {=0A= e.style.borderCollapse =3D value;=0A= }=0A= else if (name =3D=3D "border-color") {=0A= e.style.borderColor =3D value;=0A= }=0A= else if (name =3D=3D "border-left") {=0A= e.style.borderLeft =3D value;=0A= }=0A= else if (name =3D=3D "border-left-color") {=0A= e.style.borderLeftColor =3D value;=0A= }=0A= else if (name =3D=3D "border-left-style") {=0A= e.style.borderLeftStyle =3D value;=0A= }=0A= else if (name =3D=3D "border-left-width") {=0A= e.style.borderLeftWidth =3D value;=0A= }=0A= else if (name =3D=3D "border-right") {=0A= e.style.borderRight =3D value;=0A= }=0A= else if (name =3D=3D "border-right-color") {=0A= e.style.borderRightColor =3D value;=0A= }=0A= else if (name =3D=3D "border-right-style") {=0A= e.style.borderRightStyle =3D value;=0A= }=0A= else if (name =3D=3D "border-right-width") {=0A= e.style.borderRightWidth =3D value;=0A= }=0A= else if (name =3D=3D "border-style") {=0A= e.style.borderStyle =3D value;=0A= }=0A= else if (name =3D=3D "border-top") {=0A= e.style.borderTop =3D value;=0A= }=0A= else if (name =3D=3D "border-top-color") {=0A= e.style.borderTopColor =3D value;=0A= }=0A= else if (name =3D=3D "border-top-style") {=0A= e.style.borderTopStyle =3D value;=0A= }=0A= else if (name =3D=3D "border-top-width") {=0A= e.style.borderTopWidth =3D value;=0A= }=0A= else if (name =3D=3D "border-width") {=0A= e.style.borderWidth =3D value;=0A= }=0A= else if (name =3D=3D "bottom") {=0A= e.style.bottom =3D value;=0A= }=0A= else if (name =3D=3D "clear") {=0A= e.style.clear =3D value;=0A= }=0A= else if (name =3D=3D "clip") {=0A= e.style.clip =3D value;=0A= }=0A= else if (name =3D=3D "color") {=0A= e.style.color =3D value;=0A= }=0A= else if (name =3D=3D "cssText") {=0A= e.style.Sets =3D value;=0A= }=0A= else if (name =3D=3D "cursor") {=0A= e.style.cursor =3D value;=0A= }=0A= else if (name =3D=3D "direction") {=0A= e.style.direction =3D value;=0A= }=0A= else if (name =3D=3D "display") {=0A= e.style.display =3D value;=0A= }=0A= else if (name =3D=3D "font") {=0A= e.style.font =3D value;=0A= }=0A= else if (name =3D=3D "font-family") {=0A= e.style.fontFamily =3D value;=0A= }=0A= else if (name =3D=3D "font-size") {=0A= e.style.fontSize =3D value;=0A= }=0A= else if (name =3D=3D "font-style") {=0A= e.style.fontStyle =3D value;=0A= }=0A= else if (name =3D=3D "font-variant") {=0A= e.style.fontVariant =3D value;=0A= }=0A= else if (name =3D=3D "font-weight") {=0A= e.style.fontWeight =3D value;=0A= }=0A= else if (name =3D=3D "height") {=0A= e.style.height =3D value;=0A= }=0A= else if (name =3D=3D "ime-mode") {=0A= e.style.imeMode =3D value;=0A= }=0A= else if (name =3D=3D "layout-flow") {=0A= e.style.layoutFlow =3D value;=0A= }=0A= else if (name =3D=3D "layout-grid") {=0A= e.style.layoutGrid =3D value;=0A= }=0A= else if (name =3D=3D "layout-grid-char") {=0A= e.style.layoutGridChar =3D value;=0A= }=0A= else if (name =3D=3D "layout-grid-line") {=0A= e.style.layoutGridLine =3D value;=0A= }=0A= else if (name =3D=3D "layout-grid-mode") {=0A= e.style.layoutGridMode =3D value;=0A= }=0A= else if (name =3D=3D "layout-grid-type") {=0A= e.style.layoutGridType =3D value;=0A= }=0A= else if (name =3D=3D "left") {=0A= e.style.left =3D value;=0A= }=0A= else if (name =3D=3D "letter-spacing") {=0A= e.style.letterSpacing =3D value;=0A= }=0A= else if (name =3D=3D "line-break") {=0A= e.style.lineBreak =3D value;=0A= }=0A= else if (name =3D=3D "line-height") {=0A= e.style.lineHeight =3D value;=0A= }=0A= else if (name =3D=3D "list-style") {=0A= e.style.listStyle =3D value;=0A= }=0A= else if (name =3D=3D "list-style-image") {=0A= e.style.listStyleImage =3D value;=0A= }=0A= else if (name =3D=3D "list-style-position") {=0A= e.style.listStylePosition =3D value;=0A= }=0A= else if (name =3D=3D "list-style-type") {=0A= e.style.listStyleType =3D value;=0A= }=0A= else if (name =3D=3D "margin") {=0A= e.style.margin =3D value;=0A= }=0A= else if (name =3D=3D "margin-bottom") {=0A= e.style.marginBottom =3D value;=0A= }=0A= else if (name =3D=3D "margin-left") {=0A= e.style.marginLeft =3D value;=0A= }=0A= else if (name =3D=3D "margin-right") {=0A= e.style.marginRight =3D value;=0A= }=0A= else if (name =3D=3D "margin-top") {=0A= e.style.marginTop =3D value;=0A= }=0A= else if (name =3D=3D "min-height") {=0A= e.style.minHeight =3D value;=0A= }=0A= else if (name =3D=3D "overflow") {=0A= e.style.overflow =3D value;=0A= }=0A= else if (name =3D=3D "overflow-x") {=0A= e.style.overflowX =3D value;=0A= }=0A= else if (name =3D=3D "overflow-y") {=0A= e.style.overflowY =3D value;=0A= }=0A= else if (name =3D=3D "padding") {=0A= e.style.padding =3D value;=0A= }=0A= else if (name =3D=3D "padding-bottom") {=0A= e.style.paddingBottom =3D value;=0A= }=0A= else if (name =3D=3D "padding-left") {=0A= e.style.paddingLeft =3D value;=0A= }=0A= else if (name =3D=3D "padding-right") {=0A= e.style.paddingRight =3D value;=0A= }=0A= else if (name =3D=3D "padding-top") {=0A= e.style.paddingTop =3D value;=0A= }=0A= else if (name =3D=3D "page-break-after") {=0A= e.style.pageBreakAfter =3D value;=0A= }=0A= else if (name =3D=3D "page-break-before") {=0A= e.style.pageBreakBefore =3D value;=0A= }=0A= else if (name =3D=3D "pixelBottom") {=0A= e.style.pixelBottom =3D value;=0A= }=0A= else if (name =3D=3D "pixelHeight") {=0A= e.style.pixelHeight =3D value;=0A= }=0A= else if (name =3D=3D "pixelLeft") {=0A= e.style.pixelLeft =3D value;=0A= }=0A= else if (name =3D=3D "pixelRight") {=0A= e.style.pixelRight =3D value;=0A= }=0A= else if (name =3D=3D "pixelTop") {=0A= e.style.pixelTop =3D value;=0A= }=0A= else if (name =3D=3D "pixelWidth") {=0A= e.style.pixelWidth =3D value;=0A= }=0A= else if (name =3D=3D "posBottom") {=0A= e.style.posBottom =3D value;=0A= }=0A= else if (name =3D=3D "posHeight") {=0A= e.style.posHeight =3D value;=0A= }=0A= else if (name =3D=3D "position") {=0A= e.style.position =3D value;=0A= }=0A= else if (name =3D=3D "posLeft") {=0A= e.style.posLeft =3D value;=0A= }=0A= else if (name =3D=3D "posRight") {=0A= e.style.posRight =3D value;=0A= }=0A= else if (name =3D=3D "posTop") {=0A= e.style.posTop =3D value;=0A= }=0A= else if (name =3D=3D "posWidth") {=0A= e.style.posWidth =3D value;=0A= }=0A= else if (name =3D=3D "right") {=0A= e.style.right =3D value;=0A= }=0A= else if (name =3D=3D "ruby-align") {=0A= e.style.rubyAlign =3D value;=0A= }=0A= else if (name =3D=3D "ruby-overhang") {=0A= e.style.rubyOverhang =3D value;=0A= }=0A= else if (name =3D=3D "ruby-position") {=0A= e.style.rubyPosition =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-3dlight-color") {=0A= e.style.scrollbar3dLightColor =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-arrow-color") {=0A= e.style.scrollbarArrowColor =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-base-color") {=0A= e.style.scrollbarBaseColor =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-darkshadow-color") {=0A= e.style.scrollbarDarkShadowColor =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-face-color") {=0A= e.style.scrollbarFaceColor =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-highlight-color") {=0A= e.style.scrollbarHighlightColor =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-shadow-color") {=0A= e.style.scrollbarShadowColor =3D value;=0A= }=0A= else if (name =3D=3D "scrollbar-track-color") {=0A= e.style.scrollbarTrackColor =3D value;=0A= }=0A= else if (name =3D=3D "float") {=0A= e.style.styleFloat =3D value;=0A= }=0A= else if (name =3D=3D "table-layout") {=0A= e.style.tableLayout =3D value;=0A= }=0A= else if (name =3D=3D "text-align") {=0A= e.style.textAlign =3D value;=0A= }=0A= else if (name =3D=3D "text-align-last") {=0A= e.style.textAlignLast =3D value;=0A= }=0A= else if (name =3D=3D "text-autospace") {=0A= e.style.textAutospace =3D value;=0A= }=0A= else if (name =3D=3D "text-decoration") {=0A= e.style.textDecoration =3D value;=0A= }=0A= else if (name =3D=3D "textDecorationBlink") {=0A= e.style.textDecorationBlink =3D value;=0A= }=0A= else if (name =3D=3D "textDecorationLineThrough") {=0A= e.style.textDecorationLineThrough =3D value;=0A= }=0A= else if (name =3D=3D "textDecorationNone") {=0A= e.style.textDecorationNone =3D value;=0A= }=0A= else if (name =3D=3D "textDecorationOverline") {=0A= e.style.textDecorationOverline =3D value;=0A= }=0A= else if (name =3D=3D "textDecorationUnderline") {=0A= e.style.textDecorationUnderline =3D value;=0A= }=0A= else if (name =3D=3D "text-indent") {=0A= e.style.textIndent =3D value;=0A= }=0A= else if (name =3D=3D "text-justify") {=0A= e.style.textJustify =3D value;=0A= }=0A= else if (name =3D=3D "text-kashida-space") {=0A= e.style.textKashidaSpace =3D value;=0A= }=0A= else if (name =3D=3D "text-overflow") {=0A= e.style.textOverflow =3D value;=0A= }=0A= else if (name =3D=3D "text-transform") {=0A= e.style.textTransform =3D value;=0A= }=0A= else if (name =3D=3D "text-underline-position") {=0A= e.style.textUnderlinePosition =3D value;=0A= }=0A= else if (name =3D=3D "top") {=0A= e.style.top =3D value;=0A= }=0A= else if (name =3D=3D "unicode-bidi") {=0A= e.style.unicodeBidi =3D value;=0A= }=0A= else if (name =3D=3D "vertical-align") {=0A= e.style.verticalAlign =3D value;=0A= }=0A= else if (name =3D=3D "visibility") {=0A= e.style.visibility =3D value;=0A= }=0A= else if (name =3D=3D "white-space") {=0A= e.style.whiteSpace =3D value;=0A= }=0A= else if (name =3D=3D "width") {=0A= e.style.width =3D value;=0A= }=0A= else if (name =3D=3D "word-break") {=0A= e.style.wordBreak =3D value;=0A= }=0A= else if (name =3D=3D "word-spacing") {=0A= e.style.wordSpacing =3D value;=0A= }=0A= else if (name =3D=3D "word-wrap") {=0A= e.style.wordWrap =3D value;=0A= }=0A= else if (name =3D=3D "writing-mode") {=0A= e.style.writingMode =3D value;=0A= }=0A= else if (name =3D=3D "z-index") {=0A= e.style.zIndex =3D value;=0A= }=0A= else if (name =3D=3D "zoom") {=0A= e.style.zoom =3D value;=0A= }=0A= }=0A= catch (e) {=0A= /* ignore error on attempt to set e.style.[property] */=0A= }=0A= }=0A= }=0A= }=0A= ------=_NextPart_000_0000_01C7D60C.CBB8DC70 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.anesthesia-analgesia.org/javascript/entrez/callback.js /************************************************************************= *****=0A= * javascript/entrez/callback.js=0A= *=0A= * Entrez Linking callback to populate content box.=0A= *=0A= * Copyright 2006 Board of Trustees of the Leland Stanford Junior = University.=0A= = *************************************************************************= ***/=0A= =0A= /*=0A= * Execute callback to fill content box with Entrez Linking information.=0A= */=0A= function entrez_callback(pmid, callback_url) {=0A= /*=0A= * MSIE 5.5 and below have issues with the JavaScript=0A= * used for Entrez Linking. For now we have to disable=0A= * the callback until we can track down a proper fix=0A= * (or everybody sanely upgrades to version 6 or 7!).=0A= */=0A= if (navigator) {=0A= var appname =3D navigator.appName;=0A= if (appname =3D=3D "Microsoft Internet Explorer") {=0A= var userAgent =3D navigator["userAgent"];=0A= var s =3D "MSIE ";=0A= var n =3D -1; =0A= if ((n =3D userAgent.indexOf(s)) !=3D -1) {=0A= var v =3D parseFloat(userAgent.substring(n+s.length));=0A= if (v < 6) {=0A= return;=0A= }=0A= }=0A= }=0A= }=0A= =0A= /*=0A= * Acquire table row element to update, initiate callback=0A= * to update table with Entrez Links.=0A= */=0A= var tr =3D document.getElementById('entrez_callback_'+pmid);=0A= if (!tr) {=0A= return;=0A= }=0A= var req =3D new XMLHttpRequest();=0A= if (!req) {=0A= return;=0A= }=0A= req.onreadystatechange =3D function() {=0A= if (req.readyState =3D=3D 4 && (req.status =3D=3D 200 || req.status = =3D=3D 304)) {=0A= var src =3D req.responseXML.documentElement;=0A= var dst =3D document.createDocumentFragment();=0A= for (var i =3D 0; i < src.childNodes.length; i++) {=0A= copy_xml_to_html(src.childNodes[i], dst);=0A= }=0A= var tbl =3D tr.parentNode;=0A= tbl.replaceChild(dst, tr);=0A= }=0A= }=0A= req.open('GET', callback_url, true);=0A= req.send(null);=0A= }=0A= ------=_NextPart_000_0000_01C7D60C.CBB8DC70-- ]